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The emergence of powerful software in healthcare has created conditions and 
approaches for large datasets to be collected and analyzed which has led to informed 
decision-making towards tackling health issues. Big Data Analytics (BDA) in 
Healthcare, otherwise Health Analytics, express the analysis methods of the wide 
amount of electronic data related to patient healthcare and well-being that are very 
diverse and difficult to be measured by traditional software or hardware. This PhD 
Thesis includes two parts. The first part presents a systematic review using PRISMA of 
the research activity in Big Data Analytics (BDA) in the field of health and 
demonstrates the existing knowledge. The objective of this profiling study is to discuss 
this scientific field through related examples and to inform researchers about the nature 
and magnitude of the technological innovations in health information analysis tools, its 
influence, and where and how further material could be searched. With reference to the 
resource-based view theory this Doctoral Thesis has focused on how big data resources 
are utilised to create organization and social values, discussing the classification of big 
data types related to healthcare, the associate analysis techniques, the platforms and 
tools for handling big health data and the future aspects in the field.  
In recent years a large number of mobile health applications (mHealth) have 
been developed for medical practitioners and students that use apps and other digital 
technologies as part of their practice training and education. These trends have created a 
new social context in clinical diagnosis process based on technology innovation in the 
field. Inspired by this, the Second Part of the Doctoral Thesis aims to review available 
mHealth apps addressed to medical professionals and students designed to assist in the 
diagnosis process and explore the multiple dimensions of the research subject. Based on 
three conceptual frameworks, different approaches have been taken intending to 
investigate the social dimension of the intention of integration of mHealth innovation in 
the diagnosis process, explore the ethical challenges related to their data governance and 
reliability and explain how the specific consumers’ behaviour is affected by certain app 
characteristics and attributes. A special emphasis is placed on mHealth apps that use 
artificial intelligence and a future agenda is provided for the development of new apps 
for medical professionals with the use of responsible innovative methods. To investigate 
the relationships between app quality, downloads, features and users’ ratings multiple 
linear regression statistical analysis was used. The Thesis contributes to the information 
5 
 
systems and operations management research, while empowers mobile health literature 
providing a better understanding of the matter. This study also provides a multi-layered 
analysis and aims to assist health professionals and health policy makers with a better 
understanding of how the development of an innovative data driven strategy can 
improve public health and the functioning of healthcare organizations but also how such 
a strategy creates challenges that need to be addressed in the near future to avoid 
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PART A  
BIG DATA ANALYTICS.  A SYSTEMATIC REVIEW OF THE LITERATURE   
 
CHAPTER A. 1 
1. Introduction 
  
The healthcare industry is highly data intensive and could use interactive 
dynamic big data platforms with innovative technologies and tools to advance patient 
care and services (Ali et al, 2018, Carvalho et al, 2019).  Healthcare industry manages 
every day a wide amount of data from clinical and operational information systems, 
such as Electronic Health Records (EHR) (Brooks et al, 2015) and Laboratory 
Information Library Systems (LIMS) (Groves et al, 2013).  To illustrate data volume 
magnitude, the health data explosion from 500 petabytes in 2012 (Feldman et al. 2012) 
will reach 163 zettabytes in 2025and practitioners are developing new applications in 
order to assist healthcare stakeholders to increase opportunities for a greater value 
(Groves et al, 2013).  
Business Analytics include the techniques, technologies, systems, practices, 
methodologies, and applications for the analysis of the vast amount of data and help 
organizations better understand its business, market, and make timely decisions (Chen, 
Chiang & Storey, 2012; Wamba et al. 2017; Srinivasan & Swink, 2018; de Camargo 
Fiorini et al. 2018). Big Data Analytics (BDA) in healthcare involve the methods of 
analysing this wide amount of electronic data related to patient healthcare and well-
being that are so diverse and difficult to measure by traditional software or hardware. 
There are various forms of health data such as, clinical and lab data, medical notes, 
machine generated data from medical equipment or from sensors at home monitoring, 
health services financial data, hospital bills, literature data from medical journals, social 
media posts blogs in health subjects, etc. These data may be available internally in 
health services (e.g. EHR, LIMS) or come from external sources (e.g. insurance 
companies, pharmacies, government) and could be in a structured format (e.g. tables 
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with laboratory results) or unstructured (e.g. text of medical notes in EHR) (Raghupathi 
& Raghupathi, 2013).  
The term “analytics” pulls together Management Information Systems (MIS), 
Operational Research (OR), and statistics. It describes the combination of Business 
Intelligence reporting and descriptive analysis, advanced statistical methods in data 
mining and forecasting, and other OR methods such as optimization and simulation 
(Gorman & Klimberg, 2014). OR has been benefited from big data processing and 
leveraged analytics for advanced problem solving and better decision making (Turaga, 
2018). The practice of big data via advanced modeling techniques creates great 
opportunities (Hazen et al., 2018). Analytics are categorized as descriptive, predictive 
and prescriptive. This taxonomy refers to the nature of the analysis techniques and the 
information gained. Descriptive analytics aim to identify problems and trends in 
existing processes and functions, predictive involve the use of mathematical algorithms 
to discover predictive patterns and prescriptive determine decisions based on certain 
objectives for improving performance (Wang et al., 2016). 
The term BDA includes two perspectives: big data and analytics (Wang et al., 
2016).Big data are recognised by four characteristics, the so called 4Vs: volume - due to 
the incredible size of data, velocity - due to the rapid and real-time accumulation, 
variety - due to the differentiated formats (structured, unstructured and semi-structured) 
and veracity, which refers to reliable data (Gandomi & Haider, 2015). The methods of 
BDA refer to techniques such as forecasting, optimization, simulation, and others which 
assist decision-making and provide insights to managers and policy-makers (Doumpos 
& Zopounidis, 2016; Duan et al. 2019).  
 Therefore, the term “big data” does not characterize only the volume but it also 
highlights the analytical workloads associated with some combination of data variety 
and velocity, as well as volume (Ferguson, 2012). Thus, health big data are associated 
with advanced analytics and their potential to analyze complex data to improve 
operational potential and decision making. 
As a result, IT professionals constantly develop new applications with big data 
capabilities to help healthcare stakeholders increase value. One of the most used 
computing platforms for processing big data in general but in healthcare too, is Apache 
Hadoop (De Silva, Burstein & Jelinek., 2015), a software framework that allows for the 
distributed processing of large data sets across clusters of computers which allows for 
storage, refinement and analysis of vast amount of data. To this extent, remarkable is 
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also the use of the most recently developed analytics techniques of “machine learning”, 
a data driven computational approach using algorithms that are capable to recognize 
patterns and make predictions (Gruebner et al. 2017) and “visualization”, which create 
tables, images, diagrams and other intuitive display methods to understand data (Cheng 
& Zhang, 2014). 
Organizations also develop infrastructure with big data capabilities to help 
improve manager decision-making (Groves et al., 2013). It is said that 80% of the 
growth of information and communication technology will be about cloud services, big 
data analytics, mobile technology and social media technologies (Andreu-Perez et al., 
2015). 
In parallel, the emergence of powerful software for data analytics have created 
conditions and approaches for large datasets to be analyzed and utilized for the social 
good and has improved the quality of decisions towards tackling global health issues, 
such as, disease prevention and leverage, public health surveillance, timely provision of 
essential medical services in emergency conditions. Sociologists argue that data 
collected from groups of individuals using digital databases, e.g. social media groups 
discussing health issues, make visible aspects of individuals and groups that could not 
otherwise be perceptible.  Scientists can make assumptions from a vast range of details 
derived from such diverse sources (Lupton, 2014 debating about issues raised regarding 
high public concern about big data ownership and health data privacy protection 
regulation (Mooney & Pejaver, 2018). 
The effort of the interested parties (clinicians, patients, healthcare organizations, 
researchers, etc.) to address issues in order to harness and maximize the potential of big 
data analytics in healthcare is noteworthy. It is argued that only a small part of the 
available amount of data is currently captured, stored and organized so that it can be 
processed by computers and analyzed for useful information. Therefore, healthcare 
organizations need more efficient ways to manage them (Raghupathi & Raghupathi, 
2014). 
Healthcare organizations are also facing challenges, such as reduced fee 
schemes, demands for faster turnaround times, diminished numbers of qualified 
technologists, etc. (Horowitz et al. 2005).To meet these challenges, hospitals and 
healthcare systems rely more and more on automation and management of those data 
that come from clinical and operational information systems such as Electronic Health 
Records (EHR) and Laboratory Information Management Systems (LIMS) (Ward et al. 
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2014).It is suggested that the management of healthcare data could be beneficial with 
regards to fraud detection and prevention, production of effective drugs and devices for 
patients’ well-being and improvement of public health surveillance and speed of service 
(Raghupathi & Raghupathi, 2014). 
Despite these important observations, scholars have made little progress in the 
formulation of an approach to broadly identify organizational and social values and the 
related challenges of big data analytics in health. Although the published material in the 
field of BDA in the healthcare industry has rapidly increased in recent years (Ivan & 
Velicanu, 2015), there is yet no study which shows an all-encompassing organizational 
and social impact - positive or negative - of BDA in healthcare. “Challenging the 
dominant techno-utopian approach evident in digital health discourse” has been 
characterized as critical for future research (Lupton, 2014). 
In the first part of the PhD Thesis, it has been conducted a systematic literature 
review study to map the scientific field. Therefore, text mining methods have been used 
to identify the most prominent journal articles and present the described BDA tools 
according to their specialty, the types of data they process and the capabilities they 
offer.  The theoretical framework draws upon the resource-based theory and aims to 
identify the created organizational and social values along with a special interest in the 
used data, the applied analysis techniques and the information technology innovations. 
It also aspires to fulfill the need for a deeper analysis of the “state of the art status in the 
subject field” in order to connect the technological accomplishments of BDA in 
healthcare with the achieved values and the call for future work. Lastly, it aims to 
outline a critical research agenda in order to conceptualize and explore the impact on 
health organizations and the society arising from these technological advances 
(Loebbecke & Picot, 2015). 
This paper contributes to the global literature because it attempts to classify 
basic analytic terms followed by representative results and examples. As a result of an 
increasing interest in health analytics, the synthesis of the current literature, through a 
theoretical framework and the presentation of its outcomes, is beneficial to researchers 
and the industry itself.Findings from this work will be of interest to public health 
practitioners, policy-makers, and researchers that are interested in population health 
improvement, medicine and social science as well. It will also assist organizations not to 
lose the chance to understand value creation opportunities due to the unstopped hype of 
business analytics and data science (Hindle & Vidgen, 2018). This study will allow 
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governments, groups and health policy makers to gain a better understanding of how the 
development of a data driven strategy can improve public health, reduce the incidence 
of disease and better inform the populations (Bram et al., 2015), but also how such a 
strategy creates challenges that need to be addressed in the near future to avoid societal 
malfunctions.  
To summarize the existing knowledge, this study, firstly, has recorded the 
production of articles between 2000 and 2016 and then provided an analysis of the 
publication activity, to offer unique information through targeted examples in order to 
explain the use of ‘Big Data Analytics in Healthcare”.   
The structure of the first part of the Thesis is organized as follows. The next 
section presents the followed methodology continuing with an extended theoretical 
framework with an outline of the resource-based view that describes the path to value of 
big data analytics in healthcare. Chapters 3 and 4 describe the BDA values and issues 
respectively and their organizational and social impact, presented through indicative 
research examples. The next chapter presents the future perspectives of the analysis of 
health big data and the first part of the PhD Thesis concludes with the study limitations 
and the discussion. 
CΗΑPTER A. 2 
 
2. Literature Review  
 
2.1 Previous Literature 
 
Searching in the international literature for systematic reviews in big data 
analytics in healthcare, it is notable that in the existing literature there is a lack of 
holistic bibliometric approach towards the characteristics of these publications. There is 
a number of very informative papers which profile research in the field of BDA (Chen, 
Chiang & Storey, 2012; Peng et al. 2017, etc.), however only a few focus on the use of 
big data in the health sector, such as the study of  Wamba et al. (2013), which is a 
review of 215 papers about “RFID-enabled healthcare applications” and the study of 
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West, Borland & Hammond (2014) that examines  18 articles on the issue of 
“innovative information visualization of electronic health records”. These studies are of 
limited spectrum in terms of the number of papers analysed and/or the discussed 
content.  
On the other hand, there are reviews and profiling papers in OR healthcare 
which study the use of techniques to solve complex healthcare problems (Jun et al. 
1999; Brandeau, et al. 2004; Katsaliaki & Mustafee, 2011).   
Several studies have contributed in different ways to the understanding of BDA 
in healthcare. Baro et al. (2015) and Wamba et al. (2015) are literature reviews that 
discuss the meaning of big data in healthcare. The studies of Raghupathi & Raghupathi, 
(2013) and Ward et al. (2014) provide a general overview through the analysis of 
examples in the health analytics area, concentrating in certain aspects of the field. The 
study of Zhang & Li (2017) reviewed literature for a specialized healthcare domain, in 
HIV self-management. Wang et al. (2018) identified the relationships among big data 
analytics capabilities, IT-enabled transformation practices and benefits, using the health 
sector as their case study. Jakofsky (2017), in his overview, raised concerns to 
physicians about the pitfalls of analytics reports from large metadata sets in health care. 
Although the published material in the field of BDA in health is increasing in recent 
years (Wills, 2014; Ivan &Velicanu, 2015; Thouin, Hoffman & Ford, 2008), there is no 
published work that provides both a wide bibliometric and content analysis of this 
material by categorising at the same time the applications, tools and methodologies of 
BDA in healthcare for understanding how and why these benefits are achieved over 
time. The high number of publications on the medical field makes systematic reviews 
valuable to researchers in order to keep pace with the recent developments. 
 
 
2.2. Research Framework 
 
The last decades, medical scientists rely more and more on automation and 
cooperate with IT specialists for the creation of new software solutions to manage the 
vast amount of patient and other related data. Therefore, the health sector is an 
appropriate application of the resource-based view theory for examining the value chain 
created from the analysis of the vast amount of data. “Resources”, such as data and IT 
infrastructure solutions and “activities”, such as big data analysis, are described as the 
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essential mechanisms that contribute to the value creation of organizations (Lim et al, 
2018). It is important though for an organization to recognize and understand the factors 
of data-based value creation to gain competitive advantage and to provide better 
services. The resource-based view states that firm, by acquiring valuable resources and 
synthesizing them appropriately, can create unique values/capabilities that provide their 
competitive advantage (Barney, 1991). This is the most commonly used organizational 
theory to big data research (see, Gunasekaran et al. 2017; de Camargo Fiorini et al., 
2018). The data gathered from IT infrastructure is reported as an important 
organizational resource for gaining competitive advantage (Jaklič et al. 2018; Mamonov 
& Triantoro, 2018).  
Success in business analytics depends on the firm’s ability to simultaneously 
utilize multiple resources (including data) and capabilities within a business context, 
and make decisions to deliver a valued output (Vidgen et al. 2017; Srinivasan &  Swink, 
2018; Dubey et al. 2019a,b). 
In the case of the healthcare industry, data comes from clinical and operational 
information systems. Scientists use this data to address healthcare problems (reduced 
budgets, demand for faster turnaround times, etc.) and to gain value from better decision 
making.According to the resource-based view, firms gain a competitive advantage by 
bundling resources into capabilities to create value (Gunasekaran et al. 2017). IT 
infrastructure is a major business resource for gaining long-term competitive advantage 
(Bharadwaj, 2000) along with the data gathered from IT infrastructure.  
Data resources in healthcare such as clinical, patient, pharmaceutical data, etc., 
must be appropriately processed and analyzed in order to create capabilities translated 
into business values, which are going to be thorough discussed in section 4.5. Their 
analysis is based on OR techniques, such as modeling, simulation, machine learning, 
visualization, data mining and others (Yaqoob et al., 2016; Chen & Zhang, 2014) . 
These techniques develop models which are fed with raw big data and to cope with their 
volume and their processing time utilize computing applications, such as Apache 
Hadoop. These applications allow the distributed processing of large data sets across 
clusters using simple programming models. The effective use of data analytics tools or 
models can reach organizations’ “agility” only when there is continuous cooperation of 
various bundled resources (Ghasemaghaei et al.  2017). These models are useful for 
interested parties to offer solutions for observed problems based on quantifiable 
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measures and propose alternatives which can lead to improved performance (Katsaliaki, 
Mustafee & Kumar, 2014). 
The study aims to identify the use of the big data resources and their analysis 
techniques and examine the capabilities and values that are created for the healthcare 
industry (Wamba, Anand & Carter, 2013) in parallel to the positive or negative impact 
of the same dynamics in society. These values lead to the need of further developments 
and therefore future research is essential in terms of technological and organizational 
improvements that big data analytics will bring in health. According to the above 
description, there is a summary of the research framework of BDA in health in Figure 1. 





Describing in detail the “path-to-value” of the Fig. 1, the data resources that the 
healthcare industry needs to appropriately handle in order to create big data capabilities 
are categorized according to Groves et al. (2013) in (a) clinical data, (b) patient and 
sentiment data, (c) administration and cost activity data, and (d) pharmaceutical and 
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R&D data. Yet, for the transformation of data into capabilities, the process of data 
analysis is required in-between. Based on the literature (Waller & Fawcett, 2013; Chen 
& Zhang, 2014), the techniques for the analysis of healthcare data are: modeling, 
simulation, machine learning, visualization, data mining, statistics, web mining, 
optimization, text mining, forecasting, and social network analysis techniques.  In 
healthcare organizations, the five most important BDA capabilities developed from data 
resources and appropriate analysis infrastructure are (Groves et al., 2013): (a) 
“monitoring”,  includes efficiencies (using analytical methods) describing “what is 
happening now;” (b) “prediction/simulation,” provides information about future 
outcomes (what will happen); (c) “data mining,” involves methods enabling extraction 
and categorization of knowledge (what happened); (d) “evaluation” that demonstrates 
methods for testing the performance of analytical techniques or explains the outcomes 
of the application of BDA (why did it happen?); and (e) “reporting,” includes methods 
that shape collected knowledge and provide it in an informational form.   
By analysing data related to the populations’ health, the health sector could 
develop better health services by reducing costs, producing more effective drugs and 
devices for the well-being of patients, improving public health surveillance and the 
speed of service (Raghupathi & Raghupathi, 2014). The healthcare industry is highly 
data intensive and there has been an increasing role of electronic data to understand and 
improve healthcare and healthcare analytics has the potential to create more than $300 
billion profit every year and as a result there have been significant investments in 
healthcare technologies such as mobile computing devices, patient sensors, in-home 
care devices, etc. (Kambatla et al. 2014). Clinical sciences and administration functions 
must become information-driven disciplines (Burke, 2013) in order to gain the benefits 
that other disciplines have acquired through the fast analysis of big customer data. 
Different kind of stakeholders, e.g. patients, providers, researchers, pharmaceutical 
companies, medical devices and software companies, governments and insurance 
companies have different expectations from the evolution of healthcare data analytics 
(Feldman, Martin & Skotnes, 2012). 
The resource-based view theory asserts that those capabilities create new 
organizational values, which maintain their competitive advantage. Moreover, through 
the same process, the study expands the resource-based view following the “path–to 
value” approach to also identify the positive societal impact. Therefore, this paper also 
aims to identify both the organizational values and the societal values that follow from 
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harnessing health big data analysis. Both these values lead to future research in order to 
further capitalize on these values, create new ones and overcome the challenges. 
Therefore, an additional path-to-value loop is created, and leads to changes as indicated 
by the literature. According to the above description, the resource-based view is 
summarized in an alternative “path-to-value” concept shown in the schema in Figure 1 
with regard to the societal values and challenges created and followed by the description 
of the possible future improvements in technology organizations and research, that will 
be further discussed in Chapter 4. 
 
CHAPTER A. 3 
 
3. Materials and Methods 
 
The analysis of the elements of the research framework is based on the 
information gained from the synthesis of the existing literature. For conducting this 
systematic literature review the key principles of systematic reviews (PRISMA) are 
followed.The methodology approach includes three stages: 1) Input, 2) Processing and 
3) Output stage in order to identify the articles that would be most valuable for the 
research (Figure 3). 
Stage 1 involves conducting research into the Web of Science®, a database 
containing quality impact factor journals and Scopus, one of the largest citation 
databases (Aghaei et al., 2013; Jahangirian et al, 2012; Burnham, 2006). 
 






Only papers published between 2000 and 2016 has been reviewed since the term 
“analytics” was first introduced in the late 2000 (Chen, Chiang & Storey, 2012), the 
term “business intelligence”, which are considered similar, since they both investigate 
the capabilities of analytical tools in the business processes (Chae & Olson, 2013) has 
been established after 2000 (Chuah & Wong, 2011) and the term “big data” started 
appearing in many well-cited publications even later (Davenport, 2006; Akter & 
Wamba, 2016). Therefore, for the keyword search it has been used the combination of 
the terms a) “business intelligence” b) “analytics” and c) “big data”, which are the 
keywords used in many reviews as “unified terms” (Chen, Chiang & Storey 2012; O’ 
Conell, 2013; Nie & Li, 2011; Duan &Xiong, 2015) and added the term “health*” and 
its derivatives (symbol“*”) e.g. “healthcare”, “health sector”, health records”, ‘health 
datasets”, etc. It has also been used the combination of the terms a), b) and c) with the 
term “medical” e.g. “medical records” “medical data” etc. (Iqbal et al., 2016) and the 
term “clinical”. These three terms (health, medical and clinical) are mostly used in 
scientific papers to describe the nature of the data in the healthcare domain and the 
purpose of analysis and decision-making (Huang et al., 2018; Schnitzer & Blais, 2018; 
Kim et al. 2018). To avoid bias, it is not has been used in the search more specific terms 
to describe: analytics, such as “machine learning”, or health, such as “cancer”. Thus, the 
database has been searched with the following combination of keywords which could be 
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identified in the title, abstract and/or keywords of any published item in order to 
download the maximum possible number of papers: 
“ANALYTICS” AND “HEALTH*” OR 
“BUSINESS INTELLIGENCE” AND “HEALTH*” OR 
“BIG DATA” AND “HEALTH*” 
“ANALYTICS” AND “MEDICAL” OR 
“BUSINESS INTELLIGENCE” AND “MEDICAL” OR 
“BIG DATA” AND “MEDICAL” 
ANALYTICS” AND “CLINICAL” OR 
“BUSINESS INTELLIGENCE” AND “CLINICAL” OR 
“BIG DATA” AND “CLINICAL” 
 
The articles were selected based on the following inclusion-exclusion criteria 
agreed by all authors. The dataset is comprised only of: 
(1) “articles” and “reviews” 
(2) studies written in the English language 
(3) studies relevant to the health sector 
(4) studies relevant to big data analytics 
To ensure the relevance of the retrieved articles to the term “big data” included it has 
been also followed further inclusion criteria based on the above three rules: 
a. Papers that  tested, even with the use of  a relatively small sample, the 
capabilities of a proposed new technique or technology for collecting, storing or 
harnessing a potentially big amount of healthcare data.  
b Papers that refer to biomarkers’ analysis (the detection and measurement of 
biological properties or molecules in the blood or tissue which indicate either 
normal or diseased processes in the body), even if a small sample of patients is 
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involved, due to the fact that they use a large number and variety of biological 
parameters for testing, which overall may lead to the creation of big datasets.  
c. Overviews and case study papers which are descriptive of the existence, 
benefits, and use of big data and its tools and technologies in the health sector/ 
industry.  
           Only articles and reviews written in English were included in the search, for 
capturing the full information about a specific study and in particular the results which 
are usually better presented in a full published article. As indicated in Figure 4, 6817 
records were retrieved from the initial keyword search in the two databases. After 
duplicates exclusion, the article pool ended up with 3241 papers. From the first 
screening, based on the content of the title and the abstract, 1364 out of the 3241 papers 
have been excluded as they were not deemed relevant either to the health sector or the 
field of big data analytics. Nonetheless, papers that tested, even with the use of quite a 
small sample, the capabilities of a proposed new technique or technology for collecting, 
storing or harnessing potentially big healthcare data have been included in the article 
pool. In line with this, have also been included papers that refer to biomarkers analysis 
and although a small sample of patients may be involved, they use a large number and a 
variety of biological parameters for testing, which overall lead to the creation of big 
datasets. Finally, in the dataset are included overviews and case study papers which are 
descriptive of the existence, benefits, and use of big data and their tools and 
technologies in the health sector. The broadness of the keywords and the variety of the 
subjects related to the health domain concluded to a dataset that incorporates papers 
from the areas of information technology, medical, biology, pharmacology and other 
disciplines.  
After having completed the text screening of the 1877 articles, a further number 
of 1073 papers were excluded for the same reasons, leaving 804 articles in the final 
dataset which were submitted to content analysis using text analysis software (Zhang, 
Sun, &Xie, 2015; Mittelstadt & Floridi 2016). The selection procedure took place from 
September to December 2016. 
 





The stage II of the research indicates information extraction, topic tracking and 
categorisation. In order for the information to derive from the unstructured data of these 
papers, text mining has been applied (Dinov, 2016). Some of the selected categories and 
subcategories were based on the existing literature and were enhanced with additional 
groups from the knowledge generated by reading the articles in the dataset. It must be 
acknowledged here that many of the 804 studies, during the allocation process, were 
categorized in more than one subcategory. 
 The second step also refers to the outputs of the classification process. Every 
category of this classification contains several subcategories. The particular categories 
and their sub-categories, which act as the guide to the dataset content analysis, were 
inspired by a number of prominent review and overview papers relevant to big data 
analytics in general (Wang et al. 2016; Wamba et al. 2015;  Chen & Zhang, 2014; 
Groves et al, 2013; Wallet and Facett, 2013). The content analysis and text mining 
procedure was conducted with the use of NVivo10 software (Woods et al, 2016) and 
took place from January to June 2017. After reading the full-text of each paper, the 
relevant section which signifies and explains its link to a sub-dimension was recognised 
and coded with the use of the software. From the NVivo menu, all relevant papers to a 
particular sub-dimension can be retrieved to bring up the highlighted information all at 




The descriptive statistics of this dataset are presented in a number of tables and 
graphs with regards to the sources of publication, authors, affiliations, citations and 
others. Following, there is a presentation of a co-citation analysis of references that have 
been cited in the 804 papers ofthe study in order to capture the high impact publication 
activity of the broader field. VosViewer co-citation analysis and visualization software 
(Perianes-Rodriguez et al. 2016) has been used to analyze the data retrieved from the 
ISI WoS and Scopus databases. 
Finally, Stage III of the research process presents the outputs of the 
classification process in the form of tables with article frequencies per dimension and 
indicative research examples per dimension. As the collected sample of the published 
work is large, it can be considered quite representative of the health analytics field. 
Therefore, a presentation of some proportional results of this dataset could shed some 
light on the research that has been conducted thus far in this area. 
 
CHAPTER A. 4 
 
4.  Results 
 
4.1. Bibliometric Analysis and Descriptive Results 
 
For the purposes of the research as stated above, in the below subsections there 
is a demonstration of the descriptive statistics of the publications in the dataset through 
several tables. 
 
4.1a. Years of Publication, Country of Origin, Source of Publication, 
Subject Areas and Authors’ multi-disciplinarity 
  
Figure 5 and Tables 1a-c present the publication movement per year, per 
country, per source of publication and subject areas.  
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      In Figure 5, it is notable that since 2008 there has been no or little publication 
related to BDA in healthcare. From 2009 until 2013 a bigger publication activity has 
begun and after 2014 it is observed an explosion of articles. This phenomenal growth 
has also been mentioned in other reviews (Wang et al., 2016; Baro et al.  2015; Andrew-
Perez et al. 2015 etc.). Of course, the terms of the keywords search (business 
intelligence/analytics/big data) appeared in the literature after 2000 (Chen, Chiang & 
Storey, 2012) and therefore a time-lag to the wider adoption of the terms from the 
academic community was anticipated.  
The country with the greatest number of publications in the dataset (counting the 
number of authors affiliated with that country) is the USA with 466 published articles, 
followed by China (67) and the UK (65), as indicated in Table 1a.  
Overall, the 804 papers are spread in 460 journals. Table 1b shows the ten most 
popular journals that have published the higher number of articles from the dataset. The 
“Journal of the American Medical Informatics Association (JAMIA)” is the journal with 
the biggest number of publications (31), covering articles in the areas of clinical care, 
implementation science, imaging, education, consumer & public health and policy and 
holds an Impact Factor (IF) of 3.698, as of 2016. The next journal is the “Journal of 
Biomedical Informatics” with 24 articles and IF 2.753, which includes studies in the 
area of biomedical informatics and a special issue on a field related to health analytics 
“Methods of Clinical Research Informatics” in 2014. The “PLoS ONE”, which is the 
world’s first multidisciplinary Open Access journal, comes next with 20 publications.  
“Big Data” follows with 19 publications, and even though it has only been launched in 
March 2013, it has already 1.239 IF. In the review of Wang et al. (2016), about the 
trends of Big Data in social science, the “Big Data” journal was a popular publishing 
outlet as well. The next popular journal is the “Journal of Medical Systems” (16) with 
IF 2.456, an established journal in its field which has been published since 1977. The 
majority of the first ten journals are oriented mostly towards health and medical matters 
and less towards informatics or engineering. The first OR journal that appears in the list 
is the “Health Care Management Science” with 5 articles, followed by “Interfaces” with 
3 articles and a few others each with one paper. In the future, the growth of BDA in 
healthcare may lead to the launch of more specialized journals of the field. Currently no 
OR journal has made it to the top 10. 
Table 1c presents a description of the broad medical research/subject areas (as of 
Web of Science and Scopus), covered in the investigated papers. In the general area of 
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“Medicine” all medical specialties, such as oncology, pathology, cardiology etc. are 
included. “Medicine” has gathered the majority of papers (293) followed by “Computer 
Science” (262) and Medical Informatics (124).  
The study continues with the examination of authors’ multi-disciplinarity. Due 
to the nature of the scientific field that involves different subject areas and scientists 
from different affiliations, there has been an investigation upon the level of multi-
disciplinarity of the co-authors in the selected articles. Hence, the authors’ affiliated 
departments have been investigated from the authors’ list of each paper.  It has also 
been counted the specialty/discipline of every researcher that contributed to each article. 
Only in 11% (91) of the articles the authors come from three or more research areas, in 
37.5% (302) of the articles, authors come from two disciplines, with the 72% (216 
papers) of these coming from medicine and informatics, and in 411 (51%) articles all 
authors come from only one discipline, including in this number the 51 single-authored 
papers. This discipline could be medical, informatics, business, engineering or other. In 
the dataset there are 138 papers with 2 authors, and 64 articles with more than 10 
authors. The remaining 551 articles are written by 3 to 9 authors. The most populous 
article (Allen et al, 2016) includes 101 authors who form a panel of experts on the 
evaluation of the predicting performance of Alzheimer’s disease by a computational 
crowd-sourced project.  
 





Table 1a: Top 10 most popular countries of authors’ origin 
 




Country US CN UK  AU  CA  DE IN KR  ES  IT 
 
Table 1b: Top 10 most popular journals in the dataset with publications in Health 
Analytics  
Journals N IF/2016 
Journal of the American Medical Informatics Association 31 3.698 
Journal of Biomedical Informatics 24 2.753 
PLoS ONE 20 2.806 
Big Data 19 1.239 
Journal of Medical Systems 16 2.456 
BMC Bioinformatics 14 2.448 
Healthcare financial management: journal of the Healthcare Financial Management 
Association 
11 0.000 
Health Affairs 10 4.980 
IEEE Journal of Biomedical and Health Informatics 10 3.451 
Journal of Medical Internet Research 10 5.175 
Indian Journal of Science and Technology 10 2.108 
 
 
Table 1c : Most popular subject areas 
 
 
SUBJECT AREAS N 
MEDICINE 293 
TELECOMMUNICATIONS/ COMPUTER SCIENCE 262 
MEDICAL INFORMATICS 124 
HEALTH CARE SCIENCES SERVICES 117 
ENGINEERING 81 
MATHEMATICAL COMPUTATIONAL BIOLOGY 62 
GENETICS/BIOCHEMISTRY MOLECULAR BIOLOGY 53 
BUSINESS ECONOMICS/MANAGEMENT 50 
PHARMACOLOGY/ PHARMACY 42 
BIOTECHNOLOGY APPLIED MICROBIOLOGY/IMMUNOLOGY 40 
SCIENCE/TECHNOLOGY/OTHER TOPICS 36 
INFORMATION SCIENCE LIBRARY SCIENCE 33 
CHEMISTRY 22 
RESEARCH EXPERIMENTAL MEDICINE 20 
PSYCHOLOGY/PSYCHIATRY 20 
NURSING 19 
SOCIAL SCIENCES/ OTHER TOPICS 10 
ENERGY/ENVIRONMENTAL SCIENCES/ ECOLOGY 6 
INSTRUMENTS/ INSTRUMENTATION 5 
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EDUCATION/ EDUCATIONAL RESEARCH 3 
MEDICAL ETHICS 3 
 
4.1b. Popular authors and co-cited authors, affiliations and 
departments  
 
The study continues with descriptive results about the authors’ characteristics. The 
researchers with the highest number of publications (5), in alphabetical order, are:  
 Lee, Sungyoung from the department of Computer Engineering of Kyung Hee 
University, South Korea, who is not, however, the first author in any of the 5 
papers;  
 Perer, Adam from International Business Machines (IBM), USA, who is the first 
author in one of these publications; and  
 Zhang, Yin from the School of Information and Safety Engineering of Zhongnan 
University of Economics & Law, China, who is the first author in 2 out of 5 
papers.  
In an attempt to get a broader picture of influential authors in other fields related 
to health analytics, a co-citation analysis of authors has been performed, using the 
VosViewer visualization software (Van Eck & Waltman, 2017). 21437 unique authors 
have been identified in the 26988 references of the 804 papers. Table 2 presents the five 
most frequently appeared co-cited authors.  
 Chen, M. from the Huazhong University of Science and Technology, China, 
holds the first place, as he has authored/co-authored 46 papers of the 26998 
references, followed by  
 Breinman, L. from the University of Berkeley with 43 citations and  
 Holzinger, A. from the Medical University of Graz, Austria with 36 citations.  
 





Chen, M. School of Computer Science and Technology, 
Huazhong University of Science and Technology, 
Wuhan, China 
46 







Institute for Medical Informatics, Statistics and 
Documentation, Research Unit HCI, Austrian IBM 
Watson Think Group, Medical University Graz, 
Austria 
36 
Hood, L. Institute for Systems Biology (ISB), Washington, 
USA 
32 
Schadt, EE Department of Medical Biochemistry & 




The most popular affiliations of authors stemming from the 804 papers are 
presented in Table 3.  Stanford University stands at the top with 20 articles, followed by 
Harvard University with 17 articles. These Universities excel in many fields of science 
and are ranked in the top 10 universities worldwide for at least a decade now (Times 
Higher Education – World University Rankings 2010-2019).  
 







STANFORD UNIVERSITY  20  
HARVARD UNIVERSITY  17  
MAYO CLINIC  16  
UCLA  15  
UNIVERSITY OF MICHIGAN  15  
UC SAN FRANCISCO  14  
UNIVERSITY OF NORTH CAROLINA  13  
UNIVERSITY OF PITTSBURG  13  
EMORY UNIVERSITY  12  
UNIVERSITY OF WASHINGTON  12  
 
Due to the nature of the scientific field which involves different subject areas 
such as medicine, informatics, engineering etc. (Table 1c) and scientists from different 
affiliations (Table 3), there is an investigation of the level of multidisciplinarity of the 
co-authors in the articles of the dataset. Hence, there is also a description of the authors’ 
affiliated departments from the authors’ list of each paper.  There is also a description of 
the specialties /disciplines of every researcher who contributed to each article.  
 Only in the11.32 % (91) of the articles the authors come from three or more 
research areas/disciplines (based on the name of their affiliated departments),  
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 in the 37.56% (302) of the articles, authors come from two different disciplines, 
with the 72% (216 papers) of these from medicine and informatics, and  
 in 411 (51.12%) articles all authors come from only one discipline, including in 
this number the 51 single-authored papers. This discipline could be medical, 
informatics, business, engineering or other.  
In the dataset, there are 138 papers with 2 authors, and 64 articles with more than 10 
authors. The remaining 551 articles are written by 3 to 9 authors. The most populated 
article (Allen et al, 2016) includes 101 authors who form a panel of experts on the 
evaluation of the predicting performance of Alzheimer’s disease by a computational 
crowd-sourced project. 
 
4.1c. Citation and Co-citation analysis based on the bibliographic data 
and the most popular keywords found in the 804 articles 
 
Table 4 presents the citation report of the 10 most cited articles of the dataset by 
also providing a short summary of their research. In the summary, an emphasis is given 
to the nature of the studies which is related to big data. The most cited paper out of a 
total number of 804 papers is Bates et al. (2014) with 356 total citations and 36.50 
average citations per year. It currently holds the highest scores in both categories, and 
the number of total citations considering the young age of the paper is noticeable. The 
article presents six cases of high-risk patients as examples of opportunities to reduce 
costs through the use of big data. It discusses the insights emerging from clinical 
analytics (types of data, algorithms, registries, assessment scores, monitoring devices, 
and so forth) for the healthcare organizations, which can lead to better decision making 
and the implementation of changes that will improve care while at the same time reduce 
costs. The second most highly cited article is O’Driscoll et al. (2013) with 319 citations 
and 21.33 average citations per year. It holds the second place in both score categories. 
This study provides an overview of big data technologies describing the example of the 
Apache Hadoop software and its current usage within the bioinformatics.  
 









1 Bates, D. W., Saria, S., Ohno-Machado, 
L., Shah, A., & Escobar, G. (2014). Big 
data in health care: using analytics to 
identify and manage high-risk and high-
cost patients. Health Affairs, 33(7), 
1123-1131. 
Presents six examples of high-cost patients and ways to 
reduce risk and costs through the use of big data and 
discusses the types of data needed and the infrastructure 
(e.g. wear devices that monitor in real-time 
physiological parameters and remotely send data to 
clinicians; develop machine learning algorithms to learn 
from previous experience and optimize patient 
allocation to therapies, etc.). 
356 36.60 
2 O’Driscoll, A., Daugelaite, J., & Sleator, 
R. D. (2013). ‘Big data’, Hadoop and 
cloud computing in genomics. Journal of 
biomedical informatics, 46(5), 774-781. 
An overview of cloud computing and big data 
technologies handling biology large datasets, such as 
sequencing million human genomes to understand 
biological pathways and the genomic variation of a 
tumor. 
319 21.33 
3 Quinn, C. C., Clough, S. S., Minor, J. 
M., Lender, D., Okafor, M. C., & 
Gruber-Baldini, A. (2008). WellDoc™ 
mobile diabetes management 
randomized controlled trial: change in 
clinical and behavioral outcomes and 
patient and physician satisfaction. 
Diabetes technology & therapeutics, 
10(3), 160-168. 
Describes the evaluation of a smartphone diabetes 
management software which analyses, through its 
statistical model, users’ logged data, trends, and 
behavior and then, through its therapy optimization 
tools, provides to users real-time advice on diabetes for 
better managing their disease. 
306 14.18 
4 Chawla, N. V., & Davis, D. A. (2013). 
Bringing big data to personalized 
healthcare: a patient-centered 
framework. Journal of general internal 
medicine, 28(3), 660-665. 
An overview of the role of Big Data analytics and 
computation in personalized healthcare and biomedical 
discovery. Create a personalized disease risk profile for an 
individual patient by leveraging the big data resident in 
electronic medical records, patients’ experiences and 
histories, along with the biological information of diseases 
and their interactions Deliver a personalized plan to an 
individual by leveraging similarities across a large group of 
patient pool, in real-time. 
221 12.83 
5 Andreu-Perez, J., Poon, C. C., 
Merrifield, R. D., Wong, S. T., & Yang, 
G. Z. (2015). Big data for health. IEEE J 
Biomed Health Inform, 19(4), 1193-
1208. 
An overview of the progress in biomedical and health 
informatics through big data. It explains the benefits for 
medical, sensor and imaging informatics, and translational 
bioinformatics from piecing together different personalized 
information from unstructured and structured data, such as 
clinical diagnosis, imaging, continuous physiological 
sensing and genomics, proteomics, metabolomics. 
220 28 
6 Hilario, M., Kalousis, A., Pellegrini, C., 
& Mueller, M. (2006). Processing and 
classification of protein mass 
spectra. Mass spectrometry 
reviews, 25(3), 409-449. 
A study on data analytics that takes mass spectra data of 
biological specimens, like DNA microarray data and 
discovers patterns between different pathological states 
applying classification algorithms and reporting predictive 
performance. A mass spectrum contains thousands of 
different mass/charge ratios. The reduction of the size of 
the high dimensionality variable set through classification is 
crucial to biomarker discovery. 
199 8.23 
7 Zhang, X., Yang, L. T., Liu, C., & Chen, 
J. (2014). A scalable two-phase top-
down specialization approach for data 
anonymization using mapreduce on 
cloud. IEEE Transactions on Parallel 
and Distributed Systems, 25(2), 363-373 
An approach for data anonymization techniques of large 
scale electronic health records that masks sensitive 
information specializing the level of information in a top-
down manner until a minimum privacy requirement is 
compromised, making it possible to capture, manage, and 
process them within a tolerable elapsed time. 
192 17.60 
8 Castellanos, F. X., Di Martino, A., 
Craddock, R. C., Mehta, A. D., & 
Milham, M. P. (2013). Clinical 
applications of the functional 
connectome. Neuroimage, 80, 527-540. 
Focuses on predictive modeling approaches for diagnosis 
through resting state fMRI, a method of functional 
magnetic resonance imaging that is used in brain mapping, 
a tool for brain-based biomarker identification for 
neurological and psychiatric illness.  The convergence of 
dimensional approaches and large dataset of images 





9 Krumholz, H. M. (2014). Big data and 
new knowledge in medicine: the 
thinking, training, and tools needed for a 
learning health system. Health 
Affairs, 33(7), 1163-1170. 
Explores the ways in which big data, such as biological, 
clinical, behavioral, and outcomes data can be analyzed 
through advanced methods to predict, discover, and 
compare effectiveness to tackle the complexity of patients, 
populations, and health-related organizations in a similar 
way that it is done in other businesses. 
189 19.60 
10 Alyass, A., Turcotte, M., & Meyre, D. 
(2015). From big data analysis to 
personalized medicine for all: challenges 
and opportunities. BMC medical 
genomics, 8(1), 33. 
A review that discusses recent advances in high-throughput 
large omics (genomics, epigenomic, metagenomics, 
metabolomics, nutriomics, etc) technologies which have led 
to more precise modeling of complex diseases accelerating 
the global transition to personalized medicine. It also 




The most co-cited paper (the most commonly referenced paper among the 804 
articles) is by Murdoch & Detsky (2013), “The inevitable application of big data to 
health care”, published in JAMA. It is included in the reference list of 24 out of 804 
articles. It is closely followed by the papers of Breiman (2001) and Dean & Ghemawat 
(2008). Table 5 presents the 11 most co-cited papers. The majority of the papers are 
related to health with the exception of two: Breiman (2001), which is about a machine 
learning method often used in health applications and Dean & Ghemawat (2008) which 
discusses MapReduce (both big data analysis methods used often in the health care 
sector).  There is also the report from McKinsey (Manyika et al., 2011), which is about 
big data opportunities in general (with a special reference to the health sector in the 
US), and it is the only one not published in an academic journal. No overlaps are 
observed between the most cited (Table 4) and the most co-cited (Table 5) top 10 
papers, except for two: Chawla & Davies (2013) and Bates et al. (2014) with the latter 
coming last in the list of the most co-cited papers as it shares the 10th position with 
Murphy et al. (2010). Overall, the great majority of the most cited and co-cited articles 
consists overview and review papers.  
 
Table 5: Top 10 most co-cited articles 
a/a Citation Summary Frequency 
1 Murdoch, T. B., & Detsky, A. S. (2013). The 
inevitable application of big data to health 
care. Jama, 309(13), 1351-1352. 
A viewpoint that discusses the applications and 
opportunities of big data (deriving from electronic 
health records) to health care, using an economic 
framework, to improve quality and efficiency of health 
care delivery. 
24 
2 Breiman, L. (2001). Random forests. Machine 
learning, 45(1), 5-32. 
Gives insight into the random forests’ capabilities for 
classification and prediction. 
23 
3 Dean, J., & Ghemawat, S. (2008). MapReduce: 
simplified data processing on large clusters. 
Communications of the ACM, 51(1), 107-113. 





4 Raghupathi, W., & Raghupathi, V. (2014). Big data 
analytics in healthcare: promise and potential. Health 
information science and systems, 2(1), 3. 
Describes the opportunities in healthcare from the 
analysis of big data, such as electronic health records, 
financial and operational data, clinical data, genomic 
data, real-time data from health monitoring devises. 
19 
5 Chawla, N. V., & Davis, D. A. (2013). Bringing big 
data to personalized healthcare: a patient-centered 
framework. Journal of general internal 
medicine, 28(3), 660-665. 
Look at Table 4 entry 4 16 
6 Lazer, D., Kennedy, R., King, G., & Vespignani, A. 
(2014). The parable of Google Flu: traps in big data 
analysis. Science, 343(6176), 1203-1205. 
Presents the Google Flu Trends, a flu tracking system 
from social media posts, as a case study to provide 
critical lessons for the future of big data analysis.  
16 
7 Jensen, P. B., Jensen, L. J., & Brunak, S. (2012). 
Mining electronic health records: towards better 
research applications and clinical care. Nature 
Reviews Genetics, 13(6), 395. 
A review focusing on the potential knowledge 
discovery of genotype–phenotype relationship from 
integrating EHR data with genetic data and ethical, 
legal and technical reasons currently hindering the 
systematic deposition of these data in EHRs and their 
mining. 
15 
8 Manyika, J., Chui, M., Brown, B., Bughin, J., Dobbs, 
R., Roxburgh, C., & Byers, A. H. (2011). Big data: 
The next frontier for innovation, competition, and 
productivity. McKinsey & Company 
A research of McKinsey Global Institute about big data 
analytics in healthcare and other 4 domains focusing on 
the economic impact of the technology. For healthcare 
it provides examples of health insurance organizations 
deploying electronic health records, health monitoring 
data from devises, R&D data and mostly financial and 
pricing data. 
15 
9 Ginsberg, J., Mohebbi, M. H., Patel, R. S., Brammer, 
L., Smolinski, M. S., & Brilliant, L. (2009). Detecting 
influenza epidemics using search engine query 
data. Nature, 457(7232), 1012. 
Presents a method of analyzing Google search queries 
to track influenza in a population. This approach may 
make it possible to use search queries to detect 
influenza epidemics in areas with a large population of 
web search users. 
14 
10 Murphy, S. N., Weber, G., Mendis, M., Gainer, V., 
Chueh, H. C., Churchill, S., & Kohane, I. (2010). 
Serving the enterprise and beyond with informatics 
for integrating biology and the bedside (i2b2). Journal 
of the American Medical Informatics 
Association, 17(2), 124-130. 
Presents a software, i2b2, that uses large datasets of 
patient medical record data, such as diagnoses, 
medications, and laboratory values and provides 
clinical investigators with the ability to identify sets of 
patients with special health characteristics while 
preserving patient privacy. 
 
13 
11 Bates, D. W., Saria, S., Ohno-Machado, L., Shah, A., 
& Escobar, G. (2014). Big data in health care: using 
analytics to identify and manage high-risk and high-
cost patients. Health Affairs, 33(7), 1123-1131. 
Look at Table 4 entry 1 13 
36 
 
The below co-occurrence analysis is based on all keywords (6015) of the 804 
papers. The 10 most frequently used keywords are presented in Fig.6. As one 
would expect, the most popular keyword is “big data” with a frequency of 185 
times throughout the whole article pool. 
 






4.2. Content Analysis Results 
 
The information from the unstructured data of these papers has been derived 
applying text mining method (Dinov, 2016). For the demonstration of the result, it has 
been built a text classification that is presented in Table 6. Every category of this 
classification contains several subcategories. The particular categories and their sub-
categories, which act as the guide to the dataset content analysis, were inspired by a 
number of prominent review and overview papers relevant to big data analytics in 
general, [Wamba et al. (2015) for the category of “research approach”, Wang et al. 
(2016) for the category of nature of analytics, Groves et al. (2013) for the categories of 
types of data & capabilities related to health, and finally, Chen & Zhang (2014) and 
Wallet and Facett (2013) for the category of BDA techniques]. Through the analysis of 
the selected categories, it has been an attempt to answer questions like: What medical 
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specialties have benefited the most? Who are the stakeholders of the use of Big Data 
analytics? What is the type and the frequency of the big data which have been used in 
the healthcare domain?; what big data are mostly used in health analytics techniques?; 
what is the level of analysis that has been reached (nature of analytics) and what type of 
research has been conducted (research approach)?; what capabilities have been acquired 
from the application of BDA in the health sector? In addition, a new category (medical 
specialties) was added to identify to whom this research is relevant. The selection of this 
classification attempts to map the knowledge in the field and explain the elements of big 
data analytics in healthcare through examples. Table 4 presents the classification 
framework. 
Table 6 : Classification Framework 
a/a 
Classification 
Dimensions   Reference Source Tables Questions 
1 Medical specialties U.S. Government site of 
medicare 
Table  8 What medical specialties have 
benefited the most? 
2 Stakeholders of  BDA Groves et al., 2013 Table  9 Who are the stakeholders of the use 
of Big Data analytics? 
3 Research approach Wamba et al., 2015 Table  10 What type of research has been 
conducted? 
4 Nature of analytics  Wang et al., 2016 Table  11 What level of analysis have they 
reached? 
5 Types of data Groves et al., 2013  Table  12 What kind of data have been used 
for the analysis? 
6 Big data techniques  Wang et al., 2016, 
Waller & Fawcett, 2013 
 
Table  13 What techniques have been used? 
7 Big data capabilities Groves et al., 2013  Table  14 What is the purpose of the analysis? 
 
 
The demonstration of the results has been achieved using some indicative 
examples of papers based on the classification framework presented in the methodology 
section. The selection of the particular examples is based on their popularity (high-cited 
papers in their categories) and the fact that they provide a clear and comprehensive case 
for each sub-category. 




The first categorization concerns the allocation of papers to the medical 
specialties. The groupings are based on the official U.S. government site for medicine1. 
Table 7 shows the relevant specialties and the number of identified papers with an 
indicative reference. In many cases articles are allocated in more than one subcategory. 
For example, an article about breast cancer was categorized in “Gynecology” and 
“Medical Oncology”. The ten most popular specialties are presented according to the 
number of the allocated articles. The most popular subcategory is the one that includes 
articles referring to all kind of medical specialties or to “no specific specialty” (49%). 
The next popular subcategory with 77 articles (10%) combines three medical specialties 
(Neurology/Neuropsyciatry/Psychiatry) since many articles refer to these categories 
together. No similar research has been identified for comparison of results, however 
given that health analytics is a fast- growing field of research it is expected the 
publication of a great number of studies on specific medical specialties in the near 
future. The specialties with the biggest number of studies, like neurology, oncology and 
cardiology, are on the spotlight of the World Health Organization (WHO). Based on 
World Health Statistics 2016, mental disorders affect one in ten people on the planet 
and almost 40% of premature deaths are caused by cardiovascular diseases, cancer, 
diabetes and chronic respiratory diseases. Therefore, the healthcare community is 
expected to give great importance to the evolution of these specialties with the help of 
the new capabilities offered by analytics.  
Table 7: Distribution of articles to Medical Specialties 
 
Specialties     N % Indicative Reference 
No specific specialty 391 48.9 Althebyan, Yaseen, 




77 9.6 Maccione et al. 2015 
Medical oncology 56 7.0 Miriovsky, Shulman, & 
Abernethy,  2012 
Cardiology 54 6.7 Bardhan Oh, Zheng, & 
Kirksey, 2014 
Infectious disease 23 2.9 Carroll et al., 2014 
Endocrinology 22 2.7 De Silva, Burstein, 






Jelinek, & Stranieri, 
2015 
Emergency medicine 22 2.7 Baum, 2010 
Pediatric medicine 21 2.6 Basole et al., 2015 
Radiology 19 2.4 Cook & Nagy, 2014 
Pathology 19 2.4 Angelelli et al., 2015 
Pulmonary disease 13 1.6 Kenner, 2016 
 
4.2b. Stakeholders of Big Data Analytics in HealthCare 
 
In the second part of the research the allocation of the papers is based on whom 
their content was relevant and identified seven different stakeholders who might benefit 
from using big data management systems in healthcare. The most common stakeholders 
in the use of BDA in healthcare are primarily the clinicians, who appeared in almost 
half of the articles (392 articles, 48.7% of the article pool). Research has shown that 
clinicians use new technologies to achieve the highest quality of patient care. A high 
number of papers focus on the development of decision support systems which can be 
used by medical staff to take informed decisions about patient diagnosis/care or for 
developing a better understanding for progression of certain diseases. Researchers 
appeared in 48.2% of articles. The researcher is the beneficiary when s/he tries to 
further understand relationships and differences among variables e.g. to cluster data in 
meaningful categories for achieving better decision making. This research is not yet 
robust enough to be used by clinicians, patients, policy-makers, etc., but it is very close. 
This analysis found that patients make up 36.8% of the article pool, as receivers of 
health information for themselves and the environment they live in. This might be used 
primarily to optimize their treatment quality or improve their quality of life in general.  
Administrators make up 20.8% of the BDA stakeholders whereby they successfully lead 
their organizations through better decision-making, recognize revenue opportunities, 
reduce re-admissions and costs and improve staff utilization and scheduling, etc. 
Research for IT specialists is limited (9.8%) and it is aimed at designing the systems 
analysis and IT platforms for correct and desired data display. Research for Vendors, 
with 5.72% representation, is targeted at gaining competitive advantage and investing 
into new products. Finally, policy-makers with 5.1% include governments, ministries of 
health, international health organizations, with research focused on trying to take 
advantage of the technological and scientific achievements to provide higher quality 
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public care and protect people from infectious diseases and terrorism. Table 8 
summarizes these findings by also providing a definition for each beneficiary and a 
summary of the two articles given as examples of research targeted to each stakeholder. 
The selection of the examples is based on their popularity (high-cited papers in their 
categories) and the provision of a clear and comprehensive case for each sub-category.  
 
Table 8 : Stakeholders of Big Data Analytics in Healthcare 
Stakeholder
s 
Research Purpose Ν   Examples Context 
Clinicians To make sense of the vast 
amount of data using new 
technologies in order to 
achieve the highest patient 
care quality 
392 48.7 Mares et al. 
2014 
Present a system designed to help clinicians to 
improve their decision making by combining data of 
widely varying types and performing analyses which 
facilitates them in making new medical discoveries. 
McGirt, 
Sivaganesan,
, Asher & 
Devin 2016 
Offer a predictive analytic tool that combines clinical 
data and patient interviews after lumbar spine 
surgery. Data form 1800 patients were used to predict 
12-month improvement in physical disability, return 
to work, complications, readmission, and need for 
inpatient rehabilitation.  According to the authors, 
this model benefits physicians to generate knowledge 
about expectations after surgery and surgeons to have 
the ability to choose the right intervention, at the 
right time, for the right patient. 
Researchers To understand the 
differences and provide 
outcomes leveraging the 
grounded data  
388 48.2 Banaee & 
Loutfi, 
2015 
Developed a BDA model where the temporal patterns 
are mined from physiological sensor data such as 
heart rate, respiration rate, and blood pressure. The 
proposed approach enables researchers to discover 
specific behaviors of vital signs, which are not 
necessarily recorded in medical ontologies and 
exploit unseen and distinctive information per patient 
or condition. After the validation of this approach it 
can be provided to clinicians to upgrade their 
decision- making. Researchers could also benefit 
from the generation of new ideas through their 
elaboration of the BDA system. 
Banos et al. 
2016 
Present the framework “Mining Minds”, that enables 
the provision of personalized support based on the 
core ideas of the digital health and wellness 
paradigms. Mining Minds elaborates technologies, 
such as Cloud Computing, Wearables and Internet of 
Things, and concepts such as context-awareness, 
knowledge bases or analytics, to investigate on 
people’s lifestyles and provide a variety of smart 
coaching and support services. The authors present 
here the conceptual framework and strongly believe 
that their approach can create new research ideas and 
also serve as a reference for similar initiatives. 
Patients To use their own  medical 
data in order to optimize 






Presents a system that aims to improve the health of 
patients and reduce the risk of having medical 
problems. They developed a cloud based monitoring 
system that targets a crowd of individuals in a wide 
geographical area and efficiently can integrate many 
emerging technologies such as mobile computing, 
wearable sensors etc. that can offer remote 






Introduce the Kavli HUMAN Project (KHP) which 
aggregated data from 2,500 New York City 
households (roughly 10,000 individuals) whose 
biology and behavior is measured using modalities 
such as environmental conditions, events and 
geographic information over 20 years. Views were 
offered from the database of how human health and 
behavior evolve over the life cycle and why they 
evolve differently for different people. The authors 
argue that this kind of approach can improve the 




To lead their organization 
with better decision - 
making 
168 20.8 Brandley & 
Kaplan, 
2010 
Describe the benefits of predictive analytics from the 
perspective of revenue opportunity identification and 
increasing staff efficiency to recover the revenue. 
Both perspectives are key issues for administrators to 
run their organizations efficiently 
Hao et al. 
2014 
Present a decision tree based model with Electronic 
Medical Records (EMR) features to estimate 
readmitting patients. They claimed that their model 
benefits health care providers for estimating the ED 
revisit risks at the patient discharge time in order to 
maintain a perspective of health care economics for 
the future clinical resource related to ED.  
IT 
specialists 
To design the desired 
systems analysis 
79 9.8 Klein, 2015 Development of IT infrastructure of Blythedale 
Children’s Hospital, in New York. An Outcomes 
Committee composed of health care and IT 
professionals found ways to manage electronic 
medical record and administrative data and provide 
mechanisms for real time outcomes. In order to 
present information to the clinicians when they 
needed it most, so they trusted IT professionals to 
create a novel solution in elaborating dynamic 
dashboards from EMR data 
Mamary, 
2013 
Describe a new decision support system of 
Hunterdon Medical Center, a 178-bed teaching 
hospital and enhances the importance of IT Specialist 
in the management team. 
Vendors Togain competitive 
advantage and invest in 
new products  




Provide an overview of business analytics(BA) in 
healthcare hosted in the cloud computing 
environment, offered as Software as a Service (SaaS) 
solution. Identify the benefits for healthcare 
enterprises when making use of a BA SaaS 
Bose & Das, 
2012 
Develop an innovative visualization tool to help 
overcome the potential operational deficiencies of 
clinical trials by the use of Clinical Trial 
Management Systems (CTMS) in order to improve 
managerial control. This solution provides 
opportunities to reduce costs and time, to stimulate 
revenue growth, and enables companies to 
understand the entire clinical trial process from the 
global organizational perspective 
Policy-
makers 
To take advantage from the 
technology and science 
achievements in order to 
provide improved public 
care quality and protect 
people from infectious 
diseases and terrorism 




Describe how the public health departments in 
Chicago are moving from one-time programmatic 
interventions to sustainable system-level innovations 
in order to create new strategies to solve old 
problems by capitalizing on the innovative synergies 






A network using data collected by the U.S. Centers 
for Disease Control and Prevention (CDC) and 
combine this with Google Flu Trends (GFT) that 
predicts infections into the future as well as to 
identify the regions that are most likely to accelerate 
influenza spread during epidemics. The findings of 
this paper have important implications for prevention 







         The selected publications have been according to their research approach, as of  
Wamba et al. (2015) and Chen & Zhang (2014) with some additions (Table 9). For the 
diversification of the articles according to their research approach, some best examples 
of each approach are presented here. The results of the categorization indicate that most 
papers are experimental studies, followed by review studies. In general, papers under 
the categorization of “experiment” cover both a theoretical contribution (an 
advancement of an algorithm, experimentation with program running time, etc.) and a 
part where this theoretical advancement is tested or evaluated in relation to the under- 
discussion application. In a field with an expected growth in the following years 
(according to the literature above), it is anticipated that the academia will provide at 
least this volume of experimental studies. Many articles have been categorized in more 
than one subcategories [e.g. the research of Barret, et al. (2008) and Blakely et al. 
(2015)] as they include more than one approach in their methodology.  
Table 9 : Research Approach and indicative research examples 
Research approach N % Examples Context 
Experiment 
Incorporates papers that 
provide experimental 
results of new models 
318 39.6 Barret, 
Mondick, 
Narayan, 
Vijayakumar  & 
Vijayakumar., 
2008 
The study proposes mixed effect models and Bayesian 
forecasting algorithms to develop drug–specific 
dashboards for better decision making and education of 
patient caregivers on clinical pharmacology principals 
which lead to fewer medication errors, reduced 
toxicity, reduced length of hospital stay, etc. Data 
visualization tools summarize patient profiles from 
hospital electronic medical records of pediatric 
populations, such as lab values, vital signs, and 
associated biomarker and interface those data by a web-
based decision support system. 
Review & Overview 
Includes literature 
review papers that 
present a summary of 
the research methods 
and outcomes in a 
specific field 
178 22.1 Gligorijevic, 
Malod‐Dognin 
& Pržulj, 2016 
The study reviewed recent big data integrative methods 
for disease sub typing, biomarkers discovery, and drug 
repurposing, and listed the tools that are available to 
domain scientists while highlighting key issues in the 
context of personalized medicine. 
Data analysis 
Papers that contain 
methods and results 
from analyzed data 




The study analyzed large scale text related to vaccine 
opinions retrieved from Twitter for measuring the 
potential influence of these opinions based on the 
variation in the vaccination coverage rates. This 
method can be used to detect and locate communities 
against vaccination that could generate future disease 




Studies that provide 
conceptual frameworks 
and general discussions 
on the investigated 
scientific fields  
140 17.4 Kuiler, 2014 This study presents a conceptual framework for data 
analytics. An IT-supported ontology-based approach 
for health data to address the semantic challenges 
presented by Big Data sets and discusses architectural 
considerations. Future research will focus on 
developing the specifications for the lexicon, ontology, 
and other architectural artifacts to support software 
development. 
Case study 
Qualitative research  
based on a case and 
designed to suit the 
research question 
86 10.6 Chute, Beck, 
Fisk & Mohr, 
2010 
A case study about Mayo Clinic and its “semantically 
integrated warehouse of “biomedical data”.An 
information management initiative that integrates a 
huge amount of different medical data types. 
Survey 








The authors dealt with the analysis of 1941 children 
clinical data, in a Health Center of Osijek, Croatia, and 
interviewed their parents for more details of family 
history on antibiotics and other allergic and chronic 
diseases with the purpose of investigating reactions and 
allergy from antibiotics in children. Their analysis 
involved structure and unstructured data from a big 
population to present outcomes in biomedical research. 
4.2d. Nature of Analytics 
 
  The following category allocates the articles according to their descriptive, 
predictive or prescriptive nature as of Wang et al., (2016). In many cases the articles 
have been distributed in more than one subcategory because there is evidence of more 
than one dimension in some papers. The most popular subcategory with 47% (377 
papers) is that of “Predictive analytics”. The second subcategory in the classification is 
“Prescriptive Analytics”, with 33% of papers (263 out of 804) and the last one is 
“Descriptive analytics” (24% with 190 articles). In the paper of Raghupathi & 
Raghupathi (2013) descriptive analytics were found to be the most commonly used type 
due to their explanatory and easy approached nature. However, in healthcare, prediction 
is more valuable than explanation because the outcomes are measured in lives (Agarwal 
& Dhar, 2014). The majority of articles in the dataset are published after 2013, and 
therefore later than the publication of Raghupathi & Raghupathi (2013). Healthcare is a 
growing sector and as a result advanced technology and skills are needed for the 
application of models with predictive or prescriptive character. The industry may have a 
time-lag in the adoption of the more advanced nature of analytics but the research must 
pave the way (Groves et al., 2013). In the article pool, the majority of papers (40%) 
included experiments of new models with the hope that these predictive/prescriptive 
models will become s part of software and will be adopted by analysts for use in the 
decision-making in health care organizations or systems.  
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Table 10: Nature of Analytics and indicative research examples 
Nature of analytics N % Examples Context 
Predictive 
Involve the use of 
mathematical algorithms to 
discover predictive patterns 
within data and project what 
will happen in the future. 
377 46.9 Bardah et al., 
2015 
Presented a novel model to predict readmission of 
patients with congestive heart failure. The model 
tracks patient demographic, clinical, and 
administrative data across 67 hospitals in North 
Texas over a four-year period. 
Prescriptive 
Involve the use of data and 
mathematical algorithms to 
determine decisions that 
involve objectives with the 
aim to improve performance. 




Surveyed 2865 patients from the surgery unit and 
3241 from the oncology unit and proposed nurse–
patient assignment models to achieve a balanced 
assignment workload. Patient metrics used from 
QuadraMed AcuityPlus patient classification system 
(which accumulates hospital’s patient indicators 
over 20 years) to classify patients on nurses’ 
workload. 
Descriptive 
Techniques such as online 
analytical processing (OLAP) 
that aim to identify problems 
and trends in existing 
processes and functions. 
190 23.6 Basole et al., 
2015 
Presented a visual analytic tool that used clinical 
data from 5784 pediatric asthma emergency 
department patients and reported that asthma is the 
most common pediatric chronic disease and is the 
third leading cause of hospitalization among 
children, affecting 9.3% of children in the US. 
Their results assist in the improvement of health 
care quality. The data were obtained from 
Population Discovery, Children’s data warehouse. 
This included patient and provider information, 
administrative events, clinical observations, 
medications, laboratory tests, and charges in a 
elational database 
4.2e. Types of data 
 
 For the purpose of this Thesis, it has been adopted a detailed description of the 
types of primary data pools used in healthcare from the study of McKinsey and Co 
(Groves et al., 2013). These include: A. Clinical data, B. Patient and sentiment data C. 
Administration and cost activity data and D. Pharmaceutical and R&D data. The review 
papers did not take part in this classification. In Table 11 together with the allocation of 
papers according to the type of the analyzed data, there has also been provided in the 
second column a definition of these types of data. Overall, the adopted types are in line 
with the categorization used by other researchers too (Gaitanou, Garoufallou & 
Balatsoukas, 2014).  The most popular data that have been analyzed within the articles 
are “clinical data” with a 70% (562 articles out of 804) representation. The results are 
consistent with the literature which has identified that significant research has been 
focused on electronic health records (EHRs) implementation, but relatively few studies 




Table 11 : Types of data and indicative research examples  
Types of data N % Example Context 
Clinical data 
Patient data such as EHR and 
medical images 
562 69.9 Forsberg et 
al., 2015 
Collected biomarker and clinical information from 73 
patients who sustained 116 life threatening combat wound by 
conflicts in Afghanistan and Iraq, and tried to determine if 
those data could be used to predict the likelihood of wound 
failure. The collected data included clinical information, 
serum, wound effluent, and tissue and their analysis model 
indicated that it would improve clinical outcomes and reduce 
unnecessary surgical procedures. The same approach was 
also tested and performed equally well with larger samples of 
patients (67,486 patients with traumatic extremity wounds). 
Patient behavior and 
sentiment data 
Data collected from wearable 
sensors and social sites 





Described the analysis of predictive tools that gather posts 
and queries from Social Web (“Web 2.0”) tools such as 
blogs, micro-blogging and social networking sites to form 
coherent representations of real-time health events like flu 
out-breaks. Harvested data in the form of human feelings 
from a large number of blogs and social pages such as those 
hosted by MySpace. 
Administrative & cost data 
Financial and operational 
data and patient profiling 
data and choices 




Used a vast number of individuals’ administrative and 
clinical data to create a cloud based solution (Software as a 
Service) that provides personalized recommendations about 
the health insurance plans according to the user specified 
criteria. 
Pharmaceutical R&D data 
Drug therapeutic mechanisms, 
R& D data from target behavior 
in the body such us effects of 
toxicity etc. 




Described “Pharmachosychrony” as a new concept of 
analytical pharmacy solutions to improved care coordination 
and provided a high quality and patient-centric model of 
care. Among the data that this solution elaborates, pharmacy 
data are included for the effective and safe use of medication. 
Elaborated claims data from call centers, web portals, mobile 
technology, and decentralized clinical staff. 
 
4.2f Big Data Techniques 
 
The boundaries of techniques among BDA are difficult to be completely 
distinguished (Royston, 2013). For better understanding the use of the different 
techniques, there is a definition in the second column and some indicative examples in 
the last. The listed BDA techniques have derived from the literature (Chen & Zhang, 
2014; Waller & Fawcett 2013) and although some may overlap with each other or 
consist a sub-category of another, they are as inclusive as possible. For example, in 
Table 12, “web-mining” is presented separately from “data-mining” although it can be 
seen as a subcategory of the latter, acknowledging the fact that this mining field is 
represented by a quite large number of papers and has gathered momentum because of 
the high usage of internet data in the very last decades.  The case with the allocation of 
papers to the “modeling” and “simulation” techniques is also similar. The criterion for 
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allocating a paper to the “modeling” subcategory was whether the modeling technique 
mainly included mathematical formulations of variable relationships presented in a 
static form, and that for the allocation to the “simulation” subcategory was whether the 
data variability was addressed by running the model many times with different values 
taken from a distribution. Willing to address both approaches and present indicative 
research examples to explain them there are separated techniques. Moreover, in the 
statistics subcategory, the majority of articles are allocated to another technique too, and 
overall many of the papers have multiple entries as the handling of big data requires a 
combination of techniques for their analysis. As seen in Table 12, “modeling” emerges 
as the most popular technique, as it is also the most general amongst the categories. It is 
followed by “machine learning” (which includes the design of algorithms), a fast-
growing technique with lots of successful cases in the field of health, such as the 
classification of medical data and symptoms for disease diagnosis and prediction (Chen 
et al. 2017; Khalaf et al., 2017).  
 
Table 12: Big Data Techniques and indicative research examples 
Techniques N % Examples Context 
Modeling 
Methods of analytical 
mathematical analysis with 
approximate relationships 
between variables (Waller & 
Fawcett 2013) 
344 42.8 Ajorlou, 
Shams & 
Yang, 2015  
Developed a linear predictive Bayesian model indicating 
that risk adjustment for patient health conditions can 
improve the prediction power. Data from 82,000 patients 
from 888 facilities assembled for a total capture period of 
one year and assessed from the Veteran Health 
Administration. 
Machine learning 
Artificial intelligence  
aimed to design algorithms 
that allow computers to evolve 
behaviors based on empirical data. 
(Chen & Zhang 2014) 
327 40.7 Dugan, 
Mukhopadhya
y, Carroll & 
Downs,  2015 
Experimented with six different machine learning methods 
to identify the best one for predicting future obesity in 
children above two years old with 85% accuracy. Data 
collected from a pediatric clinical decision support system 
(CHICA) and used for the analysis. The data included nine 
years of clinical information collected from 4 different 
community health centers. 
Data mining 
A set of techniques to 
 extract information from 
 data (Chen & Zhang, 2014) 
200 24.9 Delen, 2009 Used three popular data mining techniques (decision trees, 
artificial neural networks and support vector machines) to 
develop prediction models for prostate cancer survivability. 
The researchers obtained around 120000 records from the 
Surveillance, Epidemiology, and End Results Program and 
formed 77 variables for statistical analysis. They concluded 
that data mining methods are capable of extracting patterns 
and relationships but are useless without medical experts’ 
feedback.  
Visualization approaches 
The techniques used to create tables, 
images,  diagrams and other  
intuitive display ways to understand 
data (Cheng & Zhang, 2014) 
153 19 Angelleli et 
al., 2014  
Presented a visualization tool “brain atlas” with cohort data 
analysis of 100+ participants. The tool, which was assessed 
by neuropsychological testing, genetic analysis and 
multimodal magnetic-resonance (MR) imaging, enables a 
first quick analysis of the identified hypotheses. 
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4.2g.Big Data Capabilities 
 
 The term “big data capabilities” refers to the different organizational 
competencies created by IT models that analyze vast amounts of complex and different 
Statistics 
The methods of organizing  
and interpreting data for exploiting 
causal relationships between 
different objectives 
(Chen & Zhang, 2014) 
132 16.4 Demir,  2014 Proposed a method to compare predictive analytic 
capabilities of emergency readmissions. Using data from 
the emergency department from 963 patients with chronic 
obstructive pulmonary disease and asthma within 45 days 
after a patient has been discharged from hospital. This data 
set was divided into derivation and validation samples 
1000 times. They actually proved that predictive logistic 
regression and regression trees could be a valuable 
decision support tool for clinicians for the prediction of 
readmissions. 
Simulation 
Quantitative analysis  
of a system in a  
stochastic setting  
(Waller & Fawcett 2013) 
55 6.8 Liu & Wu, 
2016 
Developed an agent-based simulation model to study 
accountable care organizations. It identified the critical 
determinants for the payment model design that can 
motivate provider behavior changes to achieve maximum 
financial and quality outcomes that considers payers, 
healthcare providers, and patients as agents under the 
shared saving payment model of care. It constructed a 
healthcare system analytics model that can help inform 
health policy and healthcare management decisions. 
Web mining 
The process of information 
discovery from sources across the 
World Wide Web (Cooley et 
al.,1997) 
54 6.7 Chen & 
Kotecha,  
2014 
Developed an analytics platform, called “Cytobank”, for 
community cytometry data analysis (to track cells and 
subsets in blood and tissue) using large computing 
resources for analysis on the Internet. These platforms can 
simultaneously measure up to 100 parameters. 
Optimization methods 
Methods that find the minimum or 
maximum of a function, subject to 
constraints and solve quantitative 
problems, improve the  
accuracy of forecasting and 
algorithms( Waller & Fawcett 2013) 
49 6.1 Katircioglu et 
al., 2014 
IBM Research developed a scenario modeling and analysis 
tool, supply chain scenario modeler (SCSM), for 
McKesson (the largest healthcare services company) to 
optimize its pharmaceutical supply chain policies. SCSM 
optimizes the distribution network, supply flow and 
inventory policies and quantifies the impacts of changes 
on financial, operational, and environmental metrics. They 
developed complex queries to generate all input needs and 
rigorously tested them. The resulting data model has over 
200 tables with a combined size of tens of millions of 
records. 
Text mining 
Techniques based on  
machine learning and  
data mining to find useful  
patterns in text data 
(Holzinger et al. 2014) 
42      5.2 Holzinger & 
Jurisica,  2014 
Presented an overview of some selected text mining 
methods, i.e. Latent Semantic Analysis, and Probabilistic 
Latent Semantic Analysis along with examples from the 
biomedical domain by extracting data from texts 
(unstructured patient data and, structured patient data e.g. 
biometrics or laboratory results), and biomedical images, 
which will benefit clinical decision support. It provided 
machine learning solutions for large and complex 
biomedical data analysis. 
Forecasting 
Is about predicting 
the future, while also evaluates 
what could happen 
under different circumstances  
using predictive analytic methods 
(Waller & Fawcett, 2013) 
22      2.7 Toerper et al., 
2016  
Developed and evaluated a web-based forecast tool that 
predicts the daily bed need for admissions from the cardiac 
catheterization laboratory.   The forecast model was 
derived using a 13-month retrospective cohort of 7029 
catheterization patients and included predictor variables 
such as demographics, scheduled procedures, and clinical 
indicators mined from free-text notes 
Social Network Analysis 
A technique that views and  
analyses data from social  
networks 
20 2.5 Abbas et al., 
2016 
Proposed a cloud based framework for BDA in health that 
uses the Internet and social media. The framework offers 
users disease risk assessment and consultation service from 
health experts on Twitter with high accuracy results. It 




types of data, processed in daily operations (Bharadwaj, 2000) and resulting to better 
decision making. But, on which big data capabilities healthcare should focus, in order to 
achieve its goals? To assist managers in better decision-making, organizations must 
develop infrastructure with essential big data capabilities (Groves et al., 2013). Groves 
et al. (2013) acknowledged five important BDA capabilities, which have been adopted 
in this study. These are:  a. “monitoring”, which includes articles that present 
monitoring efficiencies, and collect and analyze data (using analytical methods) 
describing “what is happening now”, b. “prediction/simulation”, which includes articles 
that present methods that provide information about future outcomes (what will 
happen), c. “data mining”, which incorporates articles that involve methods enabling 
extraction and categorization of knowledge (what happened), d. “evaluation”, which 
includes articles that demonstrate methods for testing the performance of BDA 
techniques or explain the outcomes of the application of BDA (why did it happen?) and 
e. “reporting capability”, which includes articles with methods for organizing the 
collected data in an informative format.  
Due to the plethora of capabilities described in the papers, many of them have 
been allocated to more than one subcategory. The difference between “data mining 
capability” and “data mining technique” (Table 13) is that the latter applies algorithms 
and mathematical modeling to perform clustering, etc. while the term capability refers 
to the process of applying these methods with the purpose of uncovering hidden patterns 
in large datasets. There is also a link between the BDA capabilities as described by 
Groves et al. (2013) and the nature of analytics as described by Wang et al. (2016). For 
example, the prediction/simulation capability is connected to the predictive and 
prescriptive nature of analytics respectively, and the monitoring and reporting 
capabilities are associated with the descriptive nature of analytics. However, the 
capabilities focus on the IT functionalities and the nature of analytics focuses on the 
technique’s goal. 
Table 13 provides examples of articles for each subcategory for further clarifying 
each capability. The most popular subcategory is “monitoring” with 33% of articles 
(264 papers out of 804), which shows the importance of the use of analytics methods to 
assist managers to maintain a view of “what is happening now”. The next dimension for 
the distributed articles is “prediction and simulation” with 32%. Having already 
demonstrated that in this systematic review predictive analytics is the most exploited 
type used in the examined articles, it can be justified that a good percentage of all the 
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papers would provide information about predictive BDA capabilities. The next popular 
sub-dimension is “data mining” with 29% (230 articles), followed by the “evaluation” 
with 13% (105), reflecting the publishing activity on evaluating the applications of 
BDA in healthcare. In this subcategory, articles that produce methods to evaluate the 
performance of other applications are often encountered. Finally, the last capability in 
Table 13 is “reporting” with a percentage of 9% (72 articles). A closer look at the 
allocation of articles reveals that the majority of the papers are almost equally 
distributed in the three first BDA capabilities a. monitoring (33%), b. prediction/ 
simulation (32%) and c. “data mining” (29%). However, in the reality of the health 
sector, reporting and monitoring activities are already occurring but predictive modeling 
and simulation techniques have not been used at scale yet (Groves et al., 2013).  
Table 13: Big Data Capabilities and indicative research examples 
Big data 
capabilities 





264 32.8 Althebyan et al.,  
2016 
Proposed an e-healthcare monitoring system that targets a 
crowd of individuals in a wide geographical area that 
integrates emerging technologies such as mobile 
computing, wearable sensors, cloud computing etc to offer 
remote monitoring of patients anytime and anywhere. The 
monitoring BDA capability providing through this system 
can enhance the decision support system in order to reduce 





258 32 Abdelrahman, 
Zhang, Bray & 
Kawamoto, 
2014 
Proposed a new analytical approach to develop high-
performing predictive models for congestive heart failure 
(CHF) readmission using an operational dataset with 
incomplete records and changing data over time. Data 
came from 2,787 CHF hospitalizations at University of 
Utah Health Care Center from January 2003 to June 2013. 
Data 
mining 
What did it 
happen? 
230 28.6 Chen et al., 2016 Developed a bootstrapping method for global module 
detection on features across breast cancer cohorts. They 
used electronic medical records’ data from a Medical 
Center annotated with BioCarta signaling signatures and 
provided new insights into breast cancer, such as the 
association of patient’s cultural background with 
preferences for surgical procedure. The modeling tool 
demonstrated unique ability to discover clinically 
meaningful and actionable knowledge across highly 
heterogeneous biomedical big data sets. 
Evaluation 
Why did it 
happen? 
105 13 Catlin et al., 
2015 
Proposed a web-based analytics system for conducting in 
house evaluations and comparisons of “infusion pump 
data” across hospital systems allowing users to select any 
number and combination of hospital data. Smart pump 
infusions are customizable libraries with dose limits and 
administration rates specific to medications and care areas 
and provide information in order to avoid medication 
errors like the delivery of wrong drugs or delivery to the 








72 8.9 Curcin, 
Woodcock, 
Poots, Majeed, 
& Bell, 2014 
Presented a software -Web Improvement Support in 
Healthcare (WISH) – which is a prototype tool that 
attempts to translate research into practice using local 
improvement projects. This approach facilitates electronic 
data collection and reporting in health settings and is tested 
on a Chronic Obstructive Pulmonary Disease improvement 
project run in Northwest London Hospitals. Data are 
gathered from a large class of tasks, particularly local ones 
that cannot be adequately measured by exclusively using 
routinely collected data residing in hospital’s EHRs. 
 
4.3. The association of the selected analytical techniques with the 
data types and capabilities 
  
Using the NVivo analysis software, there is a demonstration of the techniques 
that have most popularly been applied for each data type and presented value. During 
this procedure, each one of the 804 articles to the data types (as presented in Table 11) 
and performed a breakdown by technique (Table 12). Table 14 shows, for example, that 
out of all studies that deal with clinical data (562), 41.5% have used machine learning 
for their analysis, from studies with patient behavior/sentiment data 51% have used 
machine learning, etc. It seems that the most popular techniques scientists need or prefer 
to use are: modeling, machine learning. The same techniques are also popular, in the 
same order, with the exception that machine learning comes first, for all data types 
(Table 14). Overall, machine learning and modeling are the most applied techniques 
amongst all data types with a variance of 29% to 49. Noticing the percentages there is a 
level of uniform distribution throughout each technique. This is and with most data 
types as shown in Table 11. 
Table 14 : Classification of dataset articles based on the analytical techniques by 
data type 
 











% (n)  100 (562) 100(133) 100(59)     100(38)  
BDA Techniques↓ % (n)  % (n)  % (n)        % (n)   
Machine learning 41.5 (233) 51 (68) 32(19) 31.6(12) 
Modeling  28.6 (161) 33.8(45) 49(29) 44.7(17) 
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Data mining  24(135) 21.8 (29) 25.4(15) 15.8(6) 
Visualization  22.2(125) 15.8 (21) 13.5(8) 5.3(2) 
Statistical analysis  20.3(114) 11.3(15) 15.2 (9) 13(5) 
Simulation  7.1(40) 6.7 (9) 8.5(5) 13(5) 
Optimization  7 (36) 3(4) 6.8(4) 5.3(2) 
Web mining  4.5(25) 16.5(22) 5(3) 2.6(1) 
Text mining  4.5(25) 6 (8) 3.4(2) 2.6(1) 
Forecasting 2 (14) 2.2(3) 1.5(2) 0 
Social net. 
Analysis  
1(6) 12 (16) 3.4(2) 2.6(1) 
 
 
4.4. Gained values/capabilities from the use of BDA in the health 
sector 
The benefits from the analytics in healthcare have been summarized in the ability 
to provide comparative effectiveness research to determine more clinically relevant 
and cost-effective ways to diagnose and treat patients (Ragupathi & Ragupathi, 
2014).  More specifically, in order to identify the full range of the emerging 
capabilities in the health sector from the use of big data analytics there has been a 
further classification of them under 10 categories of value creation. Table 15 
presents these values sorted by popularity with a short explanation and the 
frequency of papers from the dataset that refer to one or more of these gains based 
on the research they present. 
 The first five values are similar to those identified in the study of Wamba et al. 
(2017).The most popular value “Better diagnosis for provision of more 
personalized healthcare” refers to the BDA capability to direct to better case 
diagnosis from the collection of more data and therefore offer more targeted 
therapy or health service to the individual.  This, for example, could be the analysis 
of the numerous relationships of specific patient’s biomarkers which can lead 
disease therapy to precision medicine (Alyass et al., 2015), or the investigation of 
patient health metrics and behavior through wearables and the Internet of Things 
leading to specific interventions based on the collected data (Banos et al., 2016).  
The second value “Supporting/replacing professionals’ decision-making with 
automated algorithms” is about mining knowledge from large data sets and 
training algorithms to pattern matching. This means better automatic 
categorization of new information entering the analysis process and improved 
decision-making when it comes, for example, to diagnosis and choice of therapeutic 
scheme.  
The third value “New business models, products and services” refers to the 
development of new business models, products, and services through the 
capabilities offered by BDA, such as a new visualization software with real-time 
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statistical analyses of brain images for better patient diagnosis (Angulo et al. 2016) 
or a mobile application in which people can enter symptoms and get possible 
diagnoses and recommended medication.  
The fourth value “Enabling experimentation, expose variability and improve 
performance” from the use of BDA, is for researchers to acquire a deeper 
understanding of all possible interrelationships between variables and develop 
scenarios for further experimentation with their models and expose new health 
information.  
The fifth value “Healthcare information sharing and coordination” is gained by 
the coordination and sharing of health information across healthcare services or 
even countries to improve of health professionals’ decision-making. The sixth value 
“Creating data transparency” is about the ability of BDA to collect big data and 
format them in a standardized way. This capability reduces data identification and 
analysis time and assists the previous value of coordinating meaningful and 
comprehensive health-related information. 
The next value “Identifying patient care-risk” refers to the capability of running 
the big data in advanced statistical techniques, such as logistic regression models 
and regressions trees which can identify scenarios of risk patterns and therefore 
alert for areas of health risk prevention. For example, identifying high risk 
populations for a particular disease helps policy-makers to decide on giving earlier 
access to screening to these populations.  
The following value “Offering customized actions by segmenting populations” 
refers to the use of BDA to identify new factors, through clustering and other 
methods, for segmenting populations differently or in more categories and offer 
more targeted health services or products.  
Value 9, that is “Reducing expenditure while maintaining quality” focuses on the 
capability of analytics, through process mining, visualization techniques and 
collaborative tools, to propose ways for reducing health organizations’ costs from 
better resource utilization, elimination of non-value-added actions, capturing 
hospital underpayments, etc., while maintaining the quality level. An example 
could be the use of visualization tools for identifying non-value-added processes in 
patients with chronic diseases by tracking patient data over time during home, 
ambulatory and hospital care. 
The last value, “Protecting privacy”, is about how BDA can offer data security in 
ways such as the identification of privacy breaches, the capability to extract data 
by eliminating ID recognition from electronic medical records and others. This has 
become a big issue especially for organizations that use cloud computing as their 
main processing platform in which privacy and security are difficult to be 
controlled (Larson & Chang, 2016). Overall, the majority of health data analytics 
studies attempt to direct their efforts to patient benefit. Needless to say, that almost 
all studies have this ultimate goal but their direct focus may be at the intermediate 
stage for improving the way of doing it. 
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Getting an overall picture, the values 1, 2 3 and 7 directly relate to patient 
wellbeing (P), values 4, 5, 6, 10 relate to analysts (A) for better data handling and 
values 8 and 9 relate to management (M) for better positioning their 
products/services and gaining management efficiencies respectively. The 
identification codes (P), (A), (M) are presented under the “Types” column in Table 
15.  
 
Table 15: Created Values from the use of BDA 
Value Types Definition  N % 
V1 Better diagnosis for provision of more 
personalized healthcare (P) 
Analytic approaches for better patient diagnosis which lead to 
provision of more personalized therapeutic schemes or services 
to the users  
286 35.6 
V2 Supporting/replacing professionals’ 
decision-making with automated 
algorithms (P) 
Through adaptive rules/algorithms for fast categorization of 
symptoms/medical results and pattern matching, analytics can 
provide recommendations for diagnosis and remedy/actions. 
206 25.6 
V3 New business models, products and 
services (P) 
BDA enables companies to create new products and services. 
e.g. new software for analysis of data/images, enhance existing 
ones, and invent entirely new business models, new ways of 
reaching to patients. 
197 24.5 
V4 Enabling experimentation, expose 
variability and improve performance 
(A) 
Analytics create conditions for enhanced experimental 
applications of large datasets for testing “what-if” scenarios and 
assisting performance and decision-making 
144 17.9 
V5 Healthcare information sharing and 
coordination (A) 
BDA can organize the selection and sharing of information and 
data analysis among stakeholders to gain operational efficiency 
122 15.2 
V6 Creating data transparency (A) BDA can collect/convert data in a standardized format and treat 
data in the same way for reducing time, cost of search and 
processing while maintaining clarity and quality  
115 14.3 
V7 Identifying patient care-risk (P) BDA create enhanced opportunities of health risk prediction for 
acting proactively to patient care-risk 
79 9.8 
V8 Offering customized actions by 
segmenting populations (M) 
BDA through high exploitation capabilities of big data can 
discover specific segmentations and tailor products and services 
to meet patients or health professionals’ needs. 
72 9 
V9 Reducing expenditure while 
maintaining quality (M) 
BDA enables new, cost-effective ways to intervene on the 
determinants of health, aiming at reducing expenditures while 
sustaining health outcomes. 
72 9 
V10 Protecting privacy (A) BDA can identify ways of securing privacy of health-related 
data to support the ethical principles and people respect.  
41 5.1 
 
Using the NVivo analysis software, there is a demonstration of the techniques 
that have most popularly been applied for each of the 10 identified values (Tables 15). It 
seems that the most popular techniques scientists need or prefer to use are: modeling, 
machine learning, data mining, visualization, and statistical analysis (Table 16). Overall, 
machine learning and modeling are the most applied techniques across almost all 
values, with a variance of presence between 32% and 61%.  
 
Table 16: Classification of dataset articles based on the analytical techniques by 
created value 
Values → V1 V2  V3 V4 V5 V6 V7 V8 V9 V10 







100 (122) 100(115) 100(79) 100 (72) 100(72) 100(41) 
BDA 
Techniques↓ 





48(137) 39 (80) 50 (98) 51.4 (74) 47.59(58) 31.3 (36) 38 (30) 32 (23) 26.4 (19) 61 (25) 
Μodeling 46.5 (133) 49 (101) 39.6 (78) 43 (62) 37.7 (46) 54.8 (63) 60.8 (48) 32 (23) 43 (31) 34.1 (14) 
Data mining 28 (80) 25.2 (52) 20 (39) 23 (33) 23.8 (29) 23.5 (27) 13.9 (11) 30.5 (22) 33.3 (24) 41.5 (17) 
Visualization 20.3 (58) 18.4 (38) 16.7 (33) 20.9 (30) 28.7 (35) 29.5 (34) 17.7 (14) 11 (8) 16.6 (12) 7.3 (3) 
Data mining 28 (80) 25.2 (52) 20 (39) 23 (33) 23.8 (29) 23.5 (27) 13.9 (11) 30.5 (22) 33.3 (24) 41.5 (17) 
Statistical 
analysis 
19.2 (55) 17 (35)  9.6 (19) 13.9 (20) 13.9 (17) 13 (15) 38 (30) 30.5 (22) 8.3 (6) 12.2 (5) 
Simulation 6 (17) 8.2(17) 7.1 (14) 14 (20) 1.6 (2) 12.2 (14) 3.8 (3) 7 (5) 9.7 (7) 2.4 (1) 
Optimization 5.6 (16) 6.3 (13) 5 (10) 13.2 (19) 3.3 (4) 7.8 (9) 3.8 (3) 4 (3) 9.7 (7) 0 
Web mining 5.6 (16) 4.4 (9) 7.1 (14) 9.7 (14) 11.5 (14) 18.3 (21) 7.6 (6) 11 (8) 4.2 (3) 4.9 (2) 
Text mining 2.5 (7) 4.9 (10) 5 (10) 3.5 (5) 7.4 (9) 1.7 (2) 7.6 (6) 8.3 (6) 1.4 (1) 0 
Forecasting 2.09 2 (4) 4.5 (9) 3.5 (5) 0 6 (7) 1.2 (1) 0 6.9 (5) 2.4 (1) 
Social net. 
analysis 
1.7 (5) 1.4 (3) 2 (4) 2.8 (4) 4.9 (6) 0.9 (1) 1.3 (1) 7 (5) 0 0 
 
 
4.5 Types of social value creation in healthcare  
 
As mentioned, aiming to identify the types of value creation in the healthcare 
industry from the analysis of big data, 10 value categories have been formed. The order 
of their presentation in Table 15 is based on their degree of popularity among the 804 
articles. In Table 17 there is an attempt to denote the social positive effects as well.  
The majority of researchers expect organizations to gain value from the 
“personalized innovative medical approaches (35.6%) (V1). For example the analysis of 
specific patient’s biomarkers guide disease therapy to precision medicine, which brings 
better diagnosis results tailored to individual perspectives. The capability of BDA to 
quickly monitor and analyze the health records of large patient cohorts to learn, for 
example, which individuals respond to certain types of drugs, etc., help in this direction. 
In sociology, “the concept of identity“ is a highly debated subject and concerns the 
understanding of a person’s character, situation and experiences, which can be reflected 
to the individual’s health condition and treatment as health is highly connected with 
daily life and everyday habbits (Lowton et al., 2017). Personal health-related data, 
which can easily be acquired from the use of devices e.g. sensors embedded in 
smartwatches and smartphones log data, enables the continuous collection of behavioral 
and social data too, such as communication intensity from calls, sms, twits, etc., which 
characterize social interaction, physical activity (steps count), sleep patterns and heart 
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rate monitoring which affect mood and behavior, identification in real-time hand-to-
mouth gestures that characterize smoking pattern, and many others. The associated 
social value of these new approaches to diagnosis is that utilizing such data on an 
aggregate level could allow the detection of factors such as, stress, smoking and drugs 
that have a negative social impact (Kumar et al., 2015).  
The next popular value type (V2) is defined by the improvement of decision-
making through mining all possible knowledge from vast amounts of collected data by 
supporting or even replacing human decision-making with algorithms (25.6%). Such 
capability enhances and accelerates health professionals’ diagnosis of patients and 
possibly mitigates errors in proposed therapy, when algorithmic results are explored and 
coupled with appropriate medical education. The social impact is related to the 
replacement of human labor with technology and the development of new employment 
conditions (e.g. new job positions related to medical technology management, increased 
specialization of medical staff) with debating results for the society (Loebbecke & 
Picot, 2015). It might also have an effect on the “sociology of diagnosis” theory related 
to the authority of the medical expert over the patient, and the changing power in the 
physician-patient encounter, since the patient will be aware that diagnosis and treatment 
is mainly based on automated algorithms (Lupton & Jutel, 2015), to which patient may 
have access too. Third (V3), comes the value of new business models, products, and 
services, identified in 24.5% of the articles. This includes articles that develop valuable 
tools and new products/services which assist decision-making for care and therapy for 
bigger populations. It also refers to the context of a “rapidly developing ecosystem of 
digital health technologies” including dimensions such as online forums and medical 
and health-related apps of self-diagnosis (Lupton & Jutel, 2015) that have the potential 
to be transformed to socially meaningful scientific knowledge conceptualized as a 
public good (Evangelatos et al., 2016). It is apparent from the research examples that 
the last two values are closely related. For example, the development of a 
software/application where the user can input symptoms and get a disease diagnosis and 
drug recommendation entails the support (or even replacement) of physician’s diagnosis 
and the offering of a new service available to people for everyday use.  
The next value type (V4) includes papers (17.9%) that describe researchers’ 
efforts to enable experimentation and activities to discover needs, expose inter-
experiment performance variability and improve the performance of new BDA models 
that are used in health information systems for decision-making. This will enable large 
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datasets to be analyzed and hopefully utilized for the social good, avoiding people 
suffering from resources’ misallocation (Amankwah-Amoah, 2016). For example, by 
quickly collecting and analyzing reported cases of new diseases due to the use of new 
software applications for retrieving and manipulating health-related big data, health 
systems of many developing countries can acquire an early-warning system which will 
assist public policy officials in a timely and efficient allocation of resources and 
treatments and provide people with essential health services (Amankwah-Amoah, 
2016). The following value type (V5) is gained by the coordination of healthcare 
information (15.2%) which leads to the simplification of the data service.  At the 
organizational level this can bring operational efficiencies (e.g. better resource 
utilization) and at the society level the effective information sharing across health and 
public services can improve the quality of decision towards global health issues (Dinov 
et al., 2016), such as the guidelines issued by the world health organization (WHO) 
based on health metrics gathered by national governments. 
The next value type (V6), creating efficiency (14.3%), is about the capability of 
BDA to collect data in a standardized format for reducing data identification time, 
analysis time, and the cost of search and processing while maintaining data quality. This 
will also provide the opportunity to learn, with less cost and in less time, about 
populations that were invisible only a few years ago, e.g. in developing countries 
(Grimmer, 2015) as these populations have now access to the information technology 
necessary for big data collection and sharing (Hilbert, 2014). Avoiding patient risk was 
mentioned as a value (V7) in 9.8% of the articles. It refers to the techniques (e.g. 
logistic regression models and regressions trees) that predict risk in patient health. 
Notable examples are the prediction of populations at high disease risk and the offering 
of preventive healthcare, or the likelihood of hospital re-admissions of patients and the 
recommendation of home monitoring, which promotes people’s health but also save 
money from unnecessary hospitalization and treatment. This value also refers to the 
prediction of daily events that challenge the health, security and sustainable growth of 
our society and prevent social and economic vulnerabilities (Boulos et al., 2010), such 
as violent behavior, terrorism attacks, emerging infectious diseases, etc. 
The value (V8) of segmenting populations to customize actions comes next 
(9%). Here, there are the benefits that organizations gain by capturing the share of new 
markets deriving from differentiating populations’ characteristics through clustering and 
other techniques and offering products or services tailored to the specific segments’ 
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needs, but also the societal benefits by identifying isolated or socially excluded patients, 
for example HIV patients, and offering services that can bring them together (Bram et 
al., 2015). The value (V9) of achieving cost-effectiveness holds 9% and describes the 
benefit of analytics to offer solutions for reducing organizations’ expenditures (by 
optimizing sources utilization, or capturing underpayments, etc.) while keeping up the 
quality level. These solutions, for example, could include business intelligence 
visualization and collaborative tools for identifying and eliminating non-value-added 
processes in patients with chronic diseases by tracking patient data during home, 
ambulatory and hospital care over time. On a societal level, decision support tools, 
based for example on machine learning, can provide policy-makers with more “granular 
information about the health of the population, the prevalence and geography of local 
factors that are shaping community health and where the greatest potential return on 
investment might lie if confirmatory research supports a causal link” (Lary et al., 2014). 
The hope is that policy-makers can use the freed resources to interventions that act 
positively to society or help poor communities buffer the adverse health effects (Lary et 
al., 2014), such as organize health education programs, and use public money towards 
high-risk, low-income patients that cannot afford treatment.  
The last value (V10) focuses on data security (5.1%), which is enabled by BDA. 
It may include protection from privacy breaches, securing data anonymity of electronic 
medical records, etc., suggesting the gain for organizations and society to protect 
people’s privacy.  However, the individuals seem to be likely to accept the ‘dark side’ 
of datafication through digital traces and constant monitoring through sensors, because 
they are persuaded that the benefits outweigh the costs. Businesses and governments try 
to send to citizens the message that security is more important than privacy (e.g. for 
fighting terrorism or an epidemic outbreak) (Newell & Marabelli, 2015). 
 







N % examples context 
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service to users  
Enabling the collection 
of behavioral and social 
personalized data too 
and, on an aggregate 
level, detecting factors 
with a negative social 
impact (Kumar et al. 
2015). 
286 35.6 Banos et al. 
2016 
They presented a framework called 
“Mining Minds” that enables the 
provision of personalized support 
through prominent digital technologies 
from Big Data and Cloud Computing to 
Wearables and Internet of Things, 
investigating people’s lifestyle and 
human behavior. 
  Mohan et al.  
2016 
A software in which the user can input 
information, such as the symptoms, and 
get a diagnosis for the corresponding 
disease/diseases together with the 













can be made 
available to all 
stakeholders 
1.Technology replacing 
human labor creating 
new employment 
conditions (Loebbecke 
& Picot, 2015) 
2. Challenges the 
power issues in the 
doctor-patient 
relationship (Lupton & 
Jutel, 2015). 
206 25.6 Benharref, 
Serhani, & Al 
Ramzana 2014 
Developed a decision–making system, 
the “Fuzzy Expert System” that relies on 
data collected from continuous 
monitoring (health metrics), to produce 
recommendations (related to food-intake, 
medications, and lifestyle) for both 
patients and physicians by mitigating the 
risks of chronic diseases. 
  Chalmers, Hill, 
Zhao & Lou, 
2015 
A simulation study using prescriptive 
analytics to recommend optimal in-brace 
corrections for braced Adolescent 
Idiopathic Scoliosis (AIS) patients after 
predictive modeling outcomes. The 
computer-generated recommendations 
(in-brace correction) improved treatment 
outcomes and safely reduced 
aggressiveness of treatment in some 
cases. 
















tools have the potential 
to be transformed to 
socially meaningful 
scientific knowledge 




197 24.5 Angulo et al. 
2016 
Developed a new visualization software, 
the “BRAVIZ”, that provides real-time 
statistical analyses of brain images for 
better patient diagnosis.  
  Beyan & 
Yeşim, 2014 
Developed GO-WELL, which is a 
clinical “envirogenomic knowledge 
base” to engage patients to predictive 
care using genomic data of individual 
health records to calculate risks of 
groups who have similar characteristics 














Create conditions for 
large datasets to be 
analyzed and utilized 











Developed a state-of-the-art e-health 
information system based on knowledge 
management and created a performance 
dashboard for monitoring epidemic 
diseases. 
  You, Shiaofen,  
& Jake 2008 
Proposed a new network visualization 
technique (GeneTerrainwhere) where 
differential gene expression profiles 
obtained from the human brain are 
rendered for Alzheimer's Disease 
patients with differing degrees of 
severity and compared to healthy 
individuals. The research can lead to 
innovative biomarker discovery data 
explorations for other diseases too. 
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Sharing of information 
across health services 
and countries to 
improve decision-




122 15.2 Hughes et al. 
2016 
PROACT is an application for 
smartphones which receives cancer 
patients’ clinical information and drug 
tolerability and identifies and monitors 
diet and exercise levels to improve 
patient chances of avoiding cancer 
related problems. 
  He,Wang, Gao, 
& Tang 2015 
Introduced an approach to implement 
cloud data services as a PaaS platform, 
called CDV PaaS to simplify the data 
service and balance the increasing 
demand of limited healthcare resources, 
making the citizen access to the medical 
care easier. 





and cost and 
enhancing data 
quality 
Learn, in a timely and 
less costly manner, 
about population 
metrics that were 
unthinkable only a few 
years ago (Grimmer, 
2015) 
 
115 14.3 Azadmanjir et 
al. 2015 
Described the process of creating a map 
for laboratory dashboard as a useful tool 
for laboratory managers to improve 
decision-making about costs, orders, 
time, and human resources management. 
  Boytcheva et al. 
2015 
A research for easier knowledge 
extraction by storing information from 
large amount of clinical narratives in a 
structured format. Approximately 100 
million of outpatient care notes in 
Bulgarian language were used to apply 
the method. 










Prevent daily events 
that challenge the 
health, security and 
sustainable growth of 
our society and prevent 
social and economic 
vulnerabilities (Boulos 
et al., 2010) 
79 9.8 Kulkarni et al.  
2016 
The authors explored the effectiveness of 
statistics for predicting readmission rates 
in different medical departments for 
identifying specific patients that have 
high risk of readmission. 
  Kite et al., 2015 They proved that secondary analysis of 
Electronic Medical Records improves 
patient management of chronic diseases, 
such as cardiovascular disease (CVD) for 
the identification of at-risk populations. 















information to draw 
important conclusions 
on targeted populations 
(such as HIV patients) 
(Bram et al., 2015) 
72 9 Abbas et al. 
2015 
A cloud based solution (implemented as 
Software as a Service) that provides 
personalized recommendations about the 
health insurance plans according to the 
user specified criteria. 
  Azmak et al. 
2015 
The Kavli HUMAN Project (KHP) 
aggregated biology and behavior data 
together with environmental conditions 
and events from 2,500 New York City 
households within a geographic 
information system database and 
explained how human health and 
behavior coexist over the life cycle and 







intervene on the 
determinants of 







evidence from decision 
support tools can 
allocate money to heath 
interventions which can 
save more lives and 
help poor communities 
buffer the adverse 
health effects of 
poverty (Lary et al., 
2014) 
 
72 9 Blakely et al. 
2015 
The authors provided health system 
spending estimates based on patients’ 
age and proximity to death using new 
methods of data analysis and more 
accurate costing data obtained from the 
updated health information systems 
network of New Zealand able to collect 
big data and integrate them. 
  Bradley & 
Kaplan, 2010 
Demonstrated to healthcare financial 
executives how the use of predictive 
analytics enhances their ability to capture 
charges and identify underpayments of 
















targeting of groups on 
the basis of race, 
ethnicity, or 
sociodemographics 
(Clift et al. 2014) 
41 5.1 Zhang et al. 
2016 
They presented a proximity privacy 
model of multiple sensitive attributes 
that improves the capability of defending 
the proximity privacy breaches, the 
scalability and the time efficiency of 
local-recoding anonymization.  




Present a novel application which 
provides a high level of security and 
privacy for patient data in cloud 
computing environments.  
 
4.6 Challenges from the implementation of BDA in healthcare 
industry  
 
In this section, results are presented concerning the challenges from the use of 
big data analytics in healthcare as identified in the article pool (Table 18). The Wamba 
et al. (2013) three review categories of “data management issues,” “technological 
issues,” and “organizational issues” have been used to form the table (19) and four more 
have been added: “further evaluation issues,” “regulatory issues,” “limited awareness 
and support issues,” and “political issues.” Thus, the articles have been allocated based 
on the identified challenges. Most of the issues deal with data management, security and 
privacy, with 20% representation (mentioned in 161 articles). In this category, have 
been distributed all articles that mentioned ethical issues. This important issue is related 
to informed consent for sharing, aggregating, or repurposing data related to patients. 
This further relates to the individuals’ right to maintain their privacy, and the right to be 
forgotten by erasing their personal data from health and other organizations’ databases. 
Concerns are raised in the literature about the possibility of re-identification of 
anonymized sensitive information through cross-referencing or about group-level 
ethical issues from the analysis of aggregate data, as research outcomes may favor 
populations (usually westernized) from whom data is collected. Furthermore, the 
capability of the algorithms and monitoring systems to identify relationships between 
behaviors and particular individuals raises concerns about the possibly use of this data 
for the “stigmatization” of social groups or individuals (Rich & Miah, 2017). Other 
ethical challenges involve the increasing complexity of big dataset analysis, the access 
to the technology/platforms/tools used for this purpose and the ownership of these big 
datasets, which raise issues of outcomes’ validity and capability of replicating the 
findings of BDA. An issue of paramount importance is people’s fallacy that BDA 
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diagnostic applications over the internet may replace the need to be seen by a doctor for 
diagnosis and drug prescription. In the context of a rapidly development of digital 
technologies in medicine, the existence of self-diagnosis apps will impact several 
important dimensions of patienthood and healthcare (Lupton & Jutel, 2015). This is 
both a challenge and a threat to population’s health.  
Next are “technological issues” (10.2%), which include challenges stemming 
from the lack of the required infrastructure to achieve the expected outcomes. On the 
optimistic side, technology brings advances and data that are produced more efficiently 
(Alyass et al., 2015). However, missing infrastructure is identified in cases where 
innovative analytics data-gathering platforms are absent, or information technology 
systems are poorly connected across and within healthcare organizations. The 
challenges concerning the society are mainly referred to the inequality among those that 
have the privilege of the “know-how”, such as technical specialists who know how to 
interpret and use information technology, and those who have not access to more 
complex systems (Cuquet & Fensel, 2018). 
  Under the category “Further evaluation issues,” (7.1%) are studies in which their 
authors stated issues concerning their sample, for example the sample is not 
representative of the general population or the data is inaccurate or with noise, etc. or 
there is bias in the research with regard to controlling the threats to internal validity or 
the risk of individual observer bias (Gruebner et al. 2017). Inadequate samples can 
create confusing outcomes. 
“Organizational and financing issues” are identified in 25 studies (3.1%). These 
studies report lack of cost-benefit analysis frameworks for evaluating the 
worthwhileness of the use of big data analytics for decision-making; lack of training of 
information analysts to apply big data analytics techniques in healthcare settings and of 
healthcare practitioners to comprehend the data analysis and results; lack of skills to 
support IT-enabled healthcare processes, such as telemedicine; and finally, 
organizational complexity, such as handling personal healthcare data deriving from 
different sources (labs, home devices, mobile applications, wearables and other) 
(Carroll et al., 2014).  
A small number of papers (5 papers with 0.6%) have been distributed in the 
category titled “Regulatory issues.” These include challenges for BDA due to the lack 
of new norms to integrate working practices, aligned with the new technologies. For 
example, for the creation of effective bio-surveillance systems, the governments should 
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provide to the healthcare agencies “appropriate jurisdiction to exhibit secure, continuous 
information flow with no latency across jurisdictional boundaries and to enable 
detection of previously difficult-to-detect events that span public health authorities” 
(Velsko & Bates, 2016). Four (4) articles (0.5%) have been distributed in the “Limited 
awareness and support” dimension that include papers that discuss issues about lack of 
funding for the completion of projects related to BDA in healthcare, and the lack of 
awareness for BDA and their benefits to healthcare organizations and to their decision-
makers. On the society side, dependency on private and not public funding for the 
execution of health big data projects will create a few big players in the field which will 
direct research towards their individual goals which not necessarily overlap with 
society’s goals (Cuquet & Fensel 2018). The last subcategory is “political responsibility 
issues” (noted in 3 articles, 0.4%), which describes the obstacles of political sources in 
the implementation of IT technologies, such as the lack of regulatory responsibility in 
the case of misdiagnosis and who should be medically liable for the adverse outcome: 
the developers of the software, the technology provider, the hospital that uses the 
technology, the doctor, or all of the above? (Dilsizian & Siegel, 2014). All these 
challenges were discussed by researchers as barriers to the implementation of their 
proposed approaches or to the outcomes of their research. However, more than half of 
the articles in the dataset do not refer to challenges. 
 









Issues such as  data 
integrity and privacy 
lead to poor data 
management 
Privacy violation and 
discrimination (Goh 
,Tao, Zhang, & Yong . 
2016) 
161 20 Blobel  Lopez & 
Gonzalez 2016 
Highlighted security and privacy challenges of big 
data and analytics for personalized health, such as 
bio-, nano- and mobile technologies that allow 
pervasive computing. 
  
Goh ,Tao, Zhang, & 
Yong . 2016 
Discussed current decision support systems for 
dentists and the need to be able to fully utilize 
personalized features of a clinical DSS without the 










Social inequality, as 
data are only open to a 
small elite of technical 
specialists who know 
how to interpret and 
use it", and to those 
who can employ them 
(Cuquet, & Fensel, 
2018). 
82 10.2 Zhu et al.  2015 Presented current developments in the fields of 
sensing, networking, and machine learning and 
described a project entitled “SPHERE”:a generic 
platform that gathers sensor data to generate rich 
datasets that support the detection and management 
of various health conditions. The main challenge is 
the design of innovative analytics data-gathering 
platforms. 
 Wilbanks & Langford, 
2014 
A review of dashboards for data analytics in 








Issues such as samples 
relationships or bias 
False alarms from 
missing data or not 
adequate samples 
(Dimitriadis et al. 
2015) 
57 7.1 Dimitriadis et al. 2015 The authors stated that there were bias issues 
concerning their sample to test their approach (25 
amnestic MCI patients and 15 age-matched controls 
describing it as middle-sized sample of participants). 
 
     Goldenholz et al. 2015 They reported concerns about bias in their 
simulations because they avoided to include patients 





Lack of cost-benefit 
analysis frameworks, 
lack of training, and 







conditions could also 
raise negative social 
impact (Loebbecke & 
Picot, 2015) 
25 3.1 Barkley  Greenapple,  
& Whang , 2013 
Identified the current state of data capabilities among 
oncology providers and the impact of data analytics 
on clinical and economic decision-making. This study 
revealed barriers such as lack of staff or skilled 
workforce to incorporate analytics, lack of care 
coordination, and poor internal communications. 
 Barret, 2013 Described new sources of big data in population 
health and identified as “unresolved challenges” the 
funding, administration and accessibility to a merged 




Lack of connected 
structures and of new 
ways to integrate 
working practices 
across hospitals and 
community services 
(Warrington, 
Absolom, & Velikova, 
2015) 
Lack of regulation 
about who has control 
on data creates 
confusion to data 
analytic processes. 
5 0.6 Fleurence  Grandas, & 
Meyfroidt , 2014 
Described the large national research network, 
PCORnet that has been launched by Patient-Centered 
Outcomes Research Institute to empower patients and 
their families to generate, collect, and use their health 
information for both clinical and research purposes. 
They argued that among other “if regulatory, 
challenges can be overcome, e.g. streamlining the 
consent processes while protecting patients’ rights, 
PCORnet will allow research to be conducted more 
efficiently and cost effectively and results to be 
disseminated quickly back to patients, clinicians, and 
delivery systems to improve patient health”. 
 Warrington, Absolom, 
& Velikova 2015 
Discussed the value and challenges for using Patient 
Reported Outcome Measures and e-Health 
approaches to support cancer patients care during 
treatment and their role in the development of 
appropriate and sustainable long-term follow-up 
models for cancer survivors. The biggest challenge to 
healthcare systems and professionals will be the need 
to re-organize the existing structures and create new 




Lack of funding and 
awareness 
Dependency on 
private funding will 
support few big 
players that will 
further lead to 
international economic 
competitiveness 
(Cuquet, & Fensel, 
2018). 
4 0.5 Celler et al., 2014  Demonstrated tele-health services for chronic disease 
management in Australia in a range of hospital and 
community settings and developed data analytics 
tools (modeling methods). They reported limited 
awareness and support for telehealth services among 
clinicians, service providers and patients. 
 Manchanda & Jacobs, 
2016 
Various genetic testing strategies for gynecological 
cancers, such as population-based approaches and 
genomic information along-with biological/ 
computational tools will be used to deliver predictive, 
preventive, personalized and precision medicine in 
the future, but there is lack of funding and awareness 
among clinicians about Population-based testing of 
cancer. 
Political issues Barriers to adoption of 
IT  technologies from 
political perspectives 
There are trust issues 
from the adoption of 
IT technology in 
healthcare 
3 0.4 Dilsizian& Siegel, 
2014 
Presented the advances in Cardiac Imaging using 
BDA to provide personalized medical diagnosis and 
treatment. Political perspectives (such as lack of 
liability of misdiagnosis) must be overcome for the 
adoption of new technologies. 
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4.7. The use of Machine Learning in the health field  
Machine learning, the most preferred of the analytical techniques for the variety 
of data types, offers immense potential in the healthcare predictive analytics arena for 
improving outcomes in many domains of research (López-Martínez et al., 2018). It 
facilitates the development of patient-centric models for improving diagnoses and 
intervention. Machine learning is a data analysis method that automates analytical 
model building. As a branch of artificial intelligence refers to analytical algorithms that 
iteratively learn from data, identify patterns and allow computers to make inferences 
and find insights without being explicitly programmed where to look (Breiman, 1996). 
Machine learning techniques can be used to integrate and interpret complex health data 
in scenarios where traditional statistical methods cannot perform (Shameer et al., 2018). 
Usually, a plethora of machine learning models for risk prediction are evaluated to 
choose the most accurate one. The use of machine learning based methods is important 
during data collection, dimension reduction etc. to achieve different value creation 
objectives (ur Rehman et al., 2016). 
Machine learning algorithms are proving handy in medical diagnosis that require 
more accurate prognostic models, such as detecting diabetic retinopathy (Gulshan et al, 
2016) and in medical disciplines such as oncology, and where pattern recognition is of 
ultimate importance, such as radiology and pathology (Cabitza et al., 2017).  
Through content analysis of the articles, there are some excellent examples of 
the application of the machine learning algorithm. In relation to the value for the 
diagnosis of the personalized health (V1), Bertsimas et al. (2016) developed models that 
use machine learning and optimization which identify a better combination of 
chemotherapy drugs and improve the outcome of chemotherapy regimens tested in 
clinical trials without changing toxicity levels. In line with V1 too, Voisin et al. (2013) 
identified the best performing machine learning algorithm to predict diagnostic error in 
mammography by merging gaze behavior characteristics from the radiologist and image 
features. 
To support the business value of “supporting/replacing human decision-making 
with automated algorithms (V2)”, Lary et al. (2014), used the machine learning 
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algorithms to analyze geospatial data of populations (e.g. smoking-obesity rates, 
education level, air pollution, existing health and social-support services) and to 
construct tools for public health data-driven decisions (budget allocation on health 
interventions based on best return on investment).  
A paradigm of a new innovative product (V3) that creates value to the healthcare 
business is the Wiki-Health service platform that collects, stores, and analyses personal 
health sensor data which are used for tracking existing health conditions and most 
importantly predicting them, through the use of machine learning algorithms, 
encouraging a pro-active approach to healthcare (Li & Guo, 2016). Moreover, for 
improving the performance of the model (V4), Breiman (1996) used new approaches at 
that time, such as bagging (i.e. Bootstrap Aggregation) to decrease the variance of the 
prediction.  
 
4. 8. Future perspectives as derived through the article content 
analysis 
 
 Based on content analysis, all the future goals of every article in the dataset are 
mined and grouped according to the future directions of research in health analytics. 
Not surprisingly, it is noticed that despite differences in each research’s approach, the 
future perspectives were in many cases similar. The content has been classified under 
three main headings: “technological” perspectives (the future technological 
improvements upon the presented approaches or the expected future technological 
improvements in the investigated area), “organizational perspectives (the future 
improvements of the healthcare processes on privacy, training, information 
management, cost-reduction, etc.), and “research” perspectives (the future research 
directions that the discussed approach will bring to academia). In Table 19 there is a 
summary of the classification of all future directions which provide a map of “the road 
ahead.” Since the volumes of health data will grow globally in an intense manner, and 
the demand for Information Technology (IT) infrastructure will consequently increase 
(Abbas et al., 2015), technology has the greatest role in the future of BDA in health.  
Under the “technological perspective,” many researchers reported their priority 
to develop the technological approach, as described or evaluated in their study, so that 
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in the future more advanced versions of their methods will become available.  
Researchers identified the parts of their methods that have the potential for further 
improvement with experts’ contribution and expect more innovative techniques for 
large dataset exploitation and new platforms or new mechanisms, to accrue the 
maximum value of data. They also expect from technology to extend systems’ 
capabilities and to improve the accuracy of health data advancing risk adjustment. 
Innovative digital media technologies are positioned forward for healthcare, to provide 
better, more informed and more economically-efficient medical treatment for certain 
groups (Lupton, 2014) also reducing the misallocation of resources (e.g. track patients 
across service sites, aggregate a bigger amount of data, give a more comprehensive 
view of data, make the medical record accessible to all caregivers, etc. (Barkley et al., 
2013). As it has been declared there is a definite need in health care for systems that 
support or improve the decision-making ability of clinical experts, specifically, to 
diagnose complex diseases or pathologies (López-Martínez et al., 2018). Lastly several 
researchers recognized the space for alternation in their computational approach in 
terms of proposing new modalities to successfully provide more sufficient results. 
Amongst the “organizational perspectives”, the most relevant are the future 
changes in the field of personal data privacy by the development of systems which will 
standardize and secure the process of extracting anonymized healthcare datasets from 
healthcare organizations (Al-Shaqi et al., 2016). Ensuring privacy and cybersecurity 
will enable healthcare organizations and researchers to manipulate these datasets for 
further value creation (Al-Shaqi et al., 2016). Another future direction is the need of 
healthcare organizations to train and educate both clinicians and the public regarding 
the new age of datafication or else (using the term by Lupton, 2014 ‘the digitally 
engaged patient”) the phenomenon in which people have an active role in producing and 
consuming information about health and medicine by using digital technologies. 
Organizations also are expected to integrate environmental factors into the analytics 
process and decision-making in order to detect environmental hazards, such as gas 
leakage, or to reduce environmental impact by enabling automatic operation of 
bathroom/corridor lights, reducing trips and minimizing patient falls and other.  Using 
innovative and computer-aided diagnosis systems and questioning old practices will 
bring new societal norms and will create the need for new protocols for the treatment of 
patients (Rodrigues et al., 2016) and the relationship between patients and clinicians. 
Given these created values from the implementation of data analysis in healthcare, it is 
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expected that more investments will be provided to IT infrastructure and to individuals 
with appropriate interest/expertise from healthcare organizations or from nations for 
healthcare monitoring, such as automated bio-surveillance systems at a national scale 
(Velsko & Bates, 2016). Scientists also stated that it would be useful to understand the 
extent to which design decisions are made regarding things like drug prescription 
patterns, which will affect the cost outcomes (Bjarnadottir et al., 2016). As of right now, 
little attention is given to organizational future perspective in the establishment of broad 
partnerships between manufacturers, payers, providers, and regulators in the health-care 
system to demonstrate and communicate the overall value in medicine that big data 
could bring (Szlezak et al., 2014). 
The “research perspectives” focus on researchers’ need for more studies to prove 
their hypothesis and belief that their approach could also “create value” to other 
healthcare applications. For example, including real-time sensor data from patient’s 
devices in the BDA process can further empower the clinical decision support, for the 
diabetes case, but also for other complex medical conditions, such as Alzheimer’s and 
psychosis (De Silva et al., 2015). Other researchers envision a future where big data will 
be used to guide clinical decision-making in real-time, based on individual patient 
characteristics, where large groups of patient data can be pooled from across institutions 
so that each patient and their clinicians can find ‘patients like me’ to help with real-time 
clinical decision-making (Broughman & Chen, 2016). Thus, many authors claim their 
data analytic approaches must be tested with patient demographic characteristics from 
other regions or countries to expand the scope of their models (Bardhan et al., 2015) and 
provide assumptions in a worldwide level. Lastly, there is evidence for a future use of 
the authors’ proposed approach in other scientific areas. For example, the interpretation 
of postgenomics data using certain algorithms is expected to be the center of 
knowledge-based innovations in various big data fields such as precision medicine, 
nutrigenomics, vaccinomics, pharmacogenomics, ecogenomics, and other promising 
ones on the postgenomics horizon (Ben-Ari Fuchs et al., 2016). Table 19 presents a 
summary of these future directions as they have been discussed in the article pool. 
 
Table 19 : Presentation of BDA in healthcare future aspects 
Technological perspectives N % 
Organizational  and 
societal perspectives N % Research perspectives N % 
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Development of the specific 
approach 
133 16.5 Need for privacy 37 4.6 
More studies to prove the 
hypothesis 
57 7.1 
Creation of new mechanisms to 
accrue maximum value of data 
101 12.6 
Training and education of 
clinicians and public 
20 2.5 
Propose an approach that 
can be used in other 
healthcare applications 
31 3.9 
Hardware and software development 
-extend systems capabilities 
87 10.9 
Integrating environmental 
factors in analytics for 
decision-making 
10 1.2 
Patient involvement in 
effectiveness research 
15 1.9 
Improve risk adjustment 41 5.1 
Change the protocols and 
define policy purposes 
9 1.1 
To replicate same methods 
in other countries 
14 1.7 
Identify data elements that can be 
automatically corrected 
21 2.6 
More investment in 
infrastructure 
5 0.6 
Create value to other 
sciences 
12 1.5 
Alternate the proposed approaches 17 2.1 
National investments on 
health monitoring 
4 0.5 




Cost effective analysis of the 
new tool 
3 0.4 
    
      
Create partnerships among 
stakeholders to establish the 
value of BD 
2 0.2       
 
In particular about machine learning in health, as it was identified to be the most 
used technique, future directions that derived from the dataset of the selected articles 
should focus on the following perspectives: use of unsupervised learning techniques to 
more precisely phenotype complex disease; the development of automated risk 
prediction algorithms which can be used to guide clinical care; and the implementation 
of reinforcement learning algorithms to intelligently augment healthcare providers. 
From the technological perspective, an important issue is the strain between accuracy 
and interpretability. Studies should be directed towards the development of machine 
learning decision support systems which will automatically provide clarifications, and 
offer doctors’ interactive visualization tools to examine the implications of potential 
exposure variables (Batarseh & Latif, 2016; Cabitza et al., 2017). Finally, at the 
organizational level, an important issue, is the training of doctors to assessing the value 
of machine learning–based aids in practice and avoid the reduction of the skill for 
diagnosis or the loss in judgment of the accuracy of the decision-support systems 
results. This further requires knowledge of how these machine learning algorithms work 
in practice, therefore it requires the acquisition of statistical and data analysis skills.  
Of course, as the development of technology is a step ahead of its presentation in 
academic papers, it can be assumed that recent technological innovations in analytical 
techniques are creating further opportunities deriving from hidden, up to now, 
information. Novel analytic fields, for instance, the analysis of data gathered from social 
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media or data retrieved from mobile applications, will likely lead to new information 
systems for the healthcare sector.  
 
4.9 Big Data Analytics 
 
Because big data are large, processing cannot be performed by traditional health 
informatics such as “a standalone system” with just a simple analytic software. What is 
required is a more complex, programming intensive system with a variety of skills 
(Ragupathi & Ragupathi, 2014). That is in many cases the Hadoop open-source 
platform. Hadoop released by Apache in 2011, consisting of mainly the Hadoop 
Distributed File System (HDFS/ a way to divide large data sets in smaller types and 
store them across multiple servers) and MapReduce (a computational paradigm using 
two sequences of execution - parallel processing) which includes: a) the map phase that 
produces interposed key value pairs from initial key-value pairs and b) the reduce phase 
where the interposed key-value pairs are aggregated by a key and the values are 
combined together to a final reduction output.  HBase is a distributed database built on 
top of HDFS to provide storage for Hadoop Distributed Computing using ZooKeeper as 
a coordination service (McClay et al, 2015). First, Google introduced MapReduce 
allowing big data processing on clusters with Mapping and Reducing. Yahoo developed 
Hadoop as an open source implementation of MapReduce (Van Poucke et al., 2016). 
Map/reduce jobs on Hadoop, which can also be developed on Hive (a runtime Hadoop 
support Architecture), provide a mechanism to project structure on this data and query 
them allowing MapReduce jobs in other languages when required (Van Poucke et al., 
2016).  
Business analytic tools are faced with many challenges and researchers evaluate 
them in terms of availability, continuity, ease of use, scalability, ability to manipulate at 
different levels of granularity, privacy and security enablement or quality assurance 
(Ragupathi & Ragupathi, 2014). For example, in order to overcome the major 
disadvantage of Hadoop that is tight coupling between the programming model and the 
resource management infrastructure, a new architecture was developed, called YARN, 
that decouples the programming model from the resource management infrastructure 
and delegates many scheduling functions (Van Poucke et al., 2016). Further, the Apache 
Pig dataflow system was developed to allow users to easily compose multiple data 
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processing functions because Hadoop MapReduce was restricted to practitioners with 
advanced technical skills due to the complexity of parallel operations and multi-step 
data flows (Sahoo et al., 2016). 
So overall, the computing platform most often used for the BDA tools in general 
and for the healthcare in particular is Apache Hadoop (Dinov, 2016; De Silva, Burstein 
& Jelinek, 2015). Additionally, MapReduce is a programming paradigm that provides 
scalability across many servers in a Hadoop cluster with a broad variety of real-world 
applications (Belle et al, 2015; Berger & Doban, 2014, Khan et al, 2014; Luo et al, 
2016). From the screening of the article pool, 36 papers have been published in 2016 
that present applications based on the Hadoop ecosystem with different applications and 
capabilities. From the most recent literature the presented examples come of a few 
representative studies with a reference to their data types and techniques and the 
achieved value. Along with this, there is also a discussion of the technical restrictions 
that each case brings up and attempts to overcome.  
An example of the use of Hadoop ecosystem is the one presented in the research 
of Batarseh & Latif (2016), that introduced a “user friendly” tool called CHESS and has 
been developed in Visual studio for C#, to read EΗR and provide means for analysts to 
run queries and experiments. CHESS moves the uploaded datasets to Hadoop and 
aggregated data, with much fewer rows, are settled to an SQL server for analysis. Then, 
users access them through the statistical software of their choice (e.g. excel, Tableau, 
R), and after re-organizing the data in the necessary format can run statistical tests to 
examine, for example, the importance of some factors (e.g. demographics) over certain 
health conditions.   The application relies on Hadoop for handling big data issues, and 
the users can query only smaller amounts of data to the statistical software. The 
application could benefit from more advanced clustering methods to allow for running 
statistical significance tests to identify important healthcare factors in a more automated 
way.   
In the post-genomic era, as the focus of biology has started to shift from 
mapping genomes to analyzing the vast amount of information resulting from functional 
genomics research Bodenreider & Burgun, (2005), Cui, Tao & Zhang (2016) describe 
the evolution of using Hadoop and MapReduce in the scalable and computational 
powerful cloud computing environment to perform biomedical ontology quality 
assurance (OQA). This capability has made possible to reduce the standard sequential 
approach for implementing OQA methods from weeks to hours. With this speed, more 
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exhaustive structural analysis of large ontological hierarchies can be performed and also 
structural changes between versions for evolutional analysis can be systematically 
tracked. Areas of further research are around the development of better user interfaces 
for reviewing OQA results and visualizing ontological alignment and evolution while 
also increasing the performance of the visual interface by automatically pre-computing 
intensive jobs while in interaction with the user.  
Istephan & Siadat (2016) presented a new approach of unleashing the content of 
unstructured medical data and enabling queries and processing of both structured and 
unstructured health data for the diagnosis of personalized health.  This is a step forward 
as most applications are limited to being able to query only from structured medical 
data, such as part of the EHR datasets of a population.  
For example, when it comes to medical image and EHR processing, there are 
cloud based software and platforms, such as LifeImage, Nuance mPower for sharing 
and retrieving big data medical images and other health records, but they are limited to 
using structured data (e.g. run a query on patient gender) to retrieve all relevant images 
and records and cannot handle unstructured data (e.g. query based on volume of a brain 
structure).  
Other developments incorporate models, even in a Hadoop/MapReduce 
environment (Yao, et al., 2014), that are related to pattern matching in data medical 
images. This means than an image is uploaded as an input and then feature extraction 
and similarity pattern matching techniques are used to retrieve similar images (Toews, 
et al., 2015). 
Some technology restrictions that are apparent from the selected papers with 
regards to the Hadoop and MapReduce environment is that they cannot always handle 
unstructured content from health data and medical images in the desired way.  In order 
to overcome the problem, researchers create customized tools (instead for example of a 
Hadoop component like Hive) (Istephan & Siadat, 2016). Such approaches further aid 
medical experts in getting support for decision-making with automated algorithms. 
 





In this section, there is a short description of new BDA tools to show some of 
the health decision making support systems that have been developed with the use of 
BDA. Their description give hints to health information librarians about how decision-
making is assisted through the use of BDA with examples for certain medical 
specialties. 
For this part of the study and after filtered the 804 articles and selected only 
those papers that presented BDA tools. 326 papers have been indentified, 33 of which 
were published in 2016. Because of the plethora of tools in the investigated studies there 
is an overview of the most recent developments (published in 2016) and present a mix 
of tools for different medical specialties and a variety of data types and capabilities, 
easily understood by non-technical readers.  
Table 20 includes 13 indicative tools and provides the abbreviation for each tool, 
a short description, the authors’ country (of origin) and the funding source for the 
financing of the project. Along with this, information is provided for the medical 
specialty, the developed tool, the data type analysis and the achieved capabilities (base 
on the categorization presented in the Literature Review section). The Library of 
Congress classification (LCC) coding system has been used to categorize the articles 
according to the appropriate medical specialties to assist health information 
professionals to identify the bibliographic material. Medicine is classified in LCC under 
the R class with subclasses of the medical specialties. 
 Based on an analysis of all 33 tools published in 2016 it is observed that most of 
the applications relate to medical oncology and offer predictive capabilities while the 
clinical data is the most popular data type analysed by those applications. The USA is 
the most frequently appeared country of authors’ affiliation in the dataset of the 33 
tools, with a great frequency difference from the others. Most tools were used for 
neurology and oncology specialists. For neurology, the most popular analytic capability 
of the BDA tools is monitoring, using visualisation software (such as BRAVIZ- 
presented in Table 20, or a wearable system for home monitoring (such as HMSCSE 
useful also for geriatrics). Whereas medical oncology, largely analyzed clinical data, 
either with visualized software for reporting or to differentiate cancer from other 
diseases (such as CAMA). They also use statistical methods to match patients with their 
ideal therapy (such as AED). For the cardiovascular diseases, the studies mostly use 
prediction models, using clinical data (such as the Erlang-2/BG/EG). Overall, in the 
whole dataset, most articles use clinical data for the purpose of monitoring and 
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prediction, and they are relevant to the neurology/neurosurgery/neuropsychiatry, 
medical oncology and cardiology medical specialties.  
 
Table 20: Description of new tools related to Big Data Analytics in Health 
 












clinical BRAVIZ:a visualization software that 
provides real-time statistical analyses 














AED: antiepileptic drug model 
prediction system that enables 
personalized, evidence-based 
epilepsy care, accelerating the match 












HMSCSE: Home Monitoring 
System for Care Support of Elders 
and remote monitoring of daily 
activities. 





r, et al, 2016 
Data – mining 
Reporting 
clinical G-DOC Plus: A bioinformatics 
platform that handles a variety of 
biomedical data and medical images 
for multi-omics analysisand clinical 
information for biomarker discovery 
to explore somatic mutations and 
cancer MRI images. 
USA 1.FDA CERSI Cooperative 
Agreement  





 Guo& Zheng,  
2016 




SynLethDB is the first database that 
harbors a large set of Synthetic 
lethality (SL) - a type of genetic 
interaction- and performs a 
systematic evaluation of SLs in 





 Iqbal et al, 
2016 
Reporting clinical CAMA (Cancer Associations Map 
Animation): An animated 
visualization tool  to chart the 
association of cancers with other 
disease over time. 
Taiwan, 
China 
1-3. Ministries of Science 
and Technology,Health and 
Welfare, Education, 











clinical DRESS: A double-reading/entry 
system for extracting clinical data 
from unstructured medical records 
and creating a semi-structured 
electronic health record database for 
further processing of cancer patients 










Prediction clinical Erlang-2 (BG/EG): A predictive 
analytics model, which predicts the 
propensity, frequency, and timing of 
readmissions of patients diagnosed 
with congestive heart failure. 
USA 1.UT DALLAS  










Service): a telehealth eldercare 
service that connects a remote 
physical therapist at a clinic to a 
senior at home and shows how the 
Therapist is able to monitor Patient 
status, offer verbal, auditory and 
visual cues for the patient to perform 
correct exercise movements. 
USA 1. National Science 












clinical EventFlow: a discrete event sequence 
visualization software to investigate 
patterns of drug prescription fills 
utilizing large scale healthcare data. 
USA University of Maryland/ 











GIS: A geographic information 
system that manages and visualizes 
the spatial Taiwan distribution of 
demand data and forecasting results 
for the pre-allocation of ambulances. 
Taiwan Fire Department of the 








ID-Viewer: a visual analytics 
decision support system for infectious 





RC109-216 ringPrediction clinical diseases (ID) surveillance. It is a 
blend of intelligent approaches to 
make use of real-time streaming data 
from Emergency Departments for 
early outbreak detection, health care 
resource allocation and epidemic 
response management. 
 2. DTRA (Defense Threat 





Simulation clinical IPC: an adaptable learning 
platform using virtual learning and 
distributed simulation for training 
health care workers, across a wide 
geographical area, regarding infection 
prevention control (IPC) that can be 
accessed from a conventional pc. 
England, 
Liveria 
Daily Telegraph Christmas 
Charity Appeal, United 
Kingdom 
   
CHAPTER A. 5 
5. Discussion and Conclusions 
 
Given the large numbers and frequently updating healthcare publications, 
systematic reviews assist healthcare practitioners to make decisions as they provide 
summarized research on a given topic of interest (Ali et al.  2018). The aim of the first 
part of this Thesis is to present a systematic overview of the literature in order to 
determine the way Big Data Analytics have managed to improve the healthcare domain. 
Resource–based theory is followed to identify the big data sources and the analytics 
techniques which allow big data capacities to create values which will continue to fuel 
through new research in the field. The map of the existing literature on the field of BDA 
in Healthcare has been achieved using content analysis to provide explanatory 
definitions of the categorisation through representative examples.   
Specifically, in the systematic review of the literature of 804 the created values 
from the big data resources and capabilities in the health field have indentified and 
extended the research framework to further investigate the emerging challenges and the 
field’s future perspectives. The explanatory definitions have been provided for the 
categories and the dimensions based on the literature identifying the number of articles 
discussing each dimension of values, challenges and future perspectives after content 
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analysis using the NVivo software. The results were presented and discussed through 
representative examples which focussed both on the organizational and social impact of 
BDA in health. 
The descriptive characteristics of the 804 articles which have been reviewed in 
this study reveal an explosion of publications in the field of health analytics the last 
years. Medicine and computer sciences are the most common subject areas and there is 
some multi-disciplinarity amongst authors’ backgrounds in less than half of the 
examined papers, with the authors of 11% of the papers coming from more than three 
different subject areas and around 27% of the papers being written by scientists from 
the fields of medicine and informatics..  
The findings show that the rate of publications per year, confirmed the 
assumptions of other research about the radical growth of publications in BDA from the 
beginning of this decade (Chen, Chiang & Storey, 2012; Baro et al, 2015; Wamba et al., 
2015; Andreu-Perez et al., 2015 etc.). The “Journal of the American Medical 
Informatics Association” has published a good number of papers in the field. Most 
health analytics articles are published in US journals and most of their authors work in 
the US. The domination of the US in publishing articles in the field is not surprising and 
it has also been reported in other reviews of the medical and informatics field (Brown, 
Gutman, Ho & Fong, 2018). Zhang Yin from the Zhongnan University of Economics & 
Law, China is the main author who mostly appears in publications (5 articles) and 
Stanford University is the authors’ affiliation with the biggest number of papers (20). 
The top author affiliations are also located there and the same applies with the funding 
agencies which (financially) support the research in the field. For example, the National 
Institutes for health have funded 54 studies in the article pool and the National Science 
Foundation has funded 16. Moreover, Bates et al. (2014) is currently the most cited 
paper of the 804 papers and Murdoch & Detsky (2013) is the most co-cited paper 
amongst the references of the 804 papers. Both are overview papers, describing 
applications of big data analytics to health care. Chen, M. from the School of Computer 
Science and Technology, Huazhong University of Science and Technology, Wuhan, 
China is the most co-cited author. As expected, big data is the most common keyword 
of the papers in the article pool. 
Although many different stakeholders were identified in this study, overall, it 
can be said that the final beneficiaries of BDA research in health are the patients as its 
future outcome is mainly targeted to ways of improving their health and their quality of 
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care. Most of the examined papers follow an “experimental” approach. Many of the 
papers in the article pool deal with the medical specialities of neurology, medical 
oncology and cardiology. Machine learning is a popular big data analytics technique 
that researchers use in these studies.  Almost half of the papers are predictive in nature. 
One third of the studies develop monitoring capabilities and the 70% of them use 
clinical data.  
The indicative examples provided for each subcategory aim to improve the 
comprehension of the categorization and to further increase the general understanding 
of the type of research conducted in the field of health analytics. Summarizing with the 
examples, indicative is the research in the field of population health management in 
terms of a) disease surveillance by determining disease outbreaks (mostly using social 
media and web analytics) and ensuring speedy response and needs in new vaccines 
(Lazer et al., 2014; Boulos et al., 2010; Ginsberg et al., 2009), and mostly b) (chronic) 
disease management by prediction of disease by patient profiling, in terms of 
symptoms, lab results, medical images and patient history details, for individuals’ 
accurate health diagnosis, by applying advanced analysis (such as segmentation and 
predictive modeling, machine learning, visualization, etc.) (Krumholz, 2014; Delen, 
2009). Likewise, medical staff, through decision support systems, can identify the most 
fitting treatment and medication for each patient to avoid possible complications (Barret 
et al., 2015) and identify patients with high health risk profiles to offer proactive care 
options such as screening, brief interventions, etc. (Dugan et al., 2015, Bates et al., 
2014) so as to avoid hospitalization or readmissions (Bardah et al., 2015; Demir, 2014; 
Bardhan et al., 2014). On a similar thematic area, research is concentrated on offering 
customized e-healthcare solutions, mainly at home, but in hospitals as well, by 
constantly monitoring and analyzing inbound clinical data from wearables and sensors 
and alerting health specialists about negative trends for conditions that need attention 
and possible hospitalization (Althebyan et al., 2016; Baum, 2010). Another very 
important type of research that emerges from the indicative examples is with regards to 
the use of big data technologies handling biology large datasets, such as sequencing 
human genomes to understand biological pathways and the genomic variation of e.g. 
tumor, which have led to personalized medicine, meaning offering different therapeutic 




A different type of research is about the provision of cloud services and mobile 
software that accumulates specific disease-based knowledge deriving from the 
collection of a vast amount of data from its targeted users and offers them 
“personalized” consultation for better disease management (Abbas et al., 2016; Quinn, 
2008).  From the organizational perspective, there are studies that focus on the 
improvement of health services processes and cost-reduction by evaluating performance 
of resources, monitoring workload and human error, understanding clinical and other 
processes and identifying bottlenecks in care quality with the use of modeling and 
simulation (Sir et al., 2015; Catlin et al., 2015). A similar type of research also focuses 
on more customized products/services, such as health insurance plan offerings based on 
the modeling and forecasting of a vast number of individuals’ clinical and 
administrative data (Abbas et al., 2015).  
With regard to BDA values, the most highly discussed value is that analytics 
provide “new approaches for the diagnosis and prognosis of personalized medicine” 
(35.6%), which has become more broadly applicable across healthcare (Yin & Kaynak, 
2015). It includes the process of genetic profiling to offer individual health information 
for a variety of diseases (e.g., cardiovascular disease, cancers, diabetes, etc.), enabling 
the use of personalised therapeutic schemes. This value also enables early detection of 
factors that could create a negative social impact (e.g. people with stress issues, anti-
social behavior, etc.). Another important value, is the capability to “support human 
decision-making with automated algorithms” (25.6%). Researchers need to quantify the 
real value of the analysis of the available data in everyday clinical practice. This value, 
on one hand creates new employment conditions and the demand for the acquisition of 
IT skills which in turn will lead to changing educational curriculums for health 
professionals, and on the other hand changes the doctor-patient relationship, giving 
more information to patients to challenge doctors’ knowledge. Some of the findings 
regarding the values are also supported by the review of Gaitanou et al. (2013), which 
points out that the main positive effects from big data processing in medicine are: 
positive behaviour change, improved usability and efficient decision support.  
As modernity has led to many changes in everyday social life, a remarkable 
change has been the expansion of medical activity through medical innovation in a 
variety of new areas (Lowton et al., 2017). In this study, there is also the presentation of 
the organisational and social values from the analysis of health-related big data through 
a review of the literature. This research also intends to add more knowledge to the 
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global literature by contributing to the identification of key challenges society faces by 
the explosion of analytic capabilities of health organizations. The main findings 
conclude that big data analysis offer new ways for the diagnosis and use of personalized 
medicine and for supporting decision-making with automated algorithms.  
However, there are challenges related to data management, security and privacy, 
relating also to issues of informed consent for sharing or aggregating patient data and 
issues regarding the effects of technological change to employment conditions (new 
required capabilities and skills in computer science, statistics, etc.). The development of 
the discussed approaches reveal the need for more organized ways for securing the 
privacy of personal health data, for hardware and software investment and development 
to extend systems capabilities to accrue maximum value from health-related data and 
the education of health professionals and patients to big data analytics. Data 
management challenges, which are common among fields using technology (Luo et al., 
2016), were further discussed in the papers of the article pool. Thus, the most highly 
stated challenges are related to “data management, security and privacy issues” (20%), 
in line with the findings of Wamba et al. (2013). The topic of data privacy has become 
increasingly important nowadays because of the rapid development of new forms of 
data, and the ease of transferring and sharing data. Data Protection legislation differs 
between countries as each country protects medical and health-related data at different 
level. For example, the rising concerns about data privacy have led to the General Data 
Protection Regulation (GDPR), enforceable from 2018, which strengthens 
data protection for all individuals within the European Union, and makes the export 
process of personal data outside the EU more rigorous. Under this regulation, 
pseudonymized data are still considered personal data, which means that more BDA 
health projects that use pseudonymization will now require either consent or 
authorization (Rumbold, 2017). Issues related to technological challenges come next 
(10%) and mostly relate to a lack of appropriate infrastructure for supporting big data 
analytics in health-related organizations and to the inequality among specialists’ 
knowledge of using big data analytics and their access to more complex systems 
(Cuquet & Fensel, 2018). 
In the reviewed papers, a number of issues for future directions emerged. Since 
the volumes of health data will grow globally in an intense rate, the demand for 
Information Technology (IT) infrastructure will consequently increase (Abbas, Bilal, 
Zhang & Khan, 2015). Another field for future research is the assurance of data privacy 
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and cyber security which will enable healthcare organizations and researchers to safely 
manage/ exploit the big health datasets for further value creation (Zhang et al., 2014). 
Further research is also desirable towards enabling clinical decision-making in real-
time, based on the patients’ individual characteristics, where large groups of patient data 
can be pooled from across institutions so that each patient and their clinicians can find 
‘patients like me’ to help with real-time clinical decision-making (Broughman & Chen, 
2016).  
From the presentation of BDA software, based on Hadoop ecostystem or the 
MapReduce process, this research confirms that most users use clinical or medical 
structured or unstructured data for their studies to build new approaches for the 
diagnosis of personalized health and to invent entirely new business models to reduce 
time, cost of search or processing while maintaining quality. From the articles in the 
dataset it is clear, that there is demand for research in health analytics to focus on 
improving the technological aspects. There is a definite need in healthcare for systems 
that support or improve the decision-making ability of clinical experts, specifically, to 
diagnose complex diseases or pathologies (López-Martínez et al., 2018). Progress that 
has been made via Hadoop and MapReduce has increased performance by reducing 
time and pre-computing computationally intensive jobs (Cui, Tao & Zhang, 2016). The 
main difficulty with big data in healthcare is that most data are often unstructured, 
which means that there are obstacles to computationally process the largest part of them 
(Dinov, 2016). That is why scientists are in a continuous effort to advance infrastructure 
in order to achieve the greatest possible analysis and to further develop computational 
methods in order to extend systems’ capabilities. It is expected that more investment 
will be given to IT infrastructure and to BDA experts in the health sector, or from 
nations for health monitoring, or for the development of systems that can track patients’ 
health-related data across health services and home and make these accessible to 
relevant professionals. 
This study aims to verify the status of published research on Big Data Analytics 
in Healthcare and create a descriptive classification. Trends in big data, and publication 
statistics have been widely adopted in the scholar community, but such use has yet to be 
analyzed in depth. This research adds to the existing body of knowledge and provides a 
more thorough analysis of the field with the use of content analysis, through easily 
comprehensible information based on examples.  It also attempts to continue the effort 
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of other researchers (Waller & Faucett, 2013) to explore the possibilities of big data in 
OR. 
This research is multifaceted as it deals with different health issues (different 
diseases or quality of care), it examines them from a different perspective (for 
monitoring, reporting, prediction, etc.) and with the use of different types of data 
(clinical, administrative, pharmaceutical, etc.). Overall, considering the distribution of 
papers per medical specialty it is noticeable that BDA have a crucial role to play in the 
research of the most severe diseases that humanity faces nowadays (cancer, Alzheimer, 
diabetes, etc.) and reveal the importance of innovative technological solutions to 
unanswered medical questions. Researchers from different disciplines (medicine, 
information technology, operational researchers, business administrators etc) 
collaborate to gather and actually use the vast amount of data that cannot be managed 
from the commonly implemented technology. New modeling and machine learning 
methods explore new capabilities and reveal hidden information. Since OR 
professionals are in the front line of offering improved decision-making via innovative 
modeling tools, this study provides them with the big picture of the big data analytics 
research that has been conducted in the health sector. The presented overview aims to 
answer questions like, when (chronologically), where (country and publishing journals) 
by whom (popular authors, subject areas) and what (medical specialties, research 
approach, nature of analytics) research is conducted in health big data analytics, with 
what means this is achieved (BDA data types, techniques) and through what 
competencies for health-related organizations and information analysts (BDA 
capabilities). 
Therefore, firms in the healthcare industry, in the private and public sector, 
started incorporating big data analytics for strategic decision-making (Gandomi, A., & 
Haider, 2015). However, the major reason behind big data analytics non-adoption is that 
first firms do not realize their strategic value and also their managers are not prepared to 
bring the changes because of technological or organizational difficulties (Gupta et al, 
2018). This profiling study has also the ambition to act as a trigger for health 
organizations to redesign their strategies towards a greater adoption of big data analytics 
and harness their capabilities to improve service, mitigate risks, reduce costs and grasp 
new opportunities 
In the dataset, 326 tools/applications are presented or reviewed. From these 
tools, some are already known by IT professionals and BDA researchers (e.g. Hadoop) 
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and some are introduced for the first time (e.g. BRAVIZ). From the dataset, it is 
obvious that in 2016 scientists published articles introducing new applications applied 
mostly in medical oncology and neurology/neurosurgery, with predicting and 
monitoring capabilities using, in their majority, clinical data. Many of the BDA tools 
are related to medical oncology and neurology/neurosurgery. It has been suggested in 
the literature that for certain diseases e,g. dementia, there is a demand for software 
engineers to design and develop more applications to help patients. It would, therefore, 
be beneficial for researchers to provide a road map for the investigation of this area 
(Asghar, Cang & Yu 2017) by improving current predictive, diagnostic and preventive 
models, optimizing resource allocation, and delivering more personalized treatments to 
patients with specific disease trajectories (Ienca, Vayena, & Blasimme, 2018). The 
ambition of this Thesis is also to present a research that can assist health information 
professionals in reinforcing their role in the medical and informatics scientific research 
providing practical steps to explore these in detail, e.g. investigation of the new 
technology applications of the field and the identification of new patterns for diagnosis 
and prevention of diseases.  
In terms of health and well-being, the analysis of big data offers a potentiality 
for providing enormous prognostic interventions, novel therapies, and shaping lifestyle 
and behavior, while it is the key to cost efficiencies and sustainability of healthcare 
infrastructure (Kambatla et al., 2014). Enhancing the breadth and depth of our 
knowledge about the major and minor aspects of the related field, the healthcare and 
informatics community can contribute to the creation of new approaches to strengthen 
outcomes. Methods such as machine learning that has been referred as a necessary tool 
in problem solving (Obermeyer & Emanuel, 2016), will open-up new perspectives in 
healthcare since the intelligent elaboration of more and more data will bring new 
evolution for the prognosis, diagnosis and treatment of diseases.  
 






 However, this research comes with limitations. The boundaries between big 
data analytics and data analytics as well as the boundaries between techniques and other 
subcategories are not always easily discernible, and therefore a small fragment of the 
article selection or the categorization may be debatable based on the reader’s point of 
view. Furthermore, this is a sample of the related literature and by no means is an 
exhaustive literature review of the field.  
There seems to be a deficiency of studies relevant to population and public 
health compared to these related to medicine. Although both keywords “health” and 
“medicine” were used as a sampling method and the results demonstrate that papers are 
distributed to a variety of different disciplines (Table 2c), it is true that the majority of 
the derived papers are more related to medical advancements and clinical decision 
support. This may imply that more research has been conducted towards this direction.  
The search on the two databases was conducted in December 2016.  Reviewing 
804 papers was a very demanding and time-consuming process, which took several 
months. Moreover, due to the explosion of the publications in the field (for example, 
only in 2017, 2735 new papers were identified according to the search criteria only from 
the WoS database without including Scopus), the selection and studying phase of the 
new material would take other two years. Therefore, it is inevitable to overcome the 
time lag between the year of publication of the reviewed papers and the time of the 
presentation of the synthesis of their findings. For this reason, one big limitation of the 
overview is the lack of more recent material (from 2017-19). Future research would 
include update advances in information technology in BDA. 
 Furthermore, the classification system is not exhaustive, and it could be 
expanded to include further categories and subcategories. Only the categories that could 
clarify certain questions in the area of big data analytics in healthcare are included and 
specifically with regard to what medical specialties have benefited the most, what kind 
of data are used for the analysis, what techniques are used, what is the purpose of the 
analysis (capabilities) and what is the level of analysis that has been reached (predictive, 
etc.). 
For the systematic review, articles were only obtained from Web of Science® 
and Scopus, which are, however, the world's largest multidisciplinary abstract and 
citation databases and the two mostly used in literature search (Aghaei et al., 2013) and 
comprise citations from other databases, such as MEDLINE and Biological abstracts. 
Furthermore, this study uses as a methodology a systematic literature review approach 
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which could be broaden to include many other aspects of health sociology, such as the 
effects of the commercialization of health data by organization, the changing 
environment of labor etc. The scope was to offer an overview discussion about the 
positive and negative impact of the health big data analysis in society along with the 
values and challenges created under the organizational perspective. For example, 
sociology can shed light on issues of data ownership, revealing where points of 
exploitation occur, and on issues of healthcare providers’ responsibilities and their 
capacity to enforce or discourage certain behaviors (Rich & Miah, 2017).  
 
 
CHAPTER A. 7 
 
7. Future research 
 
  Mapping the existing literature facilitates the health information professionals 
to draw new opportunities for further development. Future research under this agenda 
could investigate the benefits and the values created by BDA in healthcare and could 
focus on the new tools that are used for the analysis of the vast amount of data in the 
domain along with issues that restrict its extensive use. Therefore, further research 
could broaden the categories of this overview with more technical content (tools & 
applications) or with the identification of issues, benefits and future perspectives of 
BDA techniques and capabilities. Furthermore, it would be very interesting to follow 
the results of the presented applications over the next years with an updated study that 
could identify its contribution over the related medical fields. 
Conclusively, to take advantage of the use of BDA, and reduce risk from “false 
positives,” it is certainly important to set the focus on the exploration of the information 
provided from big data (i.e. what information, from which sources, for what purpose it 
was collected, what is the intention of the analysis, what should be explored) (Strauß, 
2015). It is unknown the extent of how digital technology and the associated big data 
analytics are going to impact society and business in the long term. Methods such as 
machine learning, which has been an essential tool in problem solving, open up new 
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perspectives in healthcare (Obermeyer, & Ezekiel, 2016). This is because the intelligent 
elaboration of more and more data brings new evolution for the prognosis, diagnosis 
and treatment of diseases. After all, the desire of medical experts is to create new 
decision support systems that reflect upon their “intuitive thinking” and minimize or 
even eliminate “personal biases” (Oztekin et al., 2018). 
A stated threat for the future is that algorithmic decision-making may lead to an 
extremely superficial understanding of why things happen, as answers will be 
prescribed from a “black box.”  This will prohibit decision-makers (such as clinicians) 
to build cumulative knowledge on phenomena and diseases, which consequently, may 
cause them to lose their capacity to make decisions on their own (Newell & Marabelli, 
2015), and therefore, be fully replaced by big data analytics. Big Data research should 
begin with a clear understanding of the value it can bring (Flechet et al., 2016). The 
demonstration of the “bright and the dark side” of the datafication in the healthcare 
industry can shed light to some of its dilemmas. Mapping the existing literature can 
facilitate health-related organizations and the society to recognize at first the impact 
from big data analytics and then revalue strategies, mitigate risks, and draw upon new 
opportunities for further development.  
Finally, mentioning that this research focuses on the contribution of big data 
analytics in the healthcare era a following research could also be oriented in the 
association between personalization, data quality, and data risk on the adoption 
decisions and find the link between social connectivity and the adoption decision 
(Koumpouros & Georgoulas, 2020). As it has been revealed in the first Part of the PhD 
Thesis the analysis of different types of data generates a lot of opportunities and 
challenges including dimensions of social, medical, and business services (Sumarsono, 
Anshari & Almunawar, 2019). Communications promote the development of emerging 
systems and applications for healthcare called mHealth can capture, store, retrieve and 
transmit various kind of data to provide instantaneous, personalized informatics and can 
be useful in monitoring health status and improving patient safety and quality of care 
(Madanian et al, 2019). For that reason, in order to discuss how health care services can 
use existing mobile healthcare systems in order to support healthcare services, the 
second Part of the Thesis proposes an analysis of the model of mobile health (mHealth) 














PART B  
BIG DATA ANALYTICS AND THE USE OF MHEALTH IN HEALTHCARE  
 
CHAPTER B. 1 
  
1. Introduction  
 
Recent trends in healthcare systems have shifted toward eHealth (electronic 
healthcare) and mHealth (mobile healthcare). The importance of these systems has 
tremendously increased due to the coronavirus (COVID-19) pandemic outbreak and the 
extraordinary need for real-time information sharing and fast decision-making 
(Soltanisehat et al. 2020). Therefore, mobile health applications (mHealth apps) are 
among the most-discussed issues for healthcare innovation, and they have potential to 
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bring revolutionary insights to the clinical research environment, providing 
opportunities as well as challenges (Cleary 2018). The term “mHealth” first appeared in 
2003 and describes the “medical and public health practice supported by mobile 
devices” (Kay et al. 2011). The concept comprises a broad range of technologies, 
including wireless, mobile, wearable and healthcare apps (Vesselkov et al. 2018).In 
recent years a large number of mHealth apps have been developed and widely used, 
making mobile technologies emerge as a powerful tool in the health care industry 
(Sedrati et al. 2016). Better understanding of digital technology creates value for 
businesses. In particular, mobile apps provide to health professionals with new 
opportunities to create value, for example by meeting new demands, increasing 
efficiency, supporting knowledge-sharing and improving competitiveness (Ehrenhard et 
al. 2017). 
Medical practitioners have begun using apps and other digital technologies as 
part of their practice, and it is also common for medical students to use a number of 
apps- such as anatomical atlases, reference tools, and question banks- for their 
education (Ellaway et al. 2014). Thus, the new digital-native generation of millennian 
students that search for and use educational content from digital devices (Montiel et al. 
2020). A 2012 survey about mHealth found that 87% of doctors use mobile devices in 
their workplace and 85% of faculty members and students of medical schools use them 
in a wide variety of clinical settings ranging from classrooms to hospitals (de Camargo 
2012). Even 80% of physicians aged 55 and above own a smartphone (Ventola, 2014), 
and this percentage will have further increased in recent years. 
Many positive outcomes of mHealth have been reported, such as faster or more 
efficient delivery of care to patients, better monitoring of diseases and increased 
productivity of healthcare service providers (Chatterjee et al. 2009). Mobile technology 
can have a positive impact on healthcare delivery processes (Free et al. 2013), offering 
connectivity and accessibility to patients records in addition to  a wide range of 
advanced capabilities (Lomotey & Deters 2018).The benefits offered to medical 
professionals can be especially valuable for their day to day activities and for making 
diagnoses (Goldhahn & Spinas, 2018; Fox and Connolly 2018) by leveraging the data 
that are collected from various sources (Sarker et al. 2020). The most recent mobile 
applications utilize advanced technologies, such as artificial intelligence (AI) to 
incorporate expert systems, speech recognition, machine learning, machine vision and 
others. As the adoption of smartphones increases, mobile apps are a natural way to 
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deliver machine learning algorithms (Zakhem et al. 2018) and there is a rising demand 
for mobile apps with AI services (Ji Wang et al. 2018).Artificial intelligence systems 
simulate the human mind by learning, reasoning and performing self-correction, and 
these systems can even be more accurate than physicians in diagnosis in specialties such 
as surgery, radiology, dermatology and intensive care (Goldhahn & Spinas, 2018).  
Several types of AI have already been employed and the applications mostly involve 
diagnosis and treatment recommendations, patient engagement, education and 
administrative activities (Davenport & Kalakota 2019). Their development has been 
lately accelerated also by the need for new diagnostic and therapeutic methods in the 
2020 coronavirus disease pandemic (Kernebeck et al. 2020).The most useful application 
of AI mobile apps for health professionals is to generate a better decision using the AI 
technology in order to report the status of the patient’s health and provide advanced 
disease control, customization and personalized diagnosis and treatment (Alotaibi 2020; 
Siuly & Zhang 2020).  
Nonetheless, the innovative use of apps for health purposes presents many 
challenges ranging from ethical issues (e.g. privacy) to credibility issues (e.g. accuracy 
of content). For example, there are privacy concerns related to ownership of the 
personal health data collected from app users and the right of mobile app companies to 
sell or store the data (Galetsi et al. 2019). Reliability issues relate to whether and how 
the information provided by mHealth apps are evaluated - there are reported cases of 
mHealth apps offering dangerous and harmful advice to medical professionals 
(Wisniewski et al. 2019). However, some have argued in favor of replacing doctors with 
these mHealth apps that provide automated decision-making, which in certain 
specialties is said to be more accurate (Goldhahn et al. 2018). “IT consumerization” - 
the  adoption of personal IT for decision-making in workplace- may influence how 
change occurs in organizations (Junglas et al. 2019). Therefore, it is essential to both 
explore these new working models that medical professionals use to enhance efficiency 
in the workplace and also to set rules for acceptable mHealth apps that respect privacy 
(Nerminathan et al. 2017). 
The doctor-patient relationship (Jutel & Lupton 2015) is also challenged with 
apps that are marketed directly to consumers for evaluating their own health. But also, 
from the moment that personal health information is digitized and entrusted to 
healthcare professionals and the app developers as vendors of the technology that 
manage health information systems (e.g. electronic health records), questions arise 
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regarding how this information is used and protected (Fox & James 2020).The 
collection of personal health data from app users also  raises privacy concerns related to 
data ownership and its right to be sold or stored by app companies. A recent example 
related to the containment of the pandemic COVID-19 is the use of AI apps for digital 
contact tracing at the societal level for which people actively resist adoption because of 
privacy concerns (Riemer et al. 2020; Kumar et al. 2020). Therefore, mobile devices 
present new challenges to the security and privacy of users where sensitive data could 
be vulnerable to attack by third parties(Ismagilova et al. 2020). 
Due to the fact that it is difficult to regulate this enormous and growing volume 
of apps, one practice that requires careful scrutiny is that of developers' privacy policies 
and data security practices (O'Loughlin et al. 2019). Since 2018, Europe has 
experienced a major change in data privacy regulation under the EU General Data 
Protection Regulation (GDPR) (Regulation 2016).More specifically, the “Privacy Code 
of Conduct” on mHealth apps, facilitated by the European Commission (European 
Commission 2018), consists of practical guidance to app developers on data protection 
principles and addresses notably topics, such as purpose limitation and data 
minimization (data may be processed only for specific and legitimate purposes), data 
retention(personal data may not be stored longer than necessary), security measures to 
ensure confidentiality throughout users’ navigation and interaction experience, etc. In 
the US, the Food and Drug Administration (FDA) has developed three distinct 
categories of mobile health apps to define the requirements of regulatory oversight. The 
Federal Trade Commission compiled a list of best practices to advise the development 
of health apps, such as for minimizing collection of user data and limiting both access 
and permissions to the users' phone (O'Loughlin et al. 2019). 
Beyond privacy concerns, there are cases of apps that have been reported to 
offer dangerous and harmful advice to professionals responsible for decision-making in 
clinical care (Wisniewski et al. 2019). mHealth apps are of variable quality, ranging 
from those that appear to have the support and input of valid health organizations, such 
as the American Heart Association and from distinguished medical experts to those that 
offer little to support their knowledge claims. The lack of information provided by 
many app developers also raises questions about how users can be reassured of their 
quality and safety. A lack of meticulous testing the efficacy, reliability and accuracy of 
these applications is reported (Wisniewski et al. 2019; Sedrati et al. 2016). Hence, due 
to the fact that health professionals use mobile devices to enhance efficiency in the 
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workplace, there is a need to investigate these new operational models in everyday 
clinical practice and a need for guidelines for acceptable and ethical use that respects 
privacy (Nerminathan et al. 2017). 
Despite rapid technological innovation and the variety of attractive medical 
apps, society demands a more regulated environment concerning their use (Cleary 
2018). Many studies report the lack of regulation in health promotion (McKay et al. 
2018) and the limited research evaluating mHealth apps’ accuracy in giving medical 
advice and the theoretical foundations that underpin them (Payne et al. 2015). 
Therefore, further investigation is needed to evaluate the quality and effectiveness of 
these apps (McKay et al. 2018). According to Sadegh et al. (2018) the outcomes of the 
use of mHealth can either positively or negatively affect stakeholders, who include the 
society (patients, their relatives and all people who are affected by the service),  health 
professionals, public or private health organizations service or infrastructure providers, 
and legislative bodies (Sadegh et al. 2018). 
  To sum up, the mHealth apps for professionals are of multiple utility ranging 
from apps useful for educational and diagnosis purposes to apps useful for improving 
operations management in a clinical routine. The apps are also of variable validity, 
ranging from those that have the support and input of known health organizations, such 
as the American College of Cardiology Foundation and distinguished medical experts to 
those that do not provide identification of their knowledge claims. Therefore, certain 
app characteristics, such as the identification of the information source, may affect the 
app’s perceived trust by the user. The lack of information provided by many app 
developers raises questions on how users can be reassured of these apps’ quality, safety, 
reliability and accuracy (Sedrati et al. 2016). On the other hand, in order to increase 
revenues from freely available applications, app developers provide in-app purchase 
options and/or in-app advertisements that may cause annoyance and disapproval, as it 
displays distracting features, such as animated banners, pop-ups and floating 
advertisements that could decrease the demand of an app (Ghose et al. 2014), especially 
when targeted for professional use. 
Triggered by the rapid development of available mobile apps related to health 
diagnosis and decision-making, this study’s goal is to analyze available mHealth apps 
targeted at health professionals and students for supporting the diagnosis procedure. For 
that reason the selected applications and their intention of adoption were examined by 
different angles to highlight each time a different way of thoroughly investigating these 
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apps for professionals. Thus, the second part of the PhD Thesis provides a multi-layered 
analysis consisting of three investigations using three different conceptual frameworks 
in order to explore and explain the introduction of mHealth in professional clinical 
routine. The three parts of the research will be structured as above. 
a. Examination of the ethical issues that are incorporating using Communication 
Privacy Management (CPM) theory to explain the process of appropriate 
mHealth apps’ selection based on their privacy, security and reliability features 
giving emphasis to Health apps that use artificial intelligence. 
b. Examination of the innovative adoption of digital tools (use of apps) in health 
diagnosis, using the Normalization Process Theory (NPT) to explain the social 
context of how users and managers relate to the system,  how the system fits 
with the working environment (Sharma et al. 1991), and how health 
professionals can engage with certain categories of health apps and use them in 
clinical practice.  
c. Acknowledging the tremendous explosion of mHealth apps and the increasing 
use of mobile devices by medical professionals, it becomes important to 
understand the underlying drivers of user demand for mobile health apps. 
Therefore, the objective of this study is also to investigate the factors of 
successful integration of health smartphone apps in clinical routine and to 
identify the factors that influence professional consumer behavior. Multiple 
regression analysis and inferential statistics was then employed to find the 
association between the groups of variables, such as perceived usefulness, 
perceived ease of use, perceived trust, app quality evaluation and intention to 
download the application using a combination of the Technology Acceptance 
Model (TAM) and the Theory of Reasoned Action (TRA). The study provides 
several recommendations to both health professionals and app developers. 
Given the reported deficit of knowledge about mHealth apps’ social dimensions 
(McKay et al. 2018; Payne et al. 2015; Nerminathan et al. 2017) and the little evidence 
to demonstrate the effectiveness of the uptake of mHealth technologies (Cegarra-
Sánchez et al. 2020), this research is the first study that investigates the social 
dimensions of the integration of mHealth practices in health environments, such as 
hospitals, medical schools and clinical workplaces. It presents an analysis of the factors 
that affect the implementation of innovative practices in health diagnosis, describes the 
requirements for their use in daily clinical practice and reveals their level of usefulness 
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and trustworthiness for professionals. It also enlightens app developers and information 
scientists about the importance of the existence of certain features and provided 
information available in the app stores to help further the engagement of people that 
intend to use the specific technology in the workplace for decision-making. 
Additionally, this research informs the stakeholders about popular health app types and 
the interrelationships of app features with app performance measures that make them 
more attractive in the specific professional field and what innovations and 
improvements could enhance the process of engagement. This research also contributes 
to the need of studies that examine expert systems in mHealth and their general benefits 
to medicine and the society.  
The next section provides the literature review upon the scientific field in 
general and about the related ethical challenges. The methodology section describes the 
followed methods for the research. Three different studies have been conducting based 
on three different conceptual frameworks in order to provide a holistic view of the 
investigated topic. The results of the analysis will be presented along with the 
conceptual frameworks to reveal the three aspects of investigation of this scientific topic 
based on the adoption of information technology innovation intervention practices in 
clinical routines. Therefore, this research refers to various fields ranging from 
information systems and digital marketing to health and social sciences, contributing 
towards the need of studies that examine consumer behavior under different information 
conditions for enhancing our understanding of new e-markets (Grover, Lim, & 
Ayyagari, 2006). 
 
CHAPTER B. 2 
 
2. Literature Review  
 
In the literature several studies investigate health apps related to patients and 
consumers. A number of them examine the effectiveness and features of apps related to 
monitoring and managing chronic diseases (e.g. Donker et al. 2013;  Wang et al. 2014) 
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or to health and fitness apps (Cowan et al. 2013; Higgins 2016). However, further 
investigation into mHealth app features is worthwhile given the inability of the most 
common features to explain a large portion of an app’s rating (Mendiola et al. 2015). 
More recently, a survey study found that prior IT experience and perceived self-efficacy 
positively influence patients’ intention to adopt mHealth apps provided by clinics or 
hospitals (Balapour et al. 2019). Despite the number of studies evaluating mHealth apps 
for patients and consumers, there is very little research focusing on mHealth apps for 
medical professionals. There are a couple of overview and review studies on the subject 
that conclude that the use of mobile devices by health care professionals will transform 
many aspects of clinical practice (Cleary 2018; Ventola 2014) and especially these apps 
that use artificial intelligence and deep learning algorithms will revolutionize the 
everyday clinical routine (Rajkomar et al. 2019; Alotaibi 2020).A meta-analysis study 
investigated the effectiveness of mHealth interventions for supporting health-care 
providers and found that mHealth modestly improved aspects of clinical diagnosis, 
management and communication between healthcare providers and patients but 
mHealth attributes, such as diagnosis based on photo sharing, had a negative effect 
(Free et al. 2013).  
With regard to studies about mHealth apps there is a main focus on patients or 
consumers. Several have investigated the usefulness and functions of health and fitness 
apps (Cowan et al. 2013; West et al. 2012; Lister et al. 2014), monitoring and managing 
chronic diseases (Donker et al. 2013; Blake 2008; Beratarrechea et al. 2016; Li et al. 
2019),or their effect on health behavior interventions (Zhao et al. 2016; Wu et al. 
2012).There are also studies about mHealth apps’ acceptability and utility (Robinson et 
al. 2013), identifying which are suitable and practical for administering health 
interventions and can benefit users and consumers (Payne et al. 2015; Donker et al. 
2013). These studies also identify that more rigorous research is needed to evaluate and 
determine their efficacy and provide evidence for best practices (McKay et al. 2018; 
Payne et al. 2015). 
 Some studies have examined user experience and desired functions (Lyles et al. 
2011), such as the existence of sufficient information, users’ evaluation (McKay et al. 
2018), and features that save time and are simple and intuitive to use (Mendiola et al. 
2015). Text explanations, visualizations, examples, simplification, and feature relevance 
are the most common techniques humans use to explain systems to others, who can then 
process the information. The selection of the most relevant technique depends on the 
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audience for which the explainability is targeted. Feature relevance explanations 
methods clarify the inner functioning of a model and the importance it places on each of 
the such variables when producing its output (Arrieta et al. 2020). 
Mobile apps can be seen as a kind of consumer product (Hsu & Lin, 2015) and 
the fact that there are over 300,000 healthcare-related apps in the market (Zulman et al., 
2016) makes it impossible for any clinician or patient to remain aware of all health 
apps.  The greater accessibility of consumers to online marketplaces the greater the 
number of options, thus consumer choice behavior has become more and more 
important to business managers (McKie et al. 2018). There have been some efforts in 
the literature to understand the selection criteria of a user when downloading a health 
app, considering their variety in app stores. A study that investigated 129 urology apps 
to identify predictors of the number of downloads found that: apps developed with 
urologists’ involvement, with higher user ratings and number of written reviews, lower 
or zero price and optional in-app purchases were more likely to have more downloads 
(Pereira-Azevedo et al., 2016). In another study about mobile apps, not exclusively in 
the health sector, researchers tracked individual apps and their presence in the top 300 
charts in the app store and used a generalized hierarchical modeling approach to 
measure sales performance and found that attributes such as, free offering, high initial 
chart rank, continuous feature updates and high user review scores have positive 
impacts on apps’ sustainability (Lee & Raghu, 2014). Moreover, according to Krishnan 
& Selvam (2019) high user ratings, frequent updating, long standing market presence, 
and those offered by US companies are among the factors that boost app downloads 
(Krishnan & Selvam, 2019). Even though literature indicates that app demand is 
affected by the price, it has been stated that the option of in-app purchases and in-app 
ads can affect a user’s decision to download the app and get access to additional 
features (Ghose & Han 2014). There has also been indicated that app demand is related 
to the file size, app’s age and the developer’s textual and visual description of an app. 
These factors can positively contribute to the willingness of users to download an app 
(Carare, 2012).  
 Sadegh et al 2018 reviewed 76 studies in order to define an evaluation 
framework for mHealth applications considering the mHealth service evaluation process 
from analysis stage to implementation stage with regard to different mHealth 
stakeholder's points of view (Sadegh et al. 2018). Based on the literature, consumer 
usability evaluation is affected not only by contextual factors, but also by consumers’ 
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beliefs about technology, technology readiness and by different belief structures 
(Massey et al., 2007) and while it has been stated that there is a correlation between the 
star rating of an app and its number of downloads, there are serious concerns for the 
lack of quality of apps across all fields of healthcare (Wisniewski et al., 2019). 
Research has shown that one of the most important challenges when using 
digital information technology and apps is related to privacy, security and accuracy 
issues of data management (Galetsi et al. 2019; Walsh et al. 2019; Yaacoub et al. 2020). 
Thus, ethical debates are raised for developers, regulators, and managers interested in 
mobile development (Shilton & Greene 2017). For example, self-diagnosis smartphone 
apps are criticized for their implications to privacy of patients’ personal data and the 
possible effects on the doctor–patient relationship and medical authority in relation to 
diagnosis (Lupton & Jutel 2015). The goal in this ethical context is to provide further 
suggestions for ethical data management, apart from legal necessity, and follow societal 
tensions regarding the ethics of data-driven products and services that existing norms 
still fail to intercept (Loi et al. 2019). However, there is still a lack of proper 
understanding of the required computational and analytical framework tools for these 
technological developments (Istepanian & Al-Anzi 2018).  
There have been some efforts in the literature on understanding whether ethical 
considerations are among the selection criteria of a user when downloading a health app 
considering the variety in app stores. A recent study used app features to identify 36 
criteria that are important to the design, development and analysis of mHealth-related 
apps. Amongst them, privacy stood out as the compliance with the law and treatment of 
users’ data, security as the data protection, authorization mechanisms and detection of 
vulnerability (Llorens-Vernet & Miro 2020). 
Another study reviewed general app features, in order to investigate the 
comprehensiveness and quality of information, the study indicated that less than a  
quarter of the investigated mHealth apps provided a privacy policy and many lacked 
source citation to help users evaluate their quality (Nicholas et al. 2015). An overview 
of the literature that discussed the methodologies introduced so far for the identification, 
characterization and assessment of health apps by doctors outlined that the most 
significant components of app trustworthiness are privacy of data, reliable app 
developer, scientific verification, clinical validated information and ease of use 
(usability) (Paglialonga et al. 2018). 
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The World Health Organization ran a global survey in 2009 about the adoption 
of mHealth. The report refers to mHealth apps that support mobile telemedicine for 
consultation between healthcare professionals and patients; patient monitoring through 
installed sensors in households; and patient records repositories, appointment reminders 
and medication reminders to improve treatment compliance and support systems for 
diagnostic decisions, all of which are relevant to medical professionals (Kay et al. 
2011). However, the survey concludes that the level of adoption of these mHealth 
categories is quite moderate and the lowest adoption is identified in diagnosis decision 
support systems. A review of health apps assessed by doctors identified that the most 
important app capability was ease of use (usability) (Paglialonga et al. 2018). It has also 
been proven that the willingness to adopt mHealth could be reduced by mistrust or 
beliefs about risk, which have an interconnected influence on adopters (Fox & Connolly 
2018). 
However, the recent literature discusses the opportunities and challenges of AI 
implementation in healthcare (Goldhahn et al. 2018; Rajkomar et al. 2019; Davenport & 
Kalakota 2019; Siuly & Zhang 2020), a review paper discusses the AI applications in 
mHealth (Alotaibi 2020) and there are papers focusing on  a single medical specialty 
that discuss mHealth apps with AI, e.g. (Zakhem et al. 2018; Gamble, 2020). 
Unfortunately, no studies have been identified in the literature, which analyze the 
features and challenges of mHealth apps for medical professionals that utilize artificial 
intelligence technologies. Therefore, another research gap has been identified.  
 
CHAPTER B. 3 
  
3. Methodology  
 
This study aims to describe and catalogue available mHealth apps for medical 
professionals and/or medical students. This analysis was focused on Android apps, 
because smartphones using the Android operating system are currently holding the 
largest market share in the United States and worldwide (Hoeppner et al. 2016). 
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Therefore, only apps available in Google Play were considered, excluding those that are 
designed only for iPhones, following the approach of other relevant studies (Jutel & 
Lupton 2015; Martínez-Pérez et al. 2014; Sedrati et al. 2016). To obtain a sample of 
such apps, a review has been followed of all smartphone apps in “Play Store” listed 
under a wide range of search terms.  
 Initially, the search included the terms of “diagnosis” and “prognosis”. 
Following selection criteria, this search provided us with a sample of 139 related health 
apps. Next, the search continued with the terms “medical”, “clinical”, “diseases”, 
“symptoms”, “doctors” and physicians”. After successive searches, it was realized that 
the returned results repeated the majority of health apps, apart from 29 new apps that 
have been included in the pool. Each app underwent an initial screening based on the 
descriptions and associated screenshot images provided by the store. Inclusion of an app 
in this evaluation required meeting the following criteria: (1) was intended for diagnosis 
and prognosis, (2) was addressed only to medical professionals or medical students, (3) 
was not requiring subscription to another program to operate and (5) was in English.  
After a day of using each app, another screening against the inclusion criteria was 
undertaken, and those failed to meet the criteria, were excluded. The apps’ selection 
took about 3 months, from December 2019 to February 2020. 
After scrutinizing all apps, data from the selected apps were added in an excel 
file. This process included tasks such as reading in-store descriptions, user reviews and 
collecting relevant information after downloading the app on an Android smartphone 
and using it. Figure 1 presents the methodology framework. 
 






 A specific taxonomy has been followed concerning the formulation of categories 
and the grouping of the apps in the sample accordingly. The target was to categorize 
apps into different types based on their main purpose. First, it has been used deductive 
reasoning for the content analysis of the apps using the descriptions provided by the 168 
apps. The deductive qualitative content analysis was based on the descriptions of the 
apps and the app types were continually refined and finally identified in full. It has also 
been used the inductive method by grouping the apps into the identified categories 
(Ameel et al 2020; Backman et al 2020). A similar process was also followed for 
identifying all app features relevant to privacy-security and all features relevant to 
reliability. Therefore, each app was reviewed for its characteristics based on the 
information provided by its developer and its user comments (Hoeppner et al. 2016; 
Stoyanov et al. 2015).  The collected descriptive information with their technical 
aspects about security/privacy and reliability dimensions (e.g. log-in, password-
protection, brand recognition) is presented in the results section and in the related tables.  
The taxonomy has been used to identify the features of the mHealth apps and the 
types of apps for medical professional and then to provide valuable insights into how 
the taxonomy is relevant to discuss which app types include more certain features and 
why. This process has been repeated for apps that utilize artificial intelligence along 
with discussing what medical and operational outcomes attempt to achieve.  
Triggered by the main results of this research the aim of this study is to compile 
an agenda for potential useful future apps for medical professionals and for this purpose 
there has been a second research in the recent relevant literature. This secondary 
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research has been conducted to fill the gap that has been created since the research in 
the App Store revealed only a small sample of AI mHealth applications for 
professionals but very useful indeed. The second search has been conducted in the Web 
of Science database by using the key terms artificial intelligence (AI), machine learning 
(ML) and health/medicine and focused on important articles from journals such as 
Nature, Health Affairs, JAMA, etc. Then a quick visit has been followed in a number of 
online sites of mobile app developers using AI and ML, such as FRITZ AI and the APP 
Solutions, and read relevant reports on how AI and ML can be used on mobile apps. 
Therefore, a future agenda for such apps further investigates the road to innovation and 
clear guidelines are provided for managing the ethical challenges that emerged from the 
main part of the research. 
Finally, for the empirical analysis of the research the SPSS statistical software 
has been used to provide the results for the empirical analysis. 
 
CHAPTER B. 4 
 
4. Conceptual frameworks and results 
4. 1a. 1st Conceptual framework. “Communication Privacy 
Management” 
 
The first study is based on the “Communication Privacy Management” (CPM) 
theory to explain the way app developers and health professionals behave towards data 
privacy issues related to a health app and expanded with the inclusion of the 
information reliability perspective. The CPM theory recognizes that individuals 
(owners) believe that they own their private information and have the right, on one 
hand, to share it with other individuals or entities (co-owners) but, on the other hand, 
need to control it using ‘privacy boundaries’ that define whether their information is 
protected (Petronio &  Child 2020). Users consider that they can decide with whom to 
share their own private information and their judgment to entrust it to a co-owner 
involves the risk-benefit dynamic, which is governed by the privacy rules, to avoid 
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boundary turbulence (when privacy rules are not followed by co-owners) (Ngwenya et 
al. 2016).Hence, this theory can contribute to the investigation of the effects of privacy 
policy on users’ perception of security in the context of information sensitivity of 
mobile apps (Zimmer et al. 2020) and provides a way to understand how security of 
private information occurs in different contexts like using mHealth apps during 
practicing diagnosis.  In the conceptual framework the CPM theory has been expanded 
considering that, especially for mHealth apps, the reliability status of those with whom 
the private information is shared (co-owners) makes a difference. Therefore, questions 
like how reliable is the app developer (brand recognition) and whether the app 
information derives from credible sources are issues that should affect the selection of 
these apps and the sharing of private data (McNiel & McArthur 2016; Nouri et al. 
2018). Moreover, the reliability aspect adds a trust element on users’ perception which 
has to do with the app accurately performing the tasks that promises in the app 
description (Boudreaux et al. 2014). Based on their tasks, which define the app’s 
purpose and usefulness, the mHealth apps for professionals are categorized into 
different types. Therefore, the features of privacy and reliability may be assessed for all 
mHealth apps together but also per their type. A special focus is given in the “smart” 
app types that use artificial intelligence as there is an evident growing demand for these 
apps (Wang et al. 2018). 
In the conceptual framework of Fig. 2 this process has been explain on the basis 
of the expanded CPM. The first stage of the conceptual schema involves the health 
professionals who are the information owners (of their patients’ data and their own data) 
and the decision-makers for considering using an app based on the app usefulness 
(defined by the type of app and the use of AI technology) created by the app developer 
(data co-owner). In other words, health professionals download apps to fulfill a variety 
of needs and use the app tasks for different diagnosis purposes. This need leads to the 
induction of personal data (their own or their patients’) in the mobile apps that decide to 
download and use, creating co-owners of the information that in this case are the app 
developers. The second stage of the process explains the criteria (boundaries) used by 
the information owner to perform judgments about the app trustworthiness, which is 
determined by the app features that inspire privacy and reliability. There has been an 
assessment of the level of the two app trustworthiness tiers that app developers have 
added to avoid boundary turbulence of medical professionals when selecting the 
mHealth app. Therefore, this stage of the conceptual framework, describes the added 
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app features by app developers to abide with the user boundaries and remove turbulence 
(non-selection of the app). During this procedure the health professionals (information 
owners) decide whether or not an application can be perceived as trustworthy for 
adoption in the medical practice. The certain app features that have been analyzed are 
the features related to privacy boundaries and the features related to reliability 
boundaries. 
Through the investigation of the health apps addressed to health professionals, 
there has been an attempt to explore the ethical debate between innovation, privacy and 
trust and to identify the most innovative of the mHealth apps for professionals by 
emphasizing the ones that use artificial intelligence methods and the expectation for 














The results of the study follow the basic elements of the conceptual model. In 
the first part of the results section, there is a description of the added app features by 
app developers with regards to privacy and reliability concerns to avoid user turbulence 
(non-selection of app by users) and the different types of health apps currently available 
for professionals that define their usefulness. Indicative examples of apps per type, 
features, and comments from user reviews are provided for better comprehension. In the 
second part, there has been an identification of the apps from the sample that include 
artificial intelligence (AI) technology and an analysis of them as per their type and 
features of privacy and reliability. The third part of the results presents an agenda for 
future useful mHealth apps for professionals and describes mitigation actions for 
overcoming privacy and reliability issues concerning the current and future use of these 
apps.  
 
4.1c. App features and related challenges of digital healthcare 
 
The sample in the current study was analyzed based on the information provided 
in the App Store. Most of the apps had more than 10,000 downloads which means that a 
good number of professionals were at least interested in finding a helpful app to assist 
them in the diagnosis or learning process. In the following tables there is a presentation 
of the accumulated descriptive characteristics of the sample of 168 mHealth apps 
targeted to medical professionals. There has been also an identification of the privacy 
and reliability feature categories available in the apps, which developers have 
incorporated to avoid turbulence in user judgment about the accepted boundaries of a 
trustworthy app based on the conceptual framework. Table 1 lists the sum of the app 
features based both on the description provided in the App Store and by finding its core 
functions after installing and opening the app. The mapping and measuring of these 
characteristics provide a first picture of the current attributes that are incorporated into 
the professional health apps. The description that follows provides an understanding for 
these features supported also by examples. 
 




Features (F) N % 
a.PRIVACY 
DATNAGEMMAAMANAGEMENT 
    
Privacy policy 147 87.50 
Authorization 66 39.28 
Email request 48 28.57 
Password protection 44 26.19 
Registration 42 25.00 
b. RELIABILITY      
Brand recognition 121 72.02 
Bug Fixes 80 47.61 
Credible source 76 45.23 
Feedback 53 31.54 
Help function 52 30.95 
 
a. Privacy is not simple to be analyzed in terms of technical characteristics because 
many factors affect privacy and some of them concern auditing of the apps while 
others concern the auditing of the apps' providers (Benjumea, 2019).The 
declaration of the “Privacy Policy” discloses information about the developer 
and the terms and conditions of using the app, as the ‘compliance with the law 
and treatment of users’ (Llorens-Vernet & Miro, 2020). In this paper, the term 
“Privacy Policy” is considered a feature. The focus has been oriented on the 
declaration that describes the Privacy Policy (known as ‘data subject’ in the 
GDPR) and it has been reassured  if its internal procedures comply with official 
regulations (e.g. GDPR). In the case of privacy concerns it has been observed 
that out of 168 health apps, 147 (87.5%) had a declaration of Privacy Policy and 
a full description of the policies that the company follows for the interpretation 
of stakeholders’ data. For example, the Privacy Policy declaration of “Skyscape 
Medpresso, Inc.” which is the company designer of many health applications, 
such as Ferri's Clinical Advisor, describes the firm's practices towards users’ 
personal information. They inform their clients about their policies on: 
children’s information, users outside of the United States, the personal and non-
personal (anonymous) information collected, and the way the company uses the 
information. Typically, this information tracks users patterns throughout the 
company’s website, and it may include information such as browser type, 
operating system, date/time stamp of their visit, IP address, domain name, 
referring URLs, statistics about the number of visitors to the site, the number of 
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pages visited, the user response rates, etc. The company also informs the app 
users that it may use or disclose personal information if it detects actions that 
damage the website or will prevent illegal activities. Lastly it states the security 
measures (e.g. use of firewalls, secure connections on website, the use of 
Secured Socket Layers) it takes to help protect and safeguard personal 
information from accidental loss, misuse, unauthorized access, disclosure, and 
alteration or accidental destruction. Most importantly, in the declaration form 
they state the possibility to make available users’ personal information available 
to third parties for marketing purposes and provide their contact details in case 
of user disagreement. On the other hand, the auditing of the mobile app provider 
is related to user’s consent to the Privacy Policy declaration. The user must 
accept the terms of the privacy statement so that the provider is permitted to 
manage the requested data, for which access has been requested or to give out 
data to third parties.  There has been also a classification of the apps in the 
“Authorization” category when users’ acceptance of the company’s terms and 
policies was necessary for allowing access to their personal data and exploitation 
based on company’s policies. Only after consent could the app be downloaded. 
It is noteworthy that only 66 (39.28%) of the apps required user consent of terms 
and conditions (authorization) before downloading the app.  The authorization 
process includes acceptance of terms for data use for marketing purposes or 
access to photos and files of the device, which for some apps, like Miniris, 
constitute the functioning condition of the app. Privacy and security concerns 
have arisen due to various network attacks. Lack of strong security 
authentication measures, that many health apps may suffer from, can easily 
allow attackers to infect devices or bypass personal data safeguards. From the 
security and protection of cyber-attacks perspective, when this happens to an 
application used for work activities, enterprise data or credentials are put at risk, 
along with personal information (Filkins 2016). It has been proven that 
consumers can take costly actions to protect and anonymize their identities 
(Valletti and Wu 2020). Sensitive data issued to verify a user’s identity before 
allowing an individual to login with their name and password in order to fully 
use the app. Authentication features such as semi registration (just email), full 
registration, and password protection application are used in this study to 
describe security attempts of both designers (identify cyber threats) and users 
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(need verification to work with the app). The “Email request” feature was 
available in 48 apps (28.57%) and requested user’s email before app use, but no 
other personal information was necessary. The feature “Password-Protection” 
(44 apps, 26.19%) refers to security and privacy provision with the use of a code 
for entry to the app after sign-in with email or full registration. “Registration” is 
the feature that requested users’ personal data in order to become functional. 
Examples of personal data included name, age, profession, gender, nationality, 
education, etc. In the sample of 168 apps, 42 apps (25%) requested registration 
(asking for a full range of personal data) in order to navigate through the app and 
almost 28% required email (including those that needed registration).  
b. Reliability is complex as it encompasses diverse elements like adherence to 
clinical guidelines and recommendations, scientific verification, and clinical 
validation (to assess apps based on the reliability of scientific sources, as 
available on literature databases) or the credentials of the developer and the 
medical professional involvement in the app development (Paglialonga et al. 
2018). Reliability also demands transparency, meaning the framework the 
designer uses in order to describe to stakeholders the mechanisms of the app to 
process their data and to arrive to specific decisions. Transparency is the right of 
health professionals to know and understand the aspects of a dataset or an input 
that could influence their clinical decision-making (Cutillo et al. 2020) avoiding 
biased and inaccurate results and ensuring the quality and reliability of data. 
Based on the apps’ specific features there is a description of both the credibility 
and reliability of information that was provided. The indication of the “Brand 
recognition” as a feature is relevant to the factors that influence the 
trustworthiness of mHealth apps when the developers on their own provide links 
to end users about the apps’ “manufacturing brand”. In the case that the 
developer is a well-known app manufacturer or medical organization, users can 
be engaged by the “Brand familiarity”  because health apps from well-known 
brands/organizations are generally perceived as more trustworthy compared to 
those of unknown brands (van Haasteren et al. 2019).“Bug Fixes” is counted 
here as an element of trust, referring to the activity of correcting software 
defects in order to enhance the provided service and is included in almost 
47.61% of the health apps of the sample. The feature describes designers’ 
technical interventions on app functions that did not work well and were noticed 
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after users’ indication (but not fixed in real time) or by designers’ effort to 
improve the app by releasing new versions. Under the feature “Credible source,”  
are classified the apps which ensured the user that their content and provided 
information have been derived from credible organizations such as FDA (U.S 
Food and Drug Administration) and EMA (European Medicines Agency) alerts, 
JAMA Rational Clinical Exam Series, Elsevier, etc. guaranteeing information 
accuracy. In the sample almost 45.23% (76 health apps) are developed and 
guided from national institutions and universities or base their content or advice 
on international peer-reviewed literature (JACC Journals, Lancet etc). The 
feature “Credible source” is indicative for the evidence base of the information 
provided from the app. To that extent, and since the nature of the app is basically 
scientific and medical, are considered the apps with the above characteristics as 
being more trusted. For example, there are health apps such as the “Diabetes 
Diagnostics” that is developed by the Diabetes Clinical Research team at the 
University of Exeter Medical School, University of Exeter, UK, or the “ACC 
Guideline Clinical App” that is developed by the American College of 
Cardiology Foundation and gives access to its official guidelines. In the 
“Feedback” feature, are allocated the apps (31.54%) that give users the 
possibility to communicate with the app’ developers or suggested health 
professionals for queries about medical issues prompted from the app. The 
“Feedback” feature indicates the trust relationship between the user and the app 
as the user can benefit from the app’s ability to provide relevant feedback by 
analyzing user data. Under the category “Help function” (52 apps) are being 
allocated the apps that had a help function tab, including a list with definitions 
and guidance, and contact details of the designer/company. The allocation of the 
apps to the 10 identified feature categories revealed that usually apps include 
only a range of these features. For example, the most common features are 
declaration of “Privacy Policy” 87.5%, “Brand Recognition” 72.02%, and “Bug 
Fixes” 47.61%. On the other hand, important features such as “Password-
protection” were included only in 26.19% of the apps.  
  




Health apps were also classified based on their type. After screening the content 
of all selected apps, 9 main categories have been formulated. Table 2 provides this 
allocation according to the app tasks and purpose it fulfills. Additionally, table 3 
presents statistics about the frequencies of features per health type of apps. 
 
Table 2: Health apps types 
 
App Type Description N % 
a. Handbook/manua
l 
Reading assistant tool to increase comprehension 
and memorization of information provided in 
medical textbooks and study material, designed for 





Designed to support doctors during the diagnosis 
process by typing patient’s clinical and lab data in 






Provide evidence-based clinical practice guidelines 
on how to diagnose, investigate and treat a condition 
or how to quickly examine it. 
32 19.0 
d. Calculator for 
doses, scales 
Calculate health related scores after the entry of 
patient’s clinical/lab results to help in diagnosis 12 7.1 
e. Games - 
simulators 
Provide gamified patient cases for practicing 
diagnosis in a variety of medical procedures. 11 6.5 
f. Tool for 
managing patients 
records 
Include a template or software for patient 
management over time by retaining patient records, 
health history, visits-appointments, etc. 10 5.6 
g. Quiz 
Multiple choice tests and other type of questions 
with detailed explanation of correct answers 
covering all areas of medicine, preparing 
professionals for exams and for exercising 
knowledge 9 5.4 
h. Scientific 
news/libraries 
Include customized health news and articles 
published by credible experts 7 4.2 
i. Connection with 
doctors  
Provide communication tools among medical 
professionals for discussing patient cases and new 
knowledge about treatments, etc. 
5 3.0 
Total  168 100 
 
a. “Handbook/manual” is the category that gathers the largest proportion of the selected 
apps (28%) and includes the apps that are mainly useful to medical students as a reading 
assistant tool to increase comprehension and memorization of the information provided 
in their textbooks and study material. They are designed for educational and training 
purposes and they are popular for helping students reduce the time needed to study to 
pass exams. The link to the brand webpage has been provided in 61.7% indicating that 
these apps were mostly developed for marketing purposes. This type of app, most of the 
times (90%), includes a Privacy Policy, but because they only provide information 
without any request of data to interpret there is no need for a feature to ensure security. 
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From the 47 apps, 21 use the Authorization feature to receive the user’s agreement for 
accessing phone’s photos and videos or the unique identifier of their device in order to 
provide personalized advertisements. There are also 10 apps that request registration in 
order to login. Most reviewers find these applications very helpful for learning 
purposes, but some of them wish to see more detailed descriptions of the studied 
elements e.g. body organs.  
b. “Differential diagnosis assisting tool” (20.8% of the apps) is the category that comes 
next in popularity and includes the apps that are designed to support doctors during the 
diagnosis process by typing patient’s clinical and lab data in order to receive disease 
matching. It improves health professionals’ differential diagnosis skills and it is useful 
in daily practice for re-assuring physicians’ choices. Among its applications are some 
(3) that use artificial intelligence (AI) technology, indicating from one side the need 
from doctors to have customized results during their clinical practice and from the other 
side the tension for personalized treatment. Technological advancements are probably 
the reason for the high score in “Bug Fixes” 60%. The users find the app informative 
and advice giving, but the recent comments ask for app enrichment with MRI images 
for diagnosis based on image matching, indicating a new potential to these apps. In this 
application there is interpretation of sensitive patient data, but there is not a noticeable 
difference in the scores with other apps (Table 3) in the two tiers (privacy, reliability). 
c. “Clinical guidelines, dictionaries and protocols” category is next in this classification 
and holds around 19% of the sample. These apps provide evidence-based clinical 
practice guidelines following a rigorous development process and guide on how to 
diagnose, investigate and treat a condition and how to quickly examine it. They also 
include disease dictionaries with conditions, symptoms, treatment drugs, treatment 
protocols, medical terminologies, and dosage guides. Most of the apps in this type 
(75%) had a credible source for the information provided based on published books 
(Elsevier, Wiley etc) or reliable organizations (American College of Physicians etc). 
Based on the privacy policy declarations, the information collected included exclusively 
mobile device information (device name, version, language) and downloadable analysis 
data by Google Firebase SDK and not sensitive information from users, like contact list, 
emails, etc. They declared that the collected data is only used for app improvement and 
monetization. Users’ comments brightly discuss the detailed explanations of diseases 
and the updated material, which is apparently what is important in this type of app; the 
quantity and quality of the content.  
109 
 
d. “Calculator for doses and scales” (12 apps) category contains apps where medical 
professionals enter their patients’ clinical or lab results and related scores are indicated 
that could help the clinical practice. Traditionally, medical calculators are used as 
clinical decision-making tools (Chen et al. 2019). However, these apps differ in nature 
from the “Differential diagnosis assisting tool” apps. Their aim is to calculate clinical 
scores and indices, such as coronary heart disease risk, body mass index (BMI), 
pregnancy due date, individual drug dosing, etc. (Mosa 2012). This category includes 
diagnostic criteria, a scoring system for various diseases or provides prognostics for 
certain diseases based on human measurements. As it is observed, almost all of the apps 
include a declaration of a Privacy Policy, while only 2 apps ask for users’ agreement to 
give access to photos and archives and another two ask for a registration and password. 
The role of these apps is to provide the right result using specific algorithms for each 
calculation.  For this reason, it is very important that the apps provide credible sources 
for their algorithm justifications. From the findings,6 of the apps provide information 
about the source of their algorithms (peer reviewed literature, American College of 
Cardiology, etc.) and the rest are based on widely accepted algorithms, such as the 
“Glasgow Coma Scale” or the “Body mass index”. It is noticeable that 75% of the app’s 
present advertisements. Most users found these apps practical and timesaving during the 
diagnosis process, although some complained about slow response times and inadequate 
formulas. Therefore, this kind of app must be fast, reliable, and accurate to increase 
downloads and high ratings.  
e. “Games/simulators” (11 apps) category includes all the apps that provide gamified 
patient cases for practicing diagnosis and better training, designed to teach specific 
techniques for a variety of medical procedures. Email was requested in 7 of the apps 
along with password protection and full registration in 6. All apps included a privacy 
policy, but authorization to the archives and photos of the device was requested in one 
app only. According to the reviews, these apps are good for strengthening clinical 
knowledge through playfully learning when doctors or students are tired from reading. 
However, it can also fulfill the need of professionals to gain more experience without 
spending money and time. Such an app is mostly useful when it covers a variety of 
medical cases with detailed explanations on the answering part.   
f. “Tool for managing patient records” (10 apps) is the category that includes a template 
or software that manages patients over time from first visit, to admission, to discharge 
and then follow-up and assists professionals to retain patient records and health history 
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as well as other related information. What is useful about this type of app is the 
management of patients’ information and their medical history, minimizing repeated 
and unnecessary data entry because it can store all kinds of medical notes and records 
(like text, audio, video, image, pdf, etc.). The most important characteristic of such apps 
is the ease of use by doctors with simple screens and with templates that can be 
customized according to professional’s needs. Users also need flexible and ergonomic 
solutions that can be accessed from their mobile devices or tablets as well as the ability 
to be synchronized quickly. They also require space for unlimited patients, 
appointments, invoices, notes, and immediate technical support. 
g. “Quiz” (9 apps) is the category that contains apps with targeted questions and 
detailed explanations covering all areas of clinical lab science, preparing students for 
exams or helping health professionals to exercise knowledge. All the apps included a 
declaration of privacy policy but only one requested authorization. According to the 
comments, many users request a larger question bank that can generate more than one 
quiz per category and a more attractive layout.  
h. “Scientific news/literature” (7 apps) is the category of apps that include news and 
articles in health topics written by experts and published by credible publishers, such as 
Elsevier or JACC (The Journal of the American College of Cardiology). This kind of 
app tries to be reliable in terms of information as they all provide their source and 
developers’ webpage. Their goal is to provide scientific information to users and not to 
sell or advertise products, thus they have less interest in capturing the personal data of 
users. According to the users’ reviews, most of the complaints are about technical issues 
like certificate downloads and requesting regular updates. Doctors are interested in 
continuous knowledge and skills upgrades and this is what this type of app offers. It is 
very important that these apps are based on trustful sources of medical information and 
material. Moreover, professionals ask for user friendly and accurate literature apps. 
i. “Connection with doctors” (5apps) category offers apps to health professionals and 
students that provides links to communicate with each other on diagnosis matters or 
discuss new knowledge about diseases and treatments. These kinds of apps are most 
useful when providing connection with large communities of professionals, while also 
achieving high privacy and security safeguards. Additionally, this app type is valuable 
as it provides the opportunity to learn and grow a professional network. According to 
reviewers’ point of views, future goals of these applications could include the 
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customization of features based on a user profile, satisfying daily clinical needs, and 
prognosis requirements.  
In Table 3, under the privacy tier’s category, it is obvious that the health 
applications that gather the highest scores are “Connection with Doctors”, which needs 
a lot of personal user data in order to work properly, “Tool for managing patients” that 
requests patient data and “Games” that also needs personal data to provide feedback. 
For the second tier, reliability, high scores again gather the “Connection with Doctors” 
that need to come from a reliable developer and share reliable material. “Literature” 
type also scores high because users naturally depend on the validity of the apps’ 
sources and “Calculators” because these apps use algorithms to measure patient data. 
It is also interesting that “Handbooks” and “Dictionaries” do not include a high 
percentage of features relevant to the ethical challenges even though they belong to the 
most popular type of apps. Overall, from the results it is obvious that privacy is 
seriously examined by developers when introducing new health apps. Security features 
are mostly incorporated in apps that require personal data to function. For example, 
“Games”, “Literature”, “Patient management tools”, and “Connection with doctors” 
need full or semi registration along with password-protection application in order to 
navigate the app. Reliability issues that are relevant to “trust”, “transparency”, and 
“explainability” are also important to these app types as their functions are more 
complex and users require a deep understanding of the provided information in order 
for the apps to be useful. 
 





4.1e. mHealth apps using Artificial intelligence 
 
 Along with the nine different types of health apps that have been identified, 
there has been also formulated a separate category of apps that use AI methods. Of the 
168 mHealth apps for professionals, 17 used AI methods. There is also a separate 
catalogue for these apps because due to their technical elements, they are capable of 
making more complex data matching and calculations and based on queries eventually 
offer more useful information to medical professionals (Deo 2015).The following 
mHealth artificial intelligence includes computerized technologies like natural language 
processing, which aids in speech recognition, text analysis, translation, and other goals 
related to expert systems (e.g. fuzzy logic). Based on collections of ‘if-then’ rules that 
are widely employed for ‘clinical decision support’ purposes, machine learning methods 
are used to learn from accessed data and with the help of statistics and classification to 
generate customized results and robotic process automation as if they were a human-
user.  Following a script or rules that rely on a combination of workflow, involving 
automated planning and scheduling focused on organizing and prioritizing the activities 
required to improve the efficiency of human procedures (Davenport & Kalakota 2019; 
Wahl et al. 2018).The examples that follow shed more light. 
 Based on the apps’ content analysis of the dataset, three of the apps that include 
AI techniques to interpret data belong to the “Diagnosis assisting tools” category, five 
are “Calculators of doses and scales”, three are “Games/simulators” and six are “Tools 
for managing patient records”. In Table 5 there is a classification of the 17 mHealth 
apps based on their type and their medical and operational benefit that is offered to 
medical professionals.  
A representative machine learning (ML) tool for “Differential Diagnosis 
assisting tool” category is “Visual DX”, its purpose is to support physicians and 
dermatologists as a quick reference tool using cutting edge machine learning at the point 
of care by uploading an image (e.g. of the patient’s inflamed skin) and getting back a 
list of a differential diagnosis. The app includes a detailed declaration of a Privacy 
Policy and requires owners’ information, acceptance, and full registration. The Privacy 
Policy declaration states that the company is allowed to disclose the users’ information 
to third parties without prior user consent. VisualDx relies on a worldwide medical 
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editorial board of practicing physician scholars to keep clinical content objective, 
reliable, and current. In practice, machine learning applications like Visual DX perform 
automated data analysis by using algorithms that iteratively identify patterns in data and 
learn from them (Wahl et al. 2018). ML algorithms provide information systems the 
ability to automatically learn and improve from experience without being explicitly 
programmed (Kodratoff, 2014). 
In the case of “Calculators” a representative example is the application 
“MDCalc Medical Calculator” that could be characterized as a fuzzy logic system, 
which assists to mimic the logic of human thought because it contains more than two 
options to provide calculated results by combining the inserted values to offer more than 
two possible solutions (Guimarães et al. 2018). The app includes a Privacy Policy and 
full registration but does not include an authorization. MDCalc’ s Editorial Board is 
comprised of scientists in several medical specialties who hold leading positions in 
healthcare institutions (e.g. Harvard Medical School in Boston, Massachusetts). This 
category includes complex calculators that need more than two measures to result in 
more accurate predictions and follow the process of converting input data into fuzzy 
components, creating fuzzy sets and the set of rules and inferences (Guimarães et al. 
2018). 
 Another artificial intelligence application from the category of 
“Games/Simulators is “In Simu patient” that intends to practice medical diagnosis from 
a virtual clinic with simulated patients and a variety of diagnostic methods. Medical 
teaching simulators may be understood as tools that assist in clinical settings without 
any potential risk to the patient (Flores 2013). This medical database includes peer-
reviewed medical literature (e.g., UpToDate, McGraw Hill, Oxford University Press 
medical books) and international guidelines. The app developer has a very informative 
website with details on privacy boundaries and reliability issues. Virtual clinical cases 
involve robotic process automation that are used for repetitive tasks combined with 
other technologies like image recognition were users are allowed to follow several tasks 
according to certain rules. 
 Lastly, a representative artificial intelligence app of the “Tools of managing 
patients category” is “Doctor Assistant”, which represents an automated planning and 
scheduling artificial intelligence system that helps health professionals stay organized 
and improves productivity using a smartphone or tablet while it creates, stores, and 
retrieves a patient’s health record and schedules the patient’s next appointments on 
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android calendars etc. This app has a Privacy Policy and requires authorization, but not 
full registration, although it handles doctor’s patients records. The app is focused more 
on its ease of use rather than setting boundaries to ensure security. It does not refer to a 
credible source of information because its character is more managerial rather than 
educational or advisable, but it has been published on the first page of the World Health 
Organization (WHO) Compendium of Innovative Health Technologies. 
Table 4 shows the percentages of the features’ inclusion between all 168 apps 
(as shown in Table 1) and the 17 AI apps. In comparison to the percentages of all apps 
according to the features, the privacy and reliability tiers of AI are higher. This is 
explained by the fact that AI apps are designed to accept different kinds of personal data 
as explained further above and must provide stronger boundaries to ensure selection 
from data owners (health professionals).  
 
 
Table 4. Artificial intelligence apps’ Features 
PRIVACY  Total% AI% RELIABILITYY   Total% AI% 
Privacy policy 28.0 94.11 Brand recognition 72.0 94.11 
Authorization 20.8 23.52 Bug Fixes 47.1 47.05 
Email request 28.6 52.94 Credible source 39.3 41.17 
 Password protection 26.2 52.94 Help function 30.9 52.94 
Registration 25.0 47.05 Feedback 23.2 23.52 
 
Big Data analytic methods and AI can be proved helpful to organizations for 
enhancing operational performance (Sivarajah et al. 2015). For example, as shown in 
Table 5, apps used as “Tools for differential diagnosis” or “Calculators” have 
implemented algorithms with diagnostic and prognostic capabilities and are used by 
health professionals as a tool for quickly providing an initial prognosis for certain 
conditions. The wide use of these kinds of apps with positive outcomes could prompt 
and further enhance research for the invention of new algorithms for diagnosis and 
prognosis. Similarly, “Games and Simulators”, that according to reviewers’ comments, 
are mostly downloaded for learning and practicing reasons could become revolutionary 
assisting tools in the training of clinicians to perform even complicated diagnosis and 
optimize treatment decisions and patient’s health outcome predictions. Lastly, there are 
mHealth apps for managing patients in clinics and care centers, which from the analysis 
of their electronic health records, could be used as tools for the early prediction of an 
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epidemic with its characteristics (e.g. peak and duration of infection) and therefore 
could protect the public health from outbreaks of infectious diseases (Noorbakhsh-Sabet 
et al. 2019).  
However, taking into consideration that medicine as a professional activity 
contains operational insights, there is a need to observe these insights under the 
managerial spectrum. For instance, the “Diagnostic assisting tools” can operationally 
assist professionals during clinical routine because they can minimize the participation 
of other specialties for advice and maximize patient engagement for interventions by 
minimizing diagnosis delays, which usually make patients lose interest when their 
health problem is not eminent at the time of the doctor’s visit. This can also lead to time 
savings for patients and medicals and become cost effective for patients and insurance 
systems. Similarly, the apps that use algorithms as “calculators” can minimize the time 
of outcome extraction in terms of diagnosis and treatment during clinical trial and 
enhance better prognosis outcomes. All types of AI solutions have the capacity to 
provide additional tools, which in many cases led to time reduction for accessing data 
and generate stronger collaboration between stakeholders (Jones et al. 2017). 
Leveraging existing remote infrastructures into a common information system (IS) 
reduces installation, monitoring time and expense and focuses on improving quality. 
The “Games /simulators” for the prediction of treatment outcomes can lead to 
knowledge improvement that assists clinicians and clinics to foster operational 
performance by knowing what comes next as well as to foster innovation by the 
acquisition of technologically updated equipment for precision medicine. Lastly, 
artificial intelligence apps used as “Tools for managing patients records” can be proven 
cost effective because of their predictive ability in managing high numbers of patients, 
which aids in avoiding congested care centers and frequent clinic visits, leaving space 
for more people in need to use the health services quicker and a reduction in patient 
expenditure for health insurance. 
 
Table 5: Artificial intelligence mHealth apps and outcomes 
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4. 2a. Conceptual Framework. “Normalization Process Theory” 
(NPT) 
 
In IS research and especially in technology adoption research, gaining insight 
into the factors related to the motivations or goals of smartphone users are key elements 
to explain important outcomes, such as usage intention, satisfaction and engagement 
(Jung 2014). 
In this study it has been used a theory borrowed from sociology the 
“Normalization Process Theory” (NPT) which is used in the field of technology, and 
originally in healthcare systems, to explain the adoption of technological and 
organizational innovations (May 2013). Since, IT-related innovativeness is associated 
with smartphone adoption and mHealth apps are regarded as an innovative product 
recently introduced in the market, this theory can explain the formed dynamics through 
the integration process (Lee & Lee, 2018). 
Based on the NPT, there is provide a systematic explanation of the dynamics 
between feature relevance and trustworthiness of mHealth apps and the engagement of 
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medical professionals in using them during clinical practice, which is measured based 
on the apps’ popularity.  
In healthcare, the introduction of innovation in an operational routine requires 
complex organizational processes and involves insights from sociology to offer a more 
comprehensive explanation of the implementation of new clinical practices (May 2013). 
NPT explains the process of the introduction (implementation) of new practices in an 
everyday work routine (embedding) sustaining social contexts (integration) (May & 
Finch, 2009). More specifically, in the study it has been investigated the usefulness of 
the health professionals’ apps as innovative practice in medicine and the offered 
features after experiencing trialability in order to explain their relevance with 
professional engagement and popularity. 
Figure 3 explains this process on the basis of NPT. The first stage of NPT 
involves the “implementation” of the actual innovative intervention (mHealth app). 
There are four main corresponding components that are followed during the 
implementation of a new intervention: “coherence” involves understanding the value, 
importance and the distinctiveness of the actual intervention or else “identification and 
sense-making of the need”, “cognitive participation” involves the effort of key 
participants to organize and sustain the new intervention, “collective action” impacts 
relations between groups of professionals and fits with the overall organizational 
context including goals, morale, leadership and resources, and “reflexive monitoring” 
involves the appraisal of the new intervention, determining how effective and useful it 
is for participants and for others (patients) (Kosse et al, 2020).The mechanisms that 
occur during the entire process of innovation intervention of mHealth apps are 
presented in Table 6 to explain the theory’s particular mechanisms and components 
through empirical contexts.  
 
Table 6: The Mechanisms of NPT of mHealth in Medicine 




Mechanisms of Implementation 
of mHealth in Medicine 
Coherence sense 
making 
Participants’ understanding of 
the intervention  
Health Categories 
Differentiation 
Cognitive Participation  
effort 
Participants' commitment to 
work with the intervention 






Fit with overall context 
including goals, morale, 




Participants’ evaluations and 
appraisals of the intervention. 
Users'  Engagement 
&Popularity 
The four contracts/components in the case of mHealth adaptation in medicine 
are mostly explained through the differentiation of mHealth app categories and the 
needs they are called to fulfill. Based on their capabilities, certain categories of apps are 
created (the need of intervention). During the process of adapting an innovation, users 
have the opportunity to validate expectations on how it can fulfill the expected or 
promising needs experiencing trialability to test the intervention before full adoption. 
The second stage of the process: “embedding”, explains the mechanisms that are used to 
perform these new practices, which in this case are the features of the apps (how the 
need is met).“Embeddness”  is comparable with the concept of social capital and 
includes relational attributes like trust and norms, tiers that are crucial for businesses 
such as healthcare that implement social innovations, which often require a deep 
understanding of complex social issues (Lashitew et al. 2020). 
During the embedding stage and experiencing trialability, users are able to 
identify three social tiers of trustworthiness (privacy, reliability and usability) that could 
lead to a greater engagement of innovative practices from professionals or organizations 
driving them to the adoption of the innovation and the formulation of new policies. 
 In the last stage, the “integration” stage of the process, describes how the new 
intervention in clinical practice is sustained (Kosse et al. 2020) based on the quality of 
the intervention and its popularity which ensures its continuation. Based on users’ 
reviews and researchers’ investigation of the apps, the Mobile App Rating Scale 
(MARS), a validated tool (Salazar et al. 2018) has been used to measure the quality of 
each app. Following the MARS methodology, each app was measured against a 5-point 
Likert scale on 23 individual MARS items clustered under the engagement, 
functionality, aesthetics and information quality categories. The MARS is targeted to 
researchers, mobile app developers and mHealth experts to assess technical information 
and capabilities of mobile apps (e.g., customization, gamification, ease of use). Its 
rating is based on scientific evidence of the mobile app during clinical trials to 




The path through the integration process explains the engagement of the 
innovative practices from professionals or organizations, measured by app popularity 
(users’ evaluations-ratings and number of downloads). It also reveals that the higher the 
app quality, the higher the engagement and the popularity of an innovative interaction. 




A. Implementation stage: Health apps’ categories 
 
After content analysis of the mHealth apps for professionals, there has been a 
classification of the apps into three distinct categories based on their purpose and 
usefulness and identified 9 main categories. Table 7 presents this allocation together 
with descriptive measures from each category, which are discussed later in sections 
BandC. The third column includes an indicative app from each category, described in 
the text in more detail. The selection of the particular app was based on the combination 
of a high number of downloads and users’ ratings. 
 
Table 7: Health apps’ categories 
App description N % 
Indicative 
app 
NFeature MARS Stars Ndownloads 
i. Education 
&Training 
   mean   sd 
mean sd mean sd mean sd 




3.1    1.3 2.9 0.6 3.4 1.8 161952 7.4 




i. The categorization of the apps based on their usefulness identified that applications 
designed for educational purposes is the majority of existing apps. These tools help 
students reduce their time of study and pass exams. Four different app categories intend 
to fulfill the need of using new technology methods during education in medicine. First 
the “Handbook/manual” category gathers the biggest proportion of the selected apps 
(28%) and includes the apps that are mainly useful to medical students as a reading 
assistant to increase comprehension and memorization of the information provided in 
their textbooks and study materials. A representative example is the “Internal Organs in 
3D (Anatomy)” app, a practical tool that provides anatomical information using 3D 
pictures with motion to help students understand the anatomy of a human person. Next 
in the classification is the “Clinical guidelines-dictionaries- protocols” category which 
holds around 19% of the sample. These apps provide evidence-based clinical practice 
guidelines on how to diagnose, investigate and treat a condition, as well as how to 
examine patients. They also include disease dictionaries with conditions, symptoms, 
treatment drugs, treatment protocols, medical terminologies and dosage guides. A very 
popular application is the “Diseases Treatments Dictionary” that explains all treatments 
of diseases providing data for causes, symptoms, prevention, drugs, prescriptions, 




3. Games/simulators 11  6.6 Prognosis: 
Your 
Diagnosis 
3.4    1.7 3.6 0.6 3.9 1.7 190954 3.3 
4. Quiz 9  5.3 BMJ On 
Examinatio
n 
2.8     1.3 3.3 0.6 4.3 0.3 32777 3.2 
5. Scientific news/lib 7 4.2 Medscape 
CME 
3.9    0.4 3.3 0.5 4.4 0.4 41428 4.2 
Totals & means 106 63.1  3.3     1.2 3.2 0.6 4.0 1.0 111491 4.2 
ii Decision-making on 
diagnosis   
        
6. Differ.diagnosis 35 20.8 Clinical 
Treatment 
3.0    1.5 3.1 0.6 3.8 1.4 44917 8.8 
7. Calculators 12  7.1 QxMD 3.3    1.9 3.6 0.6 4.5 0.3 143500 2.7 
8. Connect with docs 5  3.0 Docquity 5.0    1.5 3.6 1.5 4.9 0.5 340200 4.2 
Totals & means 52 30.9  4.0    1.5 3.4 2.7 4.2 0.7 176206 5.2 
iii. Management           
9. Patient Management 10  6.0 Doctor at 
Work 
3.2   1.1 3.9 0.5 4.3 0.3 30000 3.9 
Totals 168 100 Mean 
Totals 
3.2   1.5 3.2 0.7 4.0 1.4 117640 4.6 
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The app has a search feature where the professional can type the disease of interest and 
relevant findings appear. It is particularly useful to professionals in emergency 
departments and those giving First Aid. Third is the “Games/simulators” category (11 
apps) that includes all the apps that provide gamified patient cases for practicing 
diagnosis and better training, which are designed to teach specific techniques in a 
variety of medical procedures. An indicative app is “Prognosis: Your Diagnosis” that 
offers more than 400 cases, based on actual clinical experiences, throughout a wide 
range of medical specialties which can be played within minutes. Each case is 
accompanied by a comprehensive discussion of the diagnostic reasoning and the key 
learning points. Fourth is the “Quiz” app category that contains apps (9) with targeted 
questions and detailed explanations covering all areas of clinical lab science, preparing 
students for exams or helping health professionals exercise knowledge.“BMJ On 
Examination Exam Revision-Free Questions” is an app that offers mock examinations 
to help students practice for their real exams. Last, the category “Scientific 
news/libraries” (7 apps) includes news and articles in health topics written by experts 
and published by publishers such as Elsevier or JACC (The Journal of the American 
College of Cardiology). A representative example is “Medscape CME & Education” 
which offers online medical education with news and thousands of articles’ references 
which helps clinicians receive or find the latest information. The app offers a 
customized experience by letting users choose their content by specialty and topic of 
interest or format e.g. news, videos, expert perspectives and then creates and updates 
activity lists based on these choices. Accurate material and user-friendly layout are two 
important features for these apps. The educational category of apps is the biggest of the 
three in the sample, as it has been a wide expansion in the development and use of 
portable technologies, such as smartphones, to support learning (García et al. 2019). 
ii. The next most popular group is “Decision making on diagnosis” which includes 
mHealth applications operating as an assisting tool for doctors during diagnosis. The 
category “Differential diagnosis” (20.8% of the apps) is the most popular in this group. 
It improves medical practitioners’ differential diagnosis skills and is useful in daily 
practice for re-assuring physicians’ choices. An indicative such app is “VisualDx” that 
offers customized differential diagnosis through the matching of thousands of images 
and diagnosis reports by searching symptoms, signs and patient factors. The second app 
category of this group is “Calculators” for doses and scales with12 apps in which 
medical professionals enter specific patients’ clinical or lab results and related scores 
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are indicated that could help clinical practices, such as coronary heart disease risk, 
patient-specific drug dosing, etc. A representative app is “Calculate by QxMD”. Based 
on what the clinician wants to calculate, certain questions about patient measurements 
are asked and, after entering the answers, a result is provided. It contains more than 300 
calculators. For example, it includes a predictive model for Emergency Heart Failure 
Mortality Risk Grade (EHMRG), which is calculated after answering 10 questions 
about certain physiological measurements and other patient conditions. Its aim is to 
convert the recent research publications into a hands-on tool in order to provide, for 
example, the risk of stroke in a trial fibrillation based on the latest research. Last, is the 
“Connection with doctors” category (5apps) that offers health professionals and 
students links to communicate with each other on diagnosis matters or discuss new 
information about diseases and innovative treatments.“Docquity-The Doctors' Network” 
is such an app that offers a network which connects over 100,000 verified doctors with 
each other to discuss real world medical cases. The specific platform is an Asian 
medical education and knowledge sharing platform, exclusively for doctors.  What is 
valuable about this app category is the opportunity to learn and grow through a 
professional network.  
iii. The last group includes only one app category called “Patient management” (10 
apps) for tracking patients over time in doctors’ visits, admissions-discharges, etc. It 
assists professionals to retain patient records and health history and other related 
information. It minimizes repeated and unnecessary data entry because it can store all 
kinds of medical notes and records like text, audio, video, image, pdf, etc. “Doctor at 
Work (Plus)” is a patient electronic medical record, patient appointment tracker, biller, 
Rx printer, and sales and income report generator. The app assists doctors to document 
the history of examination, diagnosis, and treatment of a patient and manages patient 
appointments. It is also a software that can assist doctors with their billing while 
maintaining and ensuring the confidentiality of patients’ records. Ease of use, 
customized templates based on professionals’ needs and space for unlimited patients are 
important characteristics of such apps as well as simultaneous access to the app’s 
content from a device with real-time synchronization and technical support. 
Most of the identified apps (66.6%) cover a wide range of medical conditions as 
the majority of apps belong to the group of “Education & Training” offering a broad 
spectrum of knowledge in medicine.  The remaining apps are specific to a medical 
specialty or group of health provisions or health professionals, with 21 identified 
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categories. 9 were specific to cardiology, 8 about emergency care, 5 about nurses, 4 
were targeted to dermatologists, another 4 to ophthalmologists, etc.  
 
B. Embedding stage: App features analysis indicating app trustworthiness 
 
To understand the use and safety of professional health apps in everyday clinical 
routine, certain feature categories has been formulated, in which the apps have been 
classified and assigned these features to the elements of the integration process (privacy, 
reliability and usability) of the “Normalization Process Theory”. Table 8 lists the sum of 
the apps’ features based on the description provided at the App store and after installing 
and opening the app to reach its core functions. These features are classified in relation 
to the challenges arising from the introduction of innovative mechanisms in clinical 
decision processing explaining their trustworthiness. 
 
 
Table 8: mHealthFeatures’ Analysis 
Features (F) N % 
Tier 1. SECURITY     
1. Privacy policy  147 87.50 
2. Authorization 66 39.28 
Tier 2. RELIABILITY      
3. Credible source 76 45.23 
4. Feedback Contact 53 31.54 
Tier 3. USABILITY     
5. Guidance 101 60.11 
6. Social sharing 68 40.47 
7. Tutorial 30 17.85 
(Reverse Usability)   
a. Ads inclusion  82 48.11 
b.In-app purchase 65 38.70 
 
Tier 1.Trust is a pressing topic and has been found to be connected with privacy 
concerns and expectations of users (Martin et al. 2019). Privacy concern is a theoretical 
control variable that influences the consumer intentions of mobile app use and refers to 
beliefs about the safety of mobile apps and information disclosure in general (Keith et 
al. 2015). 
For that reason, two relevant features has been used to explain security of an 
app. The “Privacy Policy” feature which describes the developer’s privacy policy 
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declaration, otherwise known as the ‘data subject’ in the General Data Protection 
Regulation (GDPR). It informs users about the controller/provider and the terms and 
conditions of using the app, as the ‘compliance with the law and treatment of users’ 
(Llorens-Vernet & Miro, 2020). Out of 168 health apps, 87.5% had a declaration of 
privacy policy either at the bottom of the app description in the App store, as a tab after 
downloading the app or as information in the designer’s website. This describes the 
policies that the company follows for the interpretation of users’ data and its practices 
towards users’ personal information, for example policies on personal and anonymous 
information collected and the way the company uses it (e.g. disclosure of personal 
information if it detects actions that damage the website, for preventing illegal activities 
or the sale of users’ personal information to third parties for marketing purposes).It may 
also state the security measures (e.g. use of firewalls, secure connections on website) it 
uses to protect and safeguard personal information from accidental loss, misuse, 
unauthorized access or provide contact details in case of user disagreement with parts of 
the Privacy Policy. Users’ personal data could include, apart from those in an ID card, 
information on users’ browser type, date/time of visit, user’s location, IP address, 
referring URLs, the user responses, etc. Surprisingly, in the examined apps the lowest 
presence of privacy policy statements was identified in the Differential diagnosis 
category (71%) and the Patient management category (80%), which both deal with 
personal data, so many would think that they ought to describe their data use. Second, 
the feature “Authorization” to describes user’s consent to the Privacy Policy 
declaration. In the authorization category have been classified the apps, when users’ 
acceptance of the company’s terms and policies were necessary for allowing access to 
their personal data and exploitation based on company’s policies, for example, in order 
to give them out to third parties. Only after consent could the appbe downloaded. 66 
(39.28%) apps that required user’s consent of terms and conditions for accessing the 
consumer’s data before being able to download the app (e.g. “Patients records and 
Appointments for Doctors” app) or access to users’ device storage (e.g. “Lancet” app) 
or agreement to both privacy policy and terms and conditions of content usage (e.g. 
“Common Differential Diagnosis” app).  Authorization forms have a high presence 
(around 60%) in the categories of Patient management, Scientific news/lib and 
Connection with Doctors, since there is a need for the app to access phone features (e.g. 
calendar for booking appointments - cookies for storing choices for customized news – 
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audio/camera functions, respectively) and low presence (<16%) in the Calculators, 
Games/simulators and Quiz categories. 
Tier 2. The tier of reliability is measured by two app features, with the purpose of 
gaining users’ trust and engagement. “Reliability” describes the users’ perception that 
they receive what they believe they have ordered (Agag 2019). Under the feature 
“Credible source”  are the apps which ensured the user that their content and provided 
information have been derived from credible organizations, such as the FDA (U.S Food 
and Drug Administration), Elsevier, etc., guaranteeing information accuracy. Around 
45% of the apps have been developed and guided by national institutions and 
universities or based their content or advice on international peer-reviewed literature 
(JACC Journals, Lancet etc). Higher scores are identified in the Scientific news/libraries 
(100%) and Clinical guidelines-dictionaries-protocols (75%) categories, but not in 
Handbooks/manuals (32%) which are also under the education& training group but 
targeted mostly to students. Moreover, one would expect that Differential diagnosis and 
Calculators apps would score high in this feature as their role is to provide the right 
result using specific algorithms for each calculation, therefore, it is very important that 
the apps provide credible sources for their algorithms justification. However, their 
scores are 40% and 50%respectively.The “Feedback Contact” feature, available in 
almost 32% of the apps, gives the possibility to users to communicate with the 
developer or other health professionals (other app users or professionals in cooperation 
with the developer for the functioning of the specific app),via email or platforms that 
support calls or texting, for queries about the app’s info/results and relevant medical 
issues. It indicates the trust relationship between the app user and the application for the 
resolution of questions on the basis of feedback provision by analyzing user data. This 
feature is necessarily present in all Connection with Doctors apps and also has a high 
presence (55%) in Games/simulators for interpreting results. 
Tier 3. Usability describes the ability with which users can use an application to 
achieve a particular goal. This procedure involves the comprehension of how the system 
functions along with the features that offer a suitable environment for the user to learn 
(explainability) and attractiveness to keep using it (Zapata et al. 2015). Since a system's 
usability influences the direct effect on intention to use, business apps' usability is 
crucial for the engagement of a professional user (Gurtner et al. 2014).Therefore, 
usability is important for the adoption of these applications because, in many cases, they 
are used by stakeholders who are not familiar with technology and mobile devices 
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(Zapata et al. 2015). For this category three features have been used to measure an app’s 
trustworthiness. First, the “Guidance” feature (101 apps) including navigation 
instructions of how to interact with the app, available in the App store 
description.60.11% of the apps provided clear instructions of how to navigate the app 
and how data can be interpreted.“Social sharing” (68 apps) is the tab that gives 
customers the ability to share on social media (twitter, Facebook, etc), via email, the 
app itself or the app info/results. This dimension has been classified as a metric that 
could provide usability in terms of communication availability and the fast exchange of 
information. It provides a quick and easy way for professionals to communicate results 
and cases to their patients, admin teams or referral doctors by simply using this feature. 
All Connection with doctors apps included this feature. The lowest presence was 
observed in the Scientific news/libraries apps, although this feature could also be useful 
to those using these apps for a quick share of an interesting finding with other health 
professionals. Lastly, the feature “Tutorial” is an element of explainability as it provides 
a tutorial video for explaining the app’s functions at the App store description or app 
launch. Few apps included this feature (17%). The highest presence was identified in 
Patient management (55%) as these apps incorporate many functions and have a more 
complex use case. This was also the category with the highest presence of the Guidance 
feature (90%). 
In Table 7, column 4, titled “NFeature“, by comparing the mean of the sum of 
features per mHealth category, it indicates that in the Education & Training group, the 
health app category with the most features to indicate trustworthiness is “Scientific 
news & libraries” with a mean of 3.85 features, while the highest scores among all app 
categories gathers the “Connection with doctors” with a mean of 5 out of 7 features. 
These apps need to provide connection with large communities of professionals and 
accomplish worldwide regulations on privacy and security issues. Overall, the privacy 
policy feature is seriously considered by developers when introducing new health apps 
that require personal data to function as in many cases, nowadays, it is enforced by law 
to inform users about their data use and acquire their consent.  
The term “Reverse targeted display promotions as a business model of the 
mHealth apps. In the pool of apps, all applications are free of charge and potential 
sources of revenue comes from (pop-up or other kinds of) advertisements, in-app 
purchases (Brouard et al. 2016)to unlock extended app functionality or even from 
selling users’ data to third party companies, as explained in the Privacy Policy feature. 
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Earlier generation apps depend mostly on advertisements and in-app purchases to 
produce revenue while more and more publishers are building in-app purchase functions 
as a primary means of monetizing their work (Hsu & Lin 2016). The question is if this 
business model affects an app’s trustworthiness. Many developers provide what they 
call freemium apps, with free accessibility to limited functioning of the app in order to 
be engaged and then ask for paid full-access (premium). Other applications include 
advertisements or authorization of the user to have access to personal data for marketing 
reasons (cookies) increasing the insecurity of individuals who are seeking more for 
reassurances against potential risks by increasing the complexity in data governance. 
There is evidence in the literature that the use of these methods weakens the popularity 
of the apps and annoys users (Pujol et al., 2015). As advertisement and in-app purchases 
diminishes the usability and trustworthiness of users and most probably move 
directionally opposite to the other features, denoting them as a reverse category of 
features. Advertisements are apparent in 60% of the apps and in-app purchases in 42.2% 
and 27% of apps use both funding methods. In the Scientific news/libraries and 
Handbooks/manual app category, there is a high combination of both ads’ inclusion 
(89%and 40% respectively) and in-app purchases (89%& 62% respectively), indicating 
that these apps were mostly developed for marketing purposes. On the other hand, a low 
ads presence is reported in Connection with doctors with zero ads and 20% in-app 
purchases. 
 
C. Integration stage: Quality evaluation 
 Continuing to the implementation stage of the NPT, it has been used the MARS 
tool (Salazar et al. 2018) to measure the quality of each app. The reviewer scrutinized 
each of the 168 apps against the 23 MARS items using a 5-point Likert scale (1-
Inadequate, 2-Poor, 3-Acceptable, 4-Good, 5-Excellent) and concluded to the given 
score for each app on each item. Then the mean scores for the engagement, 
functionality, aesthetics and information quality clusters were calculated together with 
the overall MARS score. The MARS tool has been used to evaluate the apps after 
experiencing trialability, taking into consideration the reviews of the users that were 
available in the Play store. Thus, the MARS evaluation score is the result of a 
combination of the researcher’s personal experience after using the app and the users’ 
comments when they were available.  
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 The results from the Quality Evaluation column in Table 2 and their allocation 
according to their category indicate that Patient Management (3.87),  Games/simulators 
(3.61) and Calculators (3.61) gather the highest MARS scores, meaning that in the 
quality measure these health app categories are stronger than the rest. Looking in Table 
9 at the individual scores of each MARS cluster, the highest score is achieved with 
regards to apps’ information quality and that there is still room for improvement in the 
apps’ aesthetics and relatively room for improvement in all MARS clusters. “Doctor At 
Work (Plus)-Patient Medical Records” app of the Patient management category holds 
the higher score (4.9) in MARS, which is also the indicative app of this category. 
“VisualDx” app and “MedShr: Discuss Clinical Cases” come next, both with a score of 
4.62, and belong to the Differential diagnosis and Connation with doctors’ categories 
respectively. 
Table 9: MARS clusters’ scores 
MARS clusters Mean  Sd 
Engagement score 3.29 0.83 
Functionality score 3.47 0.82 
Aesthetics score 2.96 0.93 
Information quality score 3.49 0.85 
Total MARS score 3.30 0.86 
 
C. Integration stage. Health apps popularity and engagement 
 The popularity of an app is related to the user satisfaction, which can be 
measured by the average user rating and the number of app downloads (Krishnan and 
Selvam 2019).For an app to be successful, users need to download it, use it, rate it and 
provide useful reviews to other potential users who would be triggered to use it. This 
circle increases engagement with the app and the number of users (as long as the ratings 
are good) (Krishnan and Selvam 2019). 
 In Table 10, the last two columns provide descriptive statistics about the 168 
apps’ popularity based on their category and, in particular, show the number of rating 
stars (scale:1-5) and the number of downloads that were indicated in the app description 
at the App store at the period of the investigation (Jan/Feb 2020). Only 16 apps (9.5%) 
had no rating and 23 apps received an average rating below 4*. The remaining apps 
(73%) have been rated with 4 stars and over (>4*), meaning that users were satisfied. 
On the other hand, most of the apps(almost 70%)have been downloaded between 
10,000 and 100,000 times and around 26% of them less than 10,000.Observing 
simultaneously the average downloads and the mean features it seems that users mostly 
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download the “Connection with doctors”  app category which holds the most features 
across the trustworthiness tiers. “Internal Organs in 3D Anatomy”, which  belongs to 
the “Handbook/Manual” category is the app that has been downloaded more than 5 
million times and rated with 4.5 stars on average from more than 35,000 users at the 
time of the investigation. This application was released in the Play store in 2014. A data 
comparison between downloads and the years since the first release of the apps shows 
no evidence that the popularity of apps is related to the period available in the Play store 
(p<0.000). According to the results, the highest scores in the stars rating is from the 
Quiz and Scientific news/libraries categories and in downloads the highest score is from 
both the Scientific news/libraries and Connection with doctors. However, the MARS 
score has identified the Patient Management app category as the category with the 
higher quality. 
 
4. 2c. Results from statistical tests: Comparison of Means 
In order to investigate the dynamics and associations among the variables that 
consist the elements of the conceptual model for mHealth apps integration in the clinical 
practice (Fig. 3), there have been conducted statistical tests with the use of the SPSS 
statistical software. Table 10 entails the description of the variables that have been used 
in the research framework. 
 
 
Table 10: Description correlation variables 
 Variables Description 
1 Health types Based on the health type category that belongs each app takes one of 
the following values: 1. Education & training, 2. Decision making on 
diagnosis, 3. Management (measurement scale 1-3) 
2 NFeatures The sum of the 7 features as described in Table 3 without the features 
of Reverse Usability (measurement scale 0-7) 
Tier1 SECURITY  
3 Privacy policy  Dummy variable, the app takes the value  0 to indicate the absence of 
the feature  or 1 to indicate the presence of the feature (measurement 
scale 0, 1) 
4 Authorization Dummy variable (0,1) 
Tier 2 RELIABILITY   
5 Credible source Dummy variable (0,1) 
6 Feedback Contact Dummy variable (0,1) 
Tier 3 USABILITY  
7 Guidance Dummy variable (0,1) 
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8 Social sharing Dummy variable (0,1) 
9 Tutorial Dummy variable (0,1) 
 Reverse Usability  
10 Purchase Dummy variable (0,1) 
11 Ads Dummy variable (0,1) 
12 MARS Evaluation quality score MARS (measurement scale 1-5) 
13 STARS App’s average star rating (measurement scale 1-5) 
14 LgDOWNS Log number of downloads (0 < “1” < 1,000, 1,000 ≤ “2” <10,000, 
10,000 ≤ “3” < 100,000, 100,000 ≤ “4” < 1,000,000, “5” ≥1,000,000) 
(measurement scale 1-5) 
15 NDownloads Number of app downloads as described in the app store (Feb 2020) 
 
Based on the research framework, the “integration” stage of the process of the 
described innovation is based on the quality evaluation of the apps (MARS), the stars 
rating and the number of downloads. To identify whether the scores of these three 
measures are affected by the existence or not of the examined app features (described in 
tiers 1-3) there is a comparison of means using statistical hypothesis testing. The 
hypothesis have been formed between the three “integration” measures and the 9 app 
features, which are all presented in Table 11 together with the results. In order to 
determine if there is a significant difference between the means of the examined 
independent samples initially, are performed normality tests to the variables 
(Kolmogorov-Smirnov test) and found that these are normally distributed but in three 
cases. Thus, the t-test was used in the statistical analysis for all variables and Mann–
Whitney U test for the three exceptions of non-parametric data, as indicated in Table 11. 
It is clear that the only three hypotheses that are rejected are these that prove a 
relationship between the app quality score (MARS) and the existence of credible source, 
feedback and guidance features. The mean MARS scores are significantly higher when 
these features are present in the apps. Accordingly, the test of mean differences 
indicates that STARS rating is unrelated to the existence of the certain app features but 
for tutorials. Finally, the average number of downloads is only related to the existence 
of social sharing features and tutorials with a higher number of downloads when these 
features are available. 
 
Table 11: Hypothesis testing 
Hypothesis 
The average MARS score of the 
apps is not related to the existence 
of: Mean scores p-value Decision 
NPT model Existence of feature: NO YES     
TIER I SECURITY Privacy Policy 3.08 3.22 .418 Accept 
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Authorization 3.18 3.22 .658 Accept 
TIER II 
RELIABILTY 
Credible Source* 3.03 3.40 .001 Reject 
Feedback* 3.06 3.50 .003 Reject 
TIER III 
USABILITY 
Guidance* 3.00 3.33 .005 Reject 
Social Sharing 3.16 3.26 .353 Accept 
Tutorial 3.16 3.38 .088 Accept 
Reverse Usability 
In-app purchase 3.17 3.25 .472 Accept 
Ads 3.28 3.12 .126 Accept 
 
The average STARS rating of the apps is 
not related to the existence of:       
TIER I SECURITY 
Privacy Policy 4.00 3.99 .864 Accept 
Authorization 4.03 3.79 .241 Accept 
TIER II 
RELIABILTY 
Credible Source 3.91 3.94 .873 Accept 
Feedback 3.80 4.19 .085 Accept 
TIER III 
USABILITY 
Guidance 3.72 4.06 .105 Accept 
Social Sharing 3.90 3.97 .742 Accept 
Tutorial 4.03 3.45 .031 Reject 
Reverse Usability 
In-app purchase 4.02 3.79 .282 Accept 
Ads 3.99 3.87 .550 Accept 
Hypothesis The average number of app downloads is 
not related to the existence of:       
TIER I SECURITY 
Privacy Policy 32288.1 129832.7 .334 Accept 
Authorization 148017.2 74054.5 .276 Accept 
TIER II 
RELIABILTY 
Credible Source 113475.5 122680.4 .891 Accept 
Feedback 111943.2 130000.0 .802 Accept 
TIER III 
USABILITY 
Guidance 135735.2 105635.6 .660 Accept 
Social Sharing 58651.6 204386.7 .031 Reject 
Tutorial 85074.3 267440.0 .036 Reject 
Reverse Usability 
In-app purchase 72993.7 188386.3 .092 Accept 
Ads 64415.2 173460.4 .102 Accept 
* Non parametric data: use of Mann–Whitney U test 
Reject: p <0.05 
 
 
4.2d. Results from statistical tests: Correlations 
 
In addition to the previous analysis, it has been further tested the existence of 
intercollerations, and their level of significance, between any two variables that take 
part in the research framework including the mHealth apps’ categories (i, ii & iii), the 
individual app features, and the dimensions of integration of the NPT model as 
described in the research framework (MARS quality score, STARS rating and number 
of downloads).Table 12a presents the results of the Pearson Correlation matrix. To 
satisfy the linearity assumptions of the correlation model, the number of downloads was 
converted to a log number of downloads for each app as shown in Table 5.The highest 
positive significant correlation (0.558) is observed between log number of downloads 
and star rating, and between log number of downloads and the quality score (MARS) 
(0.373).MARS is the variable that presents the highest number of significant 
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correlations with other variables. Apart from the downloads it is also correlated with the 
STARS rating (0.244) and also with the features of the “reliability tier”, namely, the 
existence of credible source (0.262) and feedback mechanism(0.291) as well as with the 
guidance element(0.232), as also observed in Table 12b (comparison of means). 
Additionally, it is also correlated to the health type (0.239). The latter means that apps 
belonging to the categories 2 (decision-making) and even more 3 (patient management) 
score higher in MARS. With regards to the app features, privacy policy is positively 
related to the existence of feedback (0.179), in-app purchase and ads (0.189). This is 
logical since the privacy policy needs to inform about communication rules and the 
existence of promotional material. App credible source is related to the existence of the 
authorization feature (user consent) (0.165) and most importantly to the MARS quality 
score (0.262) meaning that the apps with credible sources are considered of better 
quality. Moreover, the existence of the social sharing tab is positively associated with 
the existence of the feedback mechanism (0.301) and ads (0.165), which latter makes 
sense since a marketing strategy would aim at increasing the ads visibility through app 
sharing. Lastly, ads and in-app purchases are also weekly positively correlated with 
each other (0.178), so one would expect that an app which includes in-app purchases 
will also include ads, and vice versa.  
 
Table12a: Correlations of the conceptual model variables and individual app 
features 
 
**p <0.001, * p <0.05 
Number of obs =  168 
NPT Var 
IMPLE
MENT. EMBEDDING INTEGRATION 
  Tier I Security Tier II Reliability Tier III Usability ReverseUsability       
Health
Type Privac Autho Credible Feedback Guide Social Tutor Purch Ads MARS STARS LgDOWN 
HealthTyp 1 -.019 .0561 -.007 .151 .187* -.014 .083 -.024 -.114 .239** .13 .03 
Privacy -.019 1 .0229 .018 .179* .133 .128 .035 .189* .189* .063 -.013 .043 
Auth/tion .056 .023 1 .165* .006 .013 .076 -.105 .057 0,000 .0344 -.090 -.083 
Credible -.007 .018 .165* 1 .129 .105 -.018 -.111 .064 -.145 .262** -.125 .118 
Feedback .151 .179* .006 .129 1 .291** .301** .118 .040 -.125 .291** .133 .098 
Guidance .187* .133 .013 .105 .291** 1 .102 .094 -.026 -.031 .232** .125 .089 
Social -.015 0.128 0.076 -.018 .301** .102 1 .059 .092 .165* .0721 .026 .010 
Tutorial .084 0.035 -.105 -.111 .118 .094 .059 1 .108 -.019 .132 -.166* .001 
Purchase -.024 .189* .057 .063 .0398 -.026 .092 .108 1 .178* .056 -.083 .163* 
Ads -.114 .189* -.040 -.145 -.125 -.031 .165* -.019 .178* 1 -.119 -.046 .083 
MARS .239**  .063 .034 .262** .291** .232** .072 .132 .056 -.119 1 .244** .373** 
STARS .13 -.013 -.090 .012 .133 .125 .026 -.166* -.083 -.046 .244** 1 .558** 





Table 12b demonstrates the intercorrelations between the research dimensions 
and the sum of the 7 features of the embedding stage (tiers 1-3), instead of the 
individual features of Table 12a. Therefore in addition to the initial correlation table, 
Table 12b indicates the dynamics of apps that gather more than one feature. The most 
interesting observation is the association of the number of features and the MARS 
quality score (0.346) indicating that the apps with more features are considered of 
higher quality. Moreover, the number of features of an app has a week positive 
correlation (0.166) with the health type it belongs. So, if the app belongs to categories 2 




Table 12b: Correlations of the NPT conceptual model elements (SUM of app 
features) 
NPT Var 
IMPLEMENTATION EMBEDING INTEGRATION 
HealthType Nfeatures MARS STARS LgDOWN 
HealthType 1 .166* .239** 0.126 0.030 
Nfeatures .166* 1 .346** 0.029 0.120 
MARS .239** .346** 1 .244** .373** 
STARS 0.130 0.029 .244** 1 .558** 
LgDOWN 0.030 0.121 .373** .558** 1 
**p <0.001, * p <0.05 
Number of obs =  168 
 
4.3a. 3rd Conceptual framework 
.  
Τhe literature addresses factors that lead to mobile app downloads, but 
researchers have yet to develop a comprehensive theoretical approach that explores 
these factors for professional users. This study, also attempts to fill this gap for health 
professionals’ mHealth apps. In detail, this study investigates both the role of 
usefulness, usability and trustworthy characteristics of mHealth apps, and the influence 
of evaluation attitudes and of subjective norms, which encourage medical professionals 
in the adoption of apps in their clinical procedure. For this purpose, there has been 
developed a theory-based structural model that identifies the consumption patterns and 
determinants of choice preference across health professional apps. 
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To achieve this, a combination of two theoretical models has been used to 
investigate the consumer behavior intention in the process of using mHealth apps in the 
everyday clinical practice. The Technology Acceptance Model (TAM) (Davis, 1989) 
uses key variables of user motivation such as, perceived usefulness (PU) which is 
translated to users’ belief that technology would enhance their job or task performance, 
perceived ease of use (PEU), meaning users’ belief that using technology would be free 
from effort, and other perceived attitudes toward technology (ATT), such as perceived 
trust (PT), to explore the behavioral intention (BI) of technology use (Scherer, 2019). 
The TAM has been widely used in several technology adoption related studies 
indifferent mobile service contexts and is the most reliable for measuring technology 
adoption intention (Shankar & Kumari, 2019). Therefore, in this study TAM has been 
used as a grounded model, where as a core variable of PU is used the health app 
capabilities, of PEU the app features that enhance usability and of ATT it has been  
included perceived trustworthiness (PT), for making it suitable to mHealth context. The 
model has been further extended using the “Theory of Reasoned Action” (TRA) to also 
explain the behavior beliefs that could influence the behavior intention of a certain 
demographic sample, this of health professionals, examining the influence of personal 
determinants and social reflections (Ye et al., 2019). The “Theory of Reasoned Action” 
is based on the concept  that humans during forming an attitude towards a behavior are 
constantly evaluating the relevant negative or positive behavior and behavior intention 
is a function of two factors, attitude towards performing the behavior itself (AB) and 
one's subjective norm (SN) (Moore & Benbasat, 1996). Table 13 describes the 
constructs that participated in the combination of the two models affecting the process 
of integration intention of professional mHealth in medical practice along with the 
created external variables.  
According to the constructs of TAM model, perceived usefulness (PU) has been 
translated as the sum of different kind of health app capabilities that each mobile app 
offers and health professionals are willing to use believing that they will increase 
performance in the workplace, perceived usability (PEU) gathers the sum of features 
that assist users to reduce time and effort while using them, and trustworthiness (PT) are 
the sum of app features that increase users’ trust. The latter has been added as a 
moderating factor due to its direct or indirect mediation effect on user intention or 
adoption of new technology (Ye et al., 2019). Continuing with the TRA constructs, 
subjective norm (SN) has been translated by social influence (SN) measured by the 
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stars’ rating evaluation and attitude towards performing the behavior (AB) has been 
based on the observability after trial of the apps before adoption measured by the 
individuals’ quality evaluation (MARS tool).  
 
Table 13: The study’s conceptual constructs of TAM & TRA 
Theory Constructs Key variables  
TAM Perceived usefulness  mHealth app capabilities (PU) 
TAM   Perceived ease of use Feature Relevance (PEU) 
TAM Moderating factor  Perceived trust  Feature Relevance (PT) 
TRA Subjective norms Social Influence (SN) 
TRA Attitude Towards Behavior  Quality Evaluation (AB) 
 
 
Fig. 4 presents the conceptual framework of the TAM & TRA model following 
the process of mHealth app adoption intention of professionals in healthcare. All the 
above variables are further explained in Table 14. Through the review of the health apps 
addressed to medical professionals, there attempt was to provide an investigation of 
their purpose and features and to explore the relationships between the constructs that 
participate in this process. Thus, 5 hypotheses have been formed to understand the 




Figure 4: Conceptual framework with research hypotheses of mHealth apps 









4.3b Hypothesis testing 
 
The current research proposes a conceptual path from perceived usefulness, 
perceived usability and trust to the motivation of a health professional to download an 
app (Donker et al., 2013; Gagnon et al. 2016; Venkatesh et al. 2002). There is still 
increasing debate among clinicians as to whether this market is driven by the 
technological novelty or by clinical usefulness (Istepanian & Al-Anzi, 2018). In order to 
test the potential effects on user behavior and given this conceptual linkage between 
perceived usefulness (Donker et al., 2013; Gagnon et al., 2016) the hypothesis are: 
H1: Usefulness (PU) is positively related to Behavior Intention (BI) to download the 
app. 
The existing literature has also indicated that usability and ease of use has 
become an important topic for smartphones, since it is necessary to prevent applications 
from being difficult to use (Llorens-Vernet, & Miró,  2020; Venkatesh et al., 2002; 
Zapata et al., 2015).  App’s clear functionality is one contributor to success as complex 
functionalities tend to confuse users in decision-making (Alnsour et al. 2016). 
Therefore, the hypothesis is that: 
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H2: Ease of use (PEU) is positively related to Behavior Intention (BI) to download the 
app. 
In addition to perceived usefulness and usability, perceived trust should also act 
as a significant determinant of behavioral intention, consistent with the findings across 
researches and since a failure to protect customer information can lead to problems 
which would threaten the trust relationship with its customers (Byambasuren et al.,  
2019). Therefore, the hypothesis is that: 
H3: Trust (PT) is positively related to Behavior Intention (BI) to download the app. 
Researchers highlight the moderators of the effects of online ratings and whether 
they have become ubiquitous (Kübler et al., 2018) indicating that download choices are 
shaped by other participants preferences (Carare, 2012). Based on that, the next 
hypothesis is:  
H4: Social influence (SI) of app star rating is positively related to Behavior Intention 
(BI) to download the app  
Similarly, extensive literature has explored the relationships between app 
characteristics and quality mostly measured via user reviews (Lee, & Raghu, 2014; Kim 
et al. 2018; Krishnan and Selvam 2019) but also with specific tools like MARS (Knitza 
et al. 2019;  Stoyanov et al. 2015). Adjusting these propositions, the hypothesis are:  
H5: Quality evaluation (AB) is positively related to Behavior Intention (BI) to 
download the app. 
The research model of Fig. 4 links the hypotheses with the moderators of user 
behavior intention, which in this case is targeted to health professionals/students, for 
creating knowledge about the role of app features’ relevance during mobile app choice 
for work related  information and management. Moreover, Table 14 depicts the 
similarities and differences between the most relevant empirical studies and our 
research approach for the specific hypotheses. Many studies have explored the 
relationship between user rating (social influence) and downloads (behavior intention) 
but not as many have focused on the other aspects of the model. 
 
Table 14: Comparison of the study with similar studies on the hypotheses testing 
Hypothesis What the Literature has investigated: How this  study 
differs/contributes: 
H1. PU  is positively related BI 




A longitudinal investigation of how employee 
moods during computer technology training 
influence motivation (behavioral intention) to use 
that technology and how the latter is affected by 
perceived technology usefulness (answers from 
survey) and perceived ease of use (required effort), 
The study uses a combination of TAM and 
TRA. It is targeted specifically  to health 
apps for professionals and measures how 
user behavior intention (downloads) is 
affected by perceived usefulness (as a 
construct-sum of app tasks) and perceived 
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based on TAM and tested in a regression model 
Venkatesh et al., 2002 
ease of use (as a construct-sum of app 
features) 
H3.PT is positively related to BI 
 
They used survey data from Australian health 
practitioners to test whether one of the barriers to 
app prescription was the lack of trust towards 
mHealth apps (Byambasuren et al. 2019) 
The study is based on a regression model for 
prediction based on data gathered from apps 
and not on a description of survey results 
from users 
H4.SI is positively related to BI 
 
Empirical analysis of any type of apps with data 
collected from Google Play and Apple App stores 
determined through a regression model that a 
greater number of downloads was significantly 
positively associated with, user rating, number of 
reviews and in-app purchases amongst other and 
negatively with in-app ads(Ghose & Han, 2014) 
The analysis is concentrated on mHealth 
apps targeted to health professionals with the 
combination of a market and social 
dimension incorporating also factors of 
reliability and usefulness as major individual 
variables IV 
 Empirical market analysis that investigated with the 
use of regression the relationship between app 
ratings and app sales (paid apps) in several 
countries (Kübler et al 2018) 
The analysis is concentrated on free apps 
targeted to health professionals with the 
combination of a market and social 
dimension including downloads as the 
dependent variable (DV) 
 Empirical analysis of all apps provided in the 
Apple’s App store that showed through a regression 
model that the willingness of consumers to pay for 
an app is greater for high rated apps. The DV of the 
model was bestseller rank (which incorporated the 
element of  downloads). The study also included 
data on age and size of apps but not on downloads 
(Carare, 2012) 
The analysis is concentrated on free apps 
available in the Android app store targeted 
specifically to health professionals and 
emphasizes the social dimension as well as 
the market dimension. The DV is downloads 
and the are numerous different IVs 
 Empirical analysis of mHealth apps specifically for 
Psychiatry with data collected from Google Play 
Store determined through a regression model that a 
greater number of downloads was significantly 
associated with apps with higher user rating, 
cheaper apps and with available in-app purchases 
but not with number of reviews, app size, number of 
screenshots, length of description, availability in the 
Apple App Store and new published versions. 
(Pinheiro et al. 2019) 
The study takes a similar approach but 
includes all free mHealth apps for 
professionals, for all medical specialties, 
incorporating also factors of reliability and 
usefulness as major IV 
 Empirical analysis of mHealth apps specifically for 
Maternal and Infant Health with data collected from 
Google Play and Apple App stores determined 
through a regression model that a greater number of 
downloads was significantly positively associated 
with user rating, in-app purchases and in-app 
advertisements and negatively associated with app 
price and period since last update (Biviji et al. 
2020) 
The study takes a similar approach but 
includes all free mHealth apps for 
professionals, for all medical specialties, 
incorporating also factors of reliability and 
usefulness as major IV 
 Empirical analysis of mHealth apps specifically for 
diabetes with data collected from Google Play Store 
determined through a regression model that a 
greater number of downloads was significantly 
positively associated with apps with higher user 
rating, free apps, app age, developed in US but 
negatively with months since last update (Krishnan 
and Selvam 2019) 
The study takes a similar approach but 
includes all free mHealth apps for 
professionals, for all medical specialties, 
incorporating also factors of reliability and 
usefulness as major IV 
 
H5.AB is positively related to BI 
 
 
There are no identified studies that investigate the 
effect of app quality (measured in other ways than 
user rating) to app downloads. 
The study incorporates the app quality score 
(measured by MARS) as an independent 
variable for determining downloads for 
mHealth apps for professionals  
 
4.3c. Regression model variables 
 
The identification of variables that were used as predictors of downloads were 
based on the literature ( Ghose, & Han,  2014; Lee, & Raghu, 2014; Pereira-Azevedo et 
al. 2016; Krishnan & Selvam 2019). Each app was reviewed for its characteristics based 
on the information provided by its developer and its user comments (Hoeppner et al. 
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2016). The collected descriptive information of the apps (e.g. number of downloads, 
star ratings, etc.) together with their usefulness, ease of use and trust aspects are all 
presented in Tables 15a-c. 
 
A. Depended variable  
 
Behavior Intention: Downloads (BI) 
 
The dependent variable derives from the number of downloads of each app 
provided by the app store. The particular variable has been chosen following the 
approach of  numerous studies that selected the particular measure to determine which 
apps are preferred for use (Ghose and Han 2014; Krishnan and Selvam 2019; Biviji et 
al. 2020; Pinheiro et al. 2019;  Pereira-Azevedo et al. 2016; Engström & Forsell 2018). 
In this case the purpose is to measure the intention to try and use the innovation 
intervention offered by these mHealth apps (Krishnan and Selvam, 2019). However, in 
order to satisfy the linearity assumption of the regression model, instead of the actual 
number of downloads, the downloads have been measured as the log number of 
downloads of every app (0 < “1” < 1,000, 1,000≤ “2” <10,000, 10,000≤ “3” <100,000, 
100,000≤ “4” <1,000,000, “5” ≥1,000,000).One app has been downloaded over 
5,000,000 times and around 30% of the apps have been downloaded between 10,000 
and 100,000 times (Table 19). In order to crosscheck the results for accuracy on 
download information, an external mobile app aggregator has been used, the App 
market platform 42matters (Krishnan & Selvam, 2019) without  finding any 
descrepancies in the provided values. 
 
B. Independent Variables  
Perceived Usefulness (PU) - Health app capabilities 
Perceived usefulness was measured based on the identified mHealth app 
capabilities of each app according to the health professionals’ needs. Following the 
conceptual model and the identified TAM variables, the ‘mHealth app capabilities” 
represent the “driving motivation of a health professional to adopt the innovation” or 
else what expected capabilities this innovation will bring to the professionals in every 
day clinical routine. Based on the literature (Mosa et al. 2012; Ventola 2014) and after 
screening the content of all selected apps, eight capabilities have been indentified that 
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would be very helpful to health professionals during practicing medicine, which were 
handled as binary variables based on whether they existed or not in each app. These 
capabilities are basically related to the purpose of the app, its content and its 
methods/processes. Table 15a presents the 8 capabilities and their percentage of their 
overall presence in the 168 apps. For the regression model the construct “perceived 
usefulness” (PU) has been created, which is measured as the sum of the capabilities 
offered by the app, assuming that medical professionals/students would consider more 
useful the apps that offer more capabilities. 
 
Table 15a: mHealth app capabilities (PU) based on app content and features  
Capabilities Description N % 
1. Bug fixes App upgrades for solving operational and 




in decision -making 
Clinical decision support systems that provide 
treatment guidelines, differential diagnosis aids, 
medical calculators, laboratory test interpretation 
78 46.4 
3. Medical Training Knowledge assessment tests, board exam preparation, 
case studies, eLearning and teaching, surgical 




Connection to medical literature databases, textbooks, 
journals, literature search portals, drug reference 




Provision of image and speech recognition, customized 
results, cognitive computing, automatic analysis, 





Keeping and/or accessing electronic medical records, 





doctors and patients 
Features designed to facilitate video conferencing, text, 




Ability to schedule appointments & meetings 6 3.6 
 
Perceived Ease of Use (PEU) 
Perceived usability (PEU) was measured based on the presence of certain app 
features (Table 15b). Ease of use describes the ability of users to use an application for a 
certain purpose without spending much time and effort to comprehend the functioning 
of the system. This is achieved through app features that offer a suitable environment 
for the user to learn (explainability) (Zapata et al. 2015). Therefore, perceived ease of 
use is important in the adoption of these applications, that in many cases are used by 
stakeholders who are not familiar with technology and mobile devices (Zapata et al. 
2015). For this category four features have been used to measure an app’s usability. 
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First, the “Guidance” feature includes the navigation instructions provided by the app 
store on how to interact with the app and how data can be interpreted.“Social sharing” is 
the tab that provides customers the ability to share on social media (twitter, Facebook, 
etc.) or via email the app itself or the app info/results. This dimension has been 
classified as a metric that could provide ease of use because it provides a quick and easy 
way for professionals to communicate results and cases to their patients, admin teams or 
referral doctors. “Offline use” refers to the ability of users to use the app without 
internet connection. For the “Tutorial” feature has been considered a tutorial video for 
explaining the app functions at the app store description or app launch. For the 
regression model, it has been examined for each app the presence of these features and 
counted the number of available features. 
 
Table 15b: Perceived Ease of Use (PEU) features 
PEU Features N % 
1. Guidance 101 60.1 
2. Social sharing 67 39.9 
3. Offline use 51 30.2 
4. Tutorial 29 19.3 
   
 
Perceived Trustworthiness (PT) 
Four relevant features have been used to explain trustworthiness of an app 
including privacy, security and reliability elements, features that describe trust and have 
been considered in the relevant literature as significant (Llorens-Vernet & Miro 2020; 
Nicholas et al. 2015). The “Privacy Policy” feature, which describes the policies that the 
company follows for the interpretation of users’ data and its practices towards users’ 
personal information and security measures(e.g. the sale of users’ personal information 
to third parties for marketing purposes, use of firewalls), known as ‘data subject’ in the 
General Data Protection Regulation (GDPR). Out of 168 health apps, 87.5% had a 
declaration of privacy policy. Second, the feature “Authorization” has been used to 
describe user’s consent to the Privacy Policy declaration and for the app accessing 
phone features and personal data. 66 (39.28%) apps required user’s consent of terms 
and conditions otherwise app downloading was not possible. For the element of 
reliability, another two app features have been measured, with the purpose of gaining 
users’ trust and engagement. Under the feature “Credible source” are been classified the 
apps, which ensured the user that their content and info have derived from credible 
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organizations such as the FDA (U.S Food and Drug Administration), Elsevier, etc. 
guaranteeing information accuracy. In the sample around 40% of the apps have been 
developed and guided by national institutions and universities or based their content or 
advice on international peer-reviewed literature (JACC Journals, Lancet, etc.). The 
“Feedback Contact” is the app feature that allow users to communicate with the 
developer or other health professionals for queries about the app’s info/results and 
relevant medical issues. It indicates the trust relationship between the app user and the 
application for the resolution of questions on the basis of feedback provision through 
the analysis of user data. For the regression analysis model, it has been measured the 
sum of the trustworthiness features of each specific app. 
 




1. Privacy policy  147 87.5 
2. Authorization 66 39.2 
3. Credible source 66 39.3 
4. Feedback Contact 53 31.5 
 
Subjective Norm - Social Influence: Star rating (SN) 
Based on the literature, positive user evaluation is a measurable characteristic of 
mobile application success (Alnsour et al. 2016) and there is relevance between the star 
rating of an app and its number of downloads (Wisniewski et al. 2019). In this research, 
the social influence of mHealth apps for professionals has been measured as the star 
ratings which reflect the positive or negative opinion of a user who has downloaded the 
health app. Taking into consideration that the nature of the investigated apps is targeted 
to professionals, their ratings are valid and their opinion is quite reliable and realistic. 
This variable as the average number of star ratings (1-5) given by its users for each app 
as described in the app store. The mean star rating of all apps was 3.9 at the time of the 
investigation, as shown in Table 18. Around 10% of the apps (16 apps) have not been 
rated at all and almost 34% have been rated with more than 4.6 stars (57 apps). 
 
Attitude towards behavior - Quality evaluation: MARS (AB) 
Descriptive characteristics and online feedback, such as consumer ratings, is 
considered an aggregation of subjective evaluations (Grover et al. 2006) and therefore 
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alone may not be an adequate measure for app evaluation. Taking this into account, at 
this stage of the analysis, MARS (Mobile App Rating Scale) validated tool (Salazar et 
al. 2018) has been used to measure the quality of each app. As mentioned in the second 
analysis of the research, the MARS evaluation scale is a reliable and objective 
instrument that measures the degree with which mHealth apps satisfy quality criteria, it 
is easy to understand and use with minimal training (Stoyanov et al. 2016;  Stoyanov et 
al. 2015). It is a common health app rating evaluation scale for apps about weight loss 
(Bardus et al. 2016) and smoking cessation (Patel 2015).  
As already mentioned the MARS 23-item rating scale is organized into 4 
clusters, the engagement, functionality, aesthetics and information quality categories. 
The average scores on each cluster for all 168 apps are shown in Table 9. The 23 
individual MARS items are measured against a 5-point Likert scale (1-Inadequate, 2-
Poor, 3-Acceptable, 4-Good, 5-Excellent).  
In the regression model the quality evaluation variable (AB) was measured for 
each app by the average MARS score (Table 9). 
          
Control Variables 
Control variables are related to dependent variables, influence the outcome, but mainly 
arise from the experimental design and are not of crucial interest variables to the 
different regression models. According to the literature, there is evidence that the 
following control variables can affect apps’ consumer intention (Ghose, & Han, S. P. 
2014; Lee, & Raghu, 2014;  Pereira-Azevedo et al. 2016; Krishnan and Selvam 2019). 
First is the variable “SIZE”, which is the size of every app in megabytes. Second is the 
variable “REVIEWS” presented as the number of users that rated the apps.  The 
estimation of the length of description in the app store has been counted as the sum of 
the words’ letters of the description text in the app store (LENGTH). The next two 
control variables are “PURCH” and “ADS” which are dummy variables, taking the 
value 1 if the app includes in-app purchases or advertisements respectively and 0 
otherwise. The “YEARS” are measured as the number of years from app’s first release 
since the date this research was conducted. The last control variable is multiplatform 
(MltPLATF), a dummy variable which identifies whether the app is offered in both 
android and its platforms or only android. Lastly, we added a control variable to capture 
developer’s experience in designing such apps (DEV) and we gave the value of  0 if the 
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app has a unique developer in our dataset and the value of 1 if the developer has 
designed more apps in our dataset. 
 
 
Table 16: Description of regression analysis variables 
 
 Depended Variables Description 




1 PU The sum of capabilities offered by apps as explained in Table 3a 
(measurement scale 0-8)  
2 PEU The sum of ease of use features as described in Table 3b 
(measurement scale 0-4) 
3 PT The sum of trust features as described in Table 3c (measurement 
scale 0-4) 
4 SN Average number of star rating (measurement scale 1-5) 







1 SIZE Average size of apps (in MB) 
2 REVIEWS Number of users who rated the app 
3 LENGTH The sum of letters in Play Store’s description without spaces 











Number of years since first release 
Dummy value 1 if app displays in other App Stοres, 0 otherwise 
8 DEV Dummy value 1 if app has been created from the same 
developer to at least one other app in the sample, 0 otherwise 
 
Table 16 presents the intercollerations, and their level of significance, between any two 
variables that take part in the research framework including the mHealth apps’ individual 
features, which in the model form constructs. The highest positive significant correlations of 
around 0.5 are observed between log number of downloads and: a) star rating, b) number of 
reviews and c) year since first release as well as the quality score (MARS) with a more 
moderate effect. Moderate correlations are also observed between MARS and feedback, MARS 
and offline use, and reviews with size of app. The feature credible source has a somehow weak 
but accurate positive correlation with most variables and app features. Ads and offline use 
features are negatively correlated with many of the other variables. Size of apps is correlated 











4.3d. Regression analysis results 
  
A. Descriptive statistics of variables 
 
In Table 18 there are the accumulated descriptive characteristics of the sample of the 
168 mHealth apps targeted to medical professionals. The mean star rating of all 168 apps is 3.9 
out of 5 and that on average 1504 users rated each app. The average MARS quality score is 3.2, 
lower than the star rating score. The mean size of the apps is 28Mb (megabytes) and most of the 
apps have between 10,000 and 100,000 downloads (log scale 3). On average, the apps have 
been available in the app store for 3.6 years. Almost 50% of them are available in more than one 
platform and include in-app ads, and almost 40% of them incorporate in-app purchases. 
 
 Table 18: Descriptive statistics and frequencies of model variables 
 Variables min max mean sd 
 LgDOWNS 0.0 6.0 3.3 0.9 
1 PU 1.0 7.0 2.0 0.8 
2 PEU 0.0 4.0 2.0 0.9 
3 PT 0.0 4.0 2.1 1.0 
4 SN 0.0 5.0 3.9 1.3 
5 AB 1.0 4.8 3.2 0.7 
6 SIZE 0.001 1658.88 27.93 128.54 
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7 REVIEWS 0.0 35646.0 1503.9 4186.0 
8 LENGTH 4.0 818.0 253.3 162.0 
9 PURCHAS 0.0 1.0 0.38 0.49 
10 ADS 0.0 1.0 0.48 0.50 
11 YEARS 0.0 9.8 3.6 2.3 
12 MltPLATF 0.0 1.0 0.48 0.5 
13 DEV 0.0 1.0 0.21 0.41 
 
B. Regression analysis results 
Multiple linear regression analysis was performed to study the association between 
the mHealth apps downloads and the independent and control variables (Table 18) 
to validate the research hypotheses H1 to H5.The validity of the regression 
assumptions was first tested for the normal distribution of errors/residues with the 
graphical representation of the normal probability. The absence of 
multicollinearity was also confirmed. The table 19 presents the Pearson correlation 
matrix. The intercorrelations among the various constructs are all within an 
acceptable range. Taking into account the evidence of this evaluation, it can be 












The regression model has the following structure: 
= + α1PU+ α2PEU+ α3PT + α4SN+ α5AB+ α6REVIEWS +α7SIZE + α8LENGTH 
+α9PURCHAS +α10ADS+ α11YEARS +α12MltPLATF+α13DEV+ u 
The results of the linear regression, Table 19, provide support for accepting 
hypotheses H1, H4 and H5 by showing that there is a positive correlation between 
the independent variables of perceived usefulness (PU), users’ star rating (SN) and 
app quality evaluation (AB) and the dependent variable of the log number of 
downloads (BI). It further indicates that downloads are positively related to the 
number of reviews (REVIEWS), length of description in app store (LENGTH), in-
app advertisements (ADS) and years since app’s first release (YEARS). 
 
 
Table 20: Hypothesis analysis results  
Hypothesis Coefficients Tvalue p-value Conclusion 
Independed Variables 
H1 (BIis affected by PU) 0.121 2.008 0.046* supported 
H2 (BI is affected by PEU) -0.022 -0.391 0.696 Not supported 
H3 (BI is affected by PT) -0.026 -0.485 0.629 Not supported 
H4 (BI is affected by SN) 0.306 8.031 0.000** supported 
H5 (BIis affected by AB) 0.181 2.290 0.023* supported 
Control variables 
REVIEWS 6,709E-5 4.942 0.000** 
SIZE 0.000 -0.638 0.525 
LENGTH 0.001 2.082 0.039* 
PURCHAS 0.119 1.106 0.270 









DEV -0.166 -2.278 0.203 
**p < 0.001, * p < 0.05 
R-sq:  = 0.615Prob> F = 18.945 





CHAPTER B. 5 
 5. Agenda with valuable insights about  mHealth apps for 
professionals 
5.1. mHealth apps: What exists 
 
 
 From the survey findings, the majority of the apps (66%) concerned a wide 
range of medical specialties and were intended to fulfill educational needs (63%) which 
appeals mostly to medical students, with “Handbooks/manuals” being the most 
populated app category (28%). “Decision making on diagnosis” was the next most 
useful group of apps (30%) with the “Differential diagnosis” category being the most 
popular of them (21%).Based on certain features are being explained three tiers that 
mHealth users based their trustworthiness on when experiencing trialability in order to 
further use an app in an everyday clinical routine. Features that describe the level of 
“security” of users’ personal data are addressed by the majority of designers (87.5%) by 
including an official declaration. However, only 39% of these apps were asking for 
users’ consent. If the users deny agreement, they are not allowed to continue with the 
app.  
 Another analysis of the 600 most used mHealth applications, as of May 2013, 
showed that, on that date, only 30% of the apps had a privacy policy (Benjumea 2019). 
Considering this statistic it can be assumed that nowadays, and after the wide discussion 
of regulations upon the security of personal data, the vast majority of health apps choose 
to inform the potential users about their privacy policy and some of them require 
acceptance before allowing navigation to the app itself. However, this take it-or-leave-it 
business model makes users powerless to negotiate with the app provider and are 
somehow forced to accept the rules without adequate information. 
Reliability, as a measure of app trustworthiness, is given by the features of 
Credible source (present in 39% of apps) and Feedback contact (29%). Both features 
have low presence if we consider that these apps are made for professional use and 
therefore should make explicit the fact that their info and results are 100% reliable. If 
the app developers wish to expand their pool of users, these features should be taken 
into serious consideration as they would be responsible for shaping part of health 
professionals’ education, diagnosis and management capabilities. Usability is the third 
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measure of building app trustworthiness. The feature of Guidance is present in only 
60% of the apps, which is considered low, and if we assume that new users would 
expect to get navigation instructions or a Tutorial (17%) for the use of the app to be able 
to use it and receive the maximum benefit of the app’s capabilities, but do not receive 
explanations on how to use the app, users may not want to keep it. 
 Connection with doctors is the health app category that gathers the most features 
relevant to trustworthiness (with a mean of 5.00 out of 7 features) and Scientific news/ 
libraries follows with a mean of 3.85 features. Both are categories that involve a lot of 
personal data and credibility expectations from users.  
App quality was evaluated with the use of the MARS tool. The average score of 
the apps were 3.2/5 which leaves room for improvement. The aesthetics category scored 
lower (2.92) and the information quality higher (3.47), but the range of scores is limited 
without any cluster exhibiting a satisfactory result. The Patient management category 
scored higher in quality (3.87)without, however, gathering high scores in the 
trustworthiness tiers (features).All mHealth apps in this study are offered free of charge 
which means that their revenue source is the online advertisements showed to 
professionals as they use the app and the potential income from satisfied users who are 
willing to pay an extra fee for unlocking the maximum capabilities of some of these 
apps. The feature of “ads inclusion” is present in 60% of these apps and “in-app 
purchases” in 42%. These features usually cause reverse usability to the targeted users. 
 The majority of the apps (77%) have received a positive rating by their users 
(>4*) and less than 10% were not rated at all.  The overall mean rating was 3.9/5 and 
the mean downloads were above 115,000 meaning that a good number of professionals 
were at least interested in looking for a helpful app to assist them in the diagnosis or 
learning process. 
Concluding, it is obvious that the integration of mHealth in medicine 
differentiates according to the category of the health apps. Professionals and students 
mostly download the applications with the most features that include trustworthy tiers 
(Connection with doctors &Scientific news/libraries).On the other hand, users’ 
evaluation rating is in line with the quality of the apps, since Patient Management, 
Games/simulators and Calculators gather the highest scores in rating stars and the 
MARS quality evaluation system. Based on that, it seems that mHealth innovation 
equally concerns all app groups (Education & Training, Decision making in diagnosis & 
Management), but users prefer to use certain app categories within these broadergroups. 
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Their criterion for downloading may be trustworthiness and their criterion for a good 
rating may be the app’s quality. 
 
5.2 Suggestions for new mHealth apps with increased usefulness 
 
As the search in the App Store revealed, a relevantly small sample of AI 
mHealth applications currently available to professionals and due to the belief that these 
apps will keep emerging ( Wang et al. 2018) following the advances of medical 
informatics the study has focused on the identification of such capabilities that could 
become useful and marketable mHealth apps. Based  on the use of AI and ML to 
investigate the future agenda of such apps as there is evidence that their capabilities in 
the health sector are limitless (Panch et al. 2018). Surveying the relevant literature and 
web developers’ sites about the use of AI in mobile apps techniques the identified 
capabilities could be integrated in mHealth apps for becoming even more useful to 
professionals.  
Company giants such as IBM and Google have focused their efforts in this area 
and much of their funding goes to this direction (Dwivedi et al. 2019). Computer 
scientists and medical scientists must work together to develop ML methods, which can 
bring benefits to healthcare. These AI algorithms must then become actionable inside a 
mobile experience in order to obtain in the near future these useful mHealth apps. There 
seems to be a massive untapped market waiting to be released with the right technology.  
The AI capabilities of image recognition that can be embedded in a mobile app, 
such as Google lens, can become extremely useful in medicine. For example, a trained 
algorithm can perform image matching and automatic diagnoses of skin cancer, of an 
MRI (Zakhem et al. 2018),or drug effectiveness from a petri dish image (Agarwal et al. 
2019). 
ML capabilities of Natural language processing (NLP) help systems learn how 
to interact with and understand human language after training the algorithm to match 
text and voice. Adapted smart reply technologies and chatbots like Alexa and Siri can 
be used by medical professionals and their clinics as patient support systems and 
communication tools for automated messages (reminders for appointments, bookings of 
new appointments or even sending lab test results and drug prescriptions through an 
authentication process. The latter requires a much more robust safeguard approach, one 
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of them being a facial recognition ML algorithm to identify one’s face from a repository 
of the individual faces of patients held in the clinic. Such systems are commonplace in 
security, surveillance, and law enforcement. 
Doctors can also use a chatbox app to monitor their patients’ health by 
scheduling questions related to their health, and through text classification and trained 
algorithms, the chatbox could provide appropriate responses. Such an app enhanced 
with analytics of social and behavioral data received by the smartphone (such as phone 
activity, step counter, sleep and heart rate monitor) and video call capabilities could be 
used for doctors to monitor and manage their patients and intervene with telemedicine 
when judged necessary. Again, privacy and security issues are raised for developing 
such apps. 
Another potential mHealth app that can greatly help expanding doctor’s 
experiences to special disease cases and evolve the practice of medicine is one named 
“patients like mine” (Gombar et al. 2019). Such an app could help clinicians collect 
reliable insights out of stored patients Electronic Health Records (EHR). Clinicians could 
pose questions and, through a search engine for indexing patient timelines, the system 
could build cohorts matching a clinical phenotype, incorporating a propensity score 
matching for patients similarity, survival analysis, causal inference, and a clinical 
interpretation of the results and their limitations (Schuler et al. 2018). Such an app could 
be further enhanced with AI capabilities of real-time translation in order to increase the 
matching EHRs, incorporating EHRs from other countries written in the local language. 
This can only become possible if countries share EHRs or consent to create a shared, 
real-time, or frequently updated, repository of anonymized EHRs. The real-time 
translation ML capability (such as Google Translate) can also be an additional useful tool 
to the “Library” type of apps to increase availability of articles and other important 
clinical notes written in different languages.  
All of these apps and many more could shape the future of mHealth for medical 
practitioners. Nonetheless, there are many issues related to privacy, security, and data 
governance that must be resolved before such apps are released in the market. 
 




 From the 168 apps, the most popular app features were “Privacy Policy 
Declaration” (87.5%) and “Brand Recognition” (72%), which might mean that such 
features are either obligatory or designers believe they are more attractive to consumers 
than “Registration” of users (25%), which might be considered as a drawback to install 
the app. 
Overall, “Connection with doctors”, “Patient management tool”, followed by 
“Games” are the mHealth types that gather the most features related to ethical concerns 
(privacy and reliability) indicating that users who need these kinds of apps in clinical 
practice have major concerns about privacy, security, and trust issues. Moreover, the 
artificial intelligence apps score higher in all privacy and security features. The research 
indicated that these apps have the potential to interpret sensitive information, not only 
of the users, but of their patients too and therefore users need more safeguards for 
privacy and reliable sources. It is also interesting that “Handbooks” and “Dictionaries”, 
the most popular in terms of number of apps available in App Stores, neither include 
enough features to ensure privacy and security, which could be justified from the nature 
of the apps since they are mostly used for self-training in exams, therefore they could 
have a supporting and temporary character, nor do they excel in reliability, which one 
should expect. The latter is also true for “Diagnosis assisting tools” and “Calculators. 
 Based on certain features are explained the challenges that mHealth faces 
nowadays. Ethical issues that include privacy of users’ personal data are addressed by 
the majority of designers by including an official declaration at the bottom of the app 
description in the App Store, or as a tab after downloading the app, or information on 
the designer’s website. In the sample 87.5% of the apps included a declaration, but only 
39% of these were asking for users’ consent to access their data (e.g. “Patients records 
and Appointments for Doctors” app) or access to users’ device storage (e.g. “Lancet” 
app) or agreement to both privacy policy and terms and conditions of content usage 
(e.g. “Common Differential Diagnosis” app). If users deny agreement, they are not 
allowed to continue with the app.  
 A study of the 600 most used mHealth applications as of May 2013 has shown 
that only 30% of the applications had a privacy policy on that date (Benjumea 2019). 
Considering this statistic, nowadays, and after the wide discussion of regulations on the 
security of personal data, the vast majority of health apps choose or are obliged to 
inform the potential users about their privacy policy and some of them require consent 
before allowing navigation to the app itself. 
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The main challenge of privacy, security, and data governance when processing 
sensitive, personal health data has become increasingly important because of the rapid 
development of new forms of data, and the ease of transferring and sharing data. Future 
research is directed towards the development of systems that will standardize and secure 
the process of extracting private healthcare datasets for further aggregated use (Galetsi 
et al. 2019). 
On the other hand, a service provider publishes a narrative privacy policy 
document made by lawyers and expects that a service is either accessed as is or not used 
(take it-or-leave-it model). As people have limited or no power to negotiate with the 
service provider, they are forced to accept service provider’s rules without sufficient 
and reliable information. However, users of mHealth apps would most probably want to 
control how and by whom their personal information is used and disclosed. One 
solution to this problem is the deployment of multiple, formal, and therefore computer 
understandable policies as defined by ISO 22600 (Blobel 2017). Unfortunately, only a 
few service providers support personal polices, and current laws do not force them to 
accept user’s privacy policies (Marsden 2017). Responsible AI devices focus on 
designing and implementing solutions allowing stakeholders to fully understand how 
applications process their data and provide information that may lead them to specific 
decisions (Wang et al. 2020). This can be addressed following practices to provide 
ethical, transparent, and accountable solutions that help maintain individual trust and 
minimize privacy invasion ( Wang et al. 2020).  
It might also be possible in the next decades that privacy is not considered a 
personal right anymore, but as a statistical risk (Hong et al. 2004) or commodity that 
can be sold to data companies (Davies 1997). There is no doubt that many governments, 
organizations, and service providers frequently interpret privacy as relative and think 
that the privacy level offered can be balanced with other interests such as business gain 
or national security (Litt 2013). 
 To make meaningful privacy decisions, a person should understand the impact 
of selected policy rules and security attributes for the reliable use of services 
(Ruotsalainen 2014). However, detection of malicious applications is difficult due to 
limited resources available within smartphone devices and an efficient and accurate 
mechanism is needed to detect malware so that security can be guaranteed (Mehtab et 
al. 2019). As health care data has become an increasingly popular target for hackers 
(Filkins 2016), significant measures are required to ensure security and privacy of data 
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using traditional privacy techniques. These require developing new security protocols 
such as device-based authentication schemes, an example being the PMSec where no 
data related to the Internet-of-Medical-Things (IoMT) devices are stored in server 
memory (Yanambaka 2019), or a new dimension of information flow for smart health 
data to the cloud (Puthal 2019), such as Lattice model (Jayaraman et al. 2019). Lastly, 
efficient detection/prevention systems in mHealth applications should employ a strong 
multi-factor authentication, which should offer to the designer the least privilege with 
the necessary permission to accomplish a specific task (Yaacoub et al. 2020).  
Thus, privacy and confidentiality should be core concepts in such apps. They 
need to guarantee the security of data that are exchanged and that the whole interaction 
between the system and the doctor/patient is confidential. For all mentioned applications, 
data processing operation must be compliant with the different data protection 
regulations of all countries. Developers must provide a detailed description of how user 
personal data is used within the service, incorporate a consent agreement for data 
processing upon registration for every sort of data or system used/accessed (camera, 
images, text, phone logs, voice, etc.), request new authorizations if the app is not used for 
a couple of weeks, have a limited retention of data (for a couple of days) from deleted 
accounts after termination(Van Der Sype & Maalej, 2014), implement cryptographic 
protocols [e.g. Transport Layer Security (TLS)] to provide communications security over 
a computer network with Advanced Encryption Standard for data transit (Sun & 
Upadhyaya, 2015),and implement computer vision algorithms for face recognition that 
run entirely on the phone avoiding sending, for example, face 3D scans (FaceID) to 
cloud servers (a neural network can take the FaceID scan embed it into a vector, store it 
locally and compare future scans to that) (Jeon et al. 2019). 
The protection of mHealth users’ data requires legal and policy attention. 
mHealth apps’ development and usage will further grow if countries share global ICT 
standards and architecture and health structures and public health systems cooperate to 
identify and use best practices for enterprise architecture that will allow both data 
protection while also ensuring that anonymized data are safe and in the right format to 
be used for research purposes. Physicians must become more educated in informatics 
(Fernando & Lindley, 2018) in order to more thoroughly understand AI methods, ML 
algorithms deployment and the datasets that they are built on. Black boxes in the 
process of mHealth should not be allowed.   
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On the other hand, there are cases were mHealth apps may enhance issues of 
confidentiality and ethics. This is true for chatbots that reduce the sharing of 
information with human intermediaries such as, clinic’s assistants and physicians and 
therefore restrain confidentiality issues between patients and professionals, as long as 
the chatbot conversations remain secure. Moreover, the medical center’s chatbot that 
helps patients answer common medical questions could increase the population’s 
(virtual) access to healthcare and offer new solutions that are less dependent on 
expensive in-patient care (Schulman and Richman 2019). 
 
5.4 Mitigation of Reliability Challenges 
 
While privacy and security are interconnected concepts, before beginning to use 
mHealth services, users also need credible and reliable information to enable them 
determine the trustworthiness level of services and avoid the use of blind trust 
(Ruotsalainen 2014). Trust could be built by empowering the engagement of all 
stakeholders such as patients, medical professionals, healthcare organizations, 
policymakers, and governments and offer them training to embrace and understand the 
latest technology (Horgan et al. 2019). To gain the most of the outcomes of AI devices, 
reassurance should be provided for the right interaction between algorithm and data as 
well as the way results are calculated and explained to users (Horgan et al. 2019). 
In this study the apps’ developer “Brand Recognition” was quite high amongst 
the 168 apps (72%), although the “Help function” with developers’ contact details 
(30%) and the “Feedback” option for asking questions to the developer and partners 
about the results and the calculation process (31%), had limited presence. Moreover, 
credible sources were identifiable in only 39% of these apps. A surprising finding was 
that one of the most popular apps in terms of rating and downloads of the 
“Handbook/manual” type [Internal Organs in 3D (Anatomy)] does not provide 
information sources. 
 
The reliability/credibility of the source and transparency of the ML algorithm are 
also very important challenges. Amongst the capabilities a system must possess in order 
to support clinical decisions are the relevance of the answer and solid scientific footing 
(Shortliffe & Sepúlveda, 2018). There are ethical and safety concerns for automated 
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healthcare consultation (Char et al. 2018) such as “Patients like mine” which may be 
offered based on incomplete and biased EHRs (Zulman et al. 2016), mostly collected 
for the Western world, that can result in inadvertent preconception and even racial 
mismatching (consider the effect of skin color on the skin cancer diagnosis app). The 
main characteristics of an ML algorithm used for diagnosis and consultation requires 
transparency so users can understand the scientific foundations of the recommendations. 
The ML algorithm should have solid, peer-reviewed, scientific evidence establishing its 
validity, reliability, usability, and reproducibility (Shortliffe & Sepúlveda, 2018). This 
requires a systematic process for identifying predictable errors and acceptable solutions, 
a monitoring system with intermediate outputs to control the calculations step by step, 
evidence of the system’s ease of workflow integration, and the use of linguistics 
variables to determine computational trust. The whole process should be designed to be 
fail-safe and the output to be as accurate as possible while doing no harm (Shortliffe 
&Sepúlveda, 2018). For more complex apps, such as “Patients like mine”, in order to 
generate safe and valid advice it would require  an “expert in the loop” to contextualize 
results for clinical decision-making (Schuler et al. 2018). The expert in the loop may be 
a whole team comprised of an app developer, a clinical informatics trained physician for 
interfacing with the requesting provider and giving clinical context when interpreting 
findings, an EHR data specialist to create patient cohorts, and a data scientist to perform 
statistical analyses. This setup is very different from the “popular paradigm of self-serve 
AI-enabled tools that undertake data processing behind the scenes and directly present 
the results to a physician for interpretation”(Gombar et al. 2019). The suggested 
system/team would require at least 48 hours to provide an answer (Schuler et al. 2018). 
To keep the “expert in the loop” it also requires a per query charge as opposed to a fee 
for service charge (paying for downloading the app) that users are more acquainted with 
or a SaaS (Software as a Service) model. This causes extra challenges with regards to 
the commercialization and sustainability of the app. 
Therefore, it is important for such apps to be triggered and provided with the 
signature of international organizations, such as the World Health Origination (WHO) 
or the European Centre for Disease Prevention and Control (EDCD). This will alleviate 
many concerns surrounding the credibility of the apps’ sources, as these organizations 
will most probably take the necessary measures to ensure validity and reliability of the 
app. They can also undertake some of the financial burden in the attempt to promote 
health and life-saving processes in everyday medical practices. They also have the 
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authority and power to direct countries’ collaboration on a given purpose for providing 
ready access to high-quality clinical data via the creation of an open, accessible, patient-
centered data architecture (contrary to the proprietary technology currently in use by 
many health structures and physicians) (Schulman and Richman 2019). 
The next argument is another reason for international organizations to take part 
in mHealth apps development. Given the increasing importance of quality metrics 
reflected on physician ratings and reviews to promote their career or on clinic 
evaluations that determine reimbursement rates, there may be a temptation from private, 
not regulated, designers who create apps for clinical use to teach ML algorithms to 
guide patients toward clinical actions (unnecessary interventions that physicians are 
experts at, recommendation of tests, drugs, devices in which they hold a stake or referral 
patterns alteration to please patients) that could improve these metrics and profits as 
well as, but not necessarily, improve individual’s health. Although ethical codes have 
been developed by professional organizations (e.g. the ACM Ethical Code for software 
Engineers and IMIA’s Ethical Code for Health Information professionals), these 
function as inspirational drivers to computing professionals rather than regulatory 
guides. Such mis-happenings are very difficult to identify since the correct diagnosis in 
a particular case and what constitutes best practice can be controversial (Char et al. 
2018). 
Another issue related to the liability of the ML algorithms, that are used for apps 
predicting certain metrics (such as the “calculators” and these that predict patient’s 
possible mortality rate and other metrics), is that the ML algorithms are based on 
existing data (time series of numerical metrics, EHRs) that reflect what happened in the 
past, but not necessarily depict the future and moreover may also mirror human biases 
in decision-making (Rajkomar et al. 2019).  Greater amounts of different data such as 
socio-economic factors, genomics, real-time data from sensors and smartphones must 
be incorporated in regression models to increase the predictability of the ML algorithms 
(Char et al. 2018). 
 




6. mHealth apps: What is needed 
Technological progress is critical to the global economy. Studies on new 
applications of information and communications technologies lead to identification of 
promising avenues for future research (Sheng et al. 2019). In this section it will be an 
attempt to answer the current and future needs of appealing mHealth apps for 
professionals, starting with the app type usefulness attribute and we will provide a quick 
view of the prospects of such apps and their benefits, not only for medical practitioners 
but for the society as a whole. Then we will conclude with some solutions of how 
mHealth apps can increase their trustworthiness and quality evaluation which will 
hopefully lead to greater health professionals’ engagement and app popularity.  The 
recommendations that follow are a synthesis of research ideas and findings from the 
recent relevant literature as well as from online sites of mobile app developers. 
 
6.1 Building Useful and Trustworthy, Quality mHealth apps 
 
The research findings have shown that decision-making and patient management 
apps score higher in quality. Therefore, further improvement of these apps will greatly 
appeal to health professionals. Differential diagnosis apps can be enhanced with image 
recognition technologies which will be increasingly useful for e.g. dermatologists, 
ophthalmologists and microbiologists who can take a picture of the patients’ skin, eye 
or petri dish and the app will match this image with the built-in library of images to 
provide a diagnosis based on the similarity percentage found between the taken image 
and the diagnosed images. This capability could prove life-saving to patients around the 
world where there is a lack of qualified health professionals and equipment, such as 
poor countries and war zones (Hu et al. 2019). 
Another important suggestion, which can greatly help expanding doctors’ 
experiences to specific disease cases so that they can provide more targeted therapeutic 
schemes to patients and also evolve the practice of medicine altogether, is the potential 
differential diagnosis app “patients like mine” (Gombar et al. 2019). Such an app could 
help clinicians collect reliable insights out of stored patients Electronic Health Records 
(EHR) and acquire medical domain expertise to contextualize results for clinical decision 
making at the point of care. 
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This app could also incorporate real-time translation for expanding the pool of 
similar EHRs from worldwide, including EHRs that are written in other languages. The 
real-time translation capability can also be a useful additional tool to the “Education & 
Training” group of apps to increase availability of articles, handbooks and other 
important clinical notes written in different languages and make them available to a 
wider population. 
Except virtual treatment and tracking of incidents, literature has reported many 
other outcomes of professional mHealth applications in the case of a general lockdown 
such as education, training and counselling  using webinars and online lectures and 
“tertiary referral” to avoid in person visits (Iyengar et al. 2020). More importantly, 
using applications that are able to analyze big data, store vast amounts of patient 
information globally is very much suitable to track and control the worldwide spread of 
a pandemic, such as the disease COVID 19 (Javaid et al. 2020). Moreover, reporting of 
infectious diseases by doctors, clinics and laboratories to governmental agencies could 
lead to faster recognition of cases of infectious disease. More direct access to such data 
could enable surveillance epidemiologists to detect potential public health threats such 
as early-level warnings for epidemics (Velasco et al. 2014). 
With regards to the “Management” of patients app category, a convenient app 
for medical specialists and their clinics could be an app that uses smart reply 
technologies to enhance patient support and communication (replies to standard  
queries, such as clinic’s working hours but also replies to more advanced queries such 
as reminders for appointments, results’ collection or even sending online drug 
prescriptions with some authentication process and first aid answers to specific cases, 
e.g. snake bite). Like this, smart technologies can take over the majority of routine 
conversations and tasks to manage patients and patients’ records and could also improve 
the population’s (virtual) access to healthcare and provide new resolutions less reliant 
on expensive care (Schulman and Richman 2019).Doctors can also use smartphone AI 
applications (Vaishya et al. 2020) to track heart-rate and temperature to accurate model 
pandemic trends (Kapoor et al. 2020). 
These apps and many more are the future of mHealth for health professionals 
offering a helping hand to the whole society in terms of provision of healthcare. The 
challenge of integrating ethical decision making into technical development settings can 
advance the dialogue between work practices and ethical discussions across healthcare 
mobile development and encourage developers to prioritize privacy practices and 
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features in software design (Shilton and Greene 2019). Therefore, many problems with 
regards to trustworthiness of such apps must be resolved before they can be launched in 
the market. For example, security, reliability and usability issues are raised for 
automated healthcare consultations (Char et al. 2018) offered by differential diagnosis 
apps. With regards to security, app results may be calculated based on biased and 
incomplete EHRs (Zulman et al. 2016), available mostly from the developed countries 
where EHR information technology is implemented. Such results may lead to 
inadvertent preconception and perhaps racial mismatching or non-usable apps (e.g. the 
skin color validity on the skin cancer differential diagnosis app). 
Moreover, a fundamental prerequisite for the adoption of such technologies in 
diagnosis is reliability and transparency, as also shown in the findings of the study, 
which means to make known and comprehensible the scientific foundations of the 
solutions to the users. In increased complexity apps, such as “Patients like mine”, for 
the app to provide safe recommendation it would need a “health informatics specialist in 
the loop” to digest the automatically generated results and feed the app with valid 
clinical decision-making options (Schuler et al. 2018).Thus, such apps are best if they 
are provided by international or national health organizations (e.g. World Health 
Origination, American Society of Clinical Oncology), which can offer increased 
credibility about the app’s info and results, as they have the resources and expertise to 
ensure mHealth app validity and the financials to budget it for offering advanced care 
services in the daily clinical practice and democratizing innovation (Bergvall‐Kåreborn 
&  Howcroft, 2014). 
Moreover, apps that are used for patient management and automated 
communication with patients, which may also involve official document exchange (as 
proposed above),would require an increased level of security measures, such as facial 
and other recognition systems, that are commonly used in electronic surveillance. 
In all mHealth apps, IT security features must be increased in order to develop a 
trusted environment for its users with regards to their personal data exploitation and the 
authentication process. Moreover, the regulators should enforce by law essential rules 
for warranting the fidelity of the mHealth apps. On the other hand, the responsibility is 
also on the users’ side who should be extra cautious when using such apps because of 
the associated security and privacy risks created by the generation of new information 
(Angst 2009).Education on the matter will make things better and will increase the 
demanding voices for trustworthy mHealth apps. 
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Small improvements in usability can be identified in all app categories, for 
example, the Connection with doctors’ apps could offer increased features’ 
customization with regards to user profile, everyday clinical requirements and prognosis 
needs. 
Nevertheless, it is also very important that mHealth apps should avoid the 
business model of free or freemium apps with income generation from ads and 
promotional material, and focus on the engagement of national health organizations, 
associations and academic institutions to finance or provide themselves the app and its 
essential updates, or else move to a business model which offers a free trial period and 
then charges a fee for its further use. In the latter case the period should be long enough 
(e.g. 1 month) for the health professionals to understand the usefulness and usability of 
the app and get involved enough to be persuaded to pay a small fee for keeping the app 
functional. This model will also trigger app providers to offer more appealing and quality 
apps in order to engage health professionals. With this addition, the MARS scores could 
be improved across all functions. 
The goal is to increase mHealth apps’ usefulness with the use of innovative 
technological capabilities to cover identified needs, starting from areas with limited 
health resources and limited access to expensive biotechnology (developing world, 
inaccessible geographic areas) but also in everyday professionals’ routine as a 
supporting tool so that the app’s recommendations are judged by experts and not taking 
for granted automated decisions. Simultaneously, innovation in healthcare technology 
must outline the four ethical principles for healthcare managers: respect for others by 
maintaining confidentiality, beneficiality by providing aid to patients, non maleficence 
by not putting at risk patients during treatment, and justice by equally providing 
treatment to all patients without taking under consideration gender, ethnicity or social 
status (Oddo 2001).  
 In this Thesis there is a presentation and discussion of the benefits and 
challenges of mHealth applications. Frameworks and taxonomies were presented to 
ensure a better understanding of the adoption process of such an innovation technology. 
mHealth apps should maintain a high level of security, reliability and usability by 
incorporating features that ensure these elements. Moreover, the development of new 
mHealth apps, which will increasingly utilize the capabilities of new technologies, will 
be of great help to medical professionals, the health sector and the society overall. Some 
of these apps, such as “Patients like mine”, under a certain spectrum may be capable of 
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evolving medical science as a whole. It is the next challenge for IT developers to create 
such apps in the most responsible way with the support of the health world.  
 
6.2 Managerial Implications 
The research also carries managerial implications for app developers, health 
professionals and the health system. The increasing in size mobile app industry can 
find valuable implications for the future direction of health e–commerce (Ghose, & 
Han, 2014) and in particular the features that customer value the most in the 
mHealth app market .This study revealed that features relevant to usefulness (app 
content/capabilities), in contrast to features relevant to reliability and usability, 
affect mHealth apps’ downloads. Health professionals’ intentions to use mobile 
health apps during their daily clinical activities follow certain dimensions and app 
developers should consider that consumers’ behavior is related to their need to 
gain assistance while performing their work. Therefore, this study shows that 
health professionals are mostly attracted by the sought result/info which derives 
from the app in order to increase their job performance. The comments and rating 
of other colleagues that have already used the application and the quality of the 
app, including engagement, functionality, aesthetics and information quality are 
also important factors in their decision to download the app. The length of the 
description is also crucial and includes the needed explainability that a heath 
professional expects in order to use an app.  
The 21st century is a technology era, information age, network trade era and 
artificial intelligence era. In this rapidly evolving environment, management and 
administration practices need to be quickly adjusted and innovations must 
adopted in a continuous mode (Chong & Sheng-bin 2006).mHealth is considered 
one of the most transformative drivers for healthcare delivery innovations and has 
brought to the clinical research environment revolutionary insights with new 
challenges and opportunities (Cleary 2018). Based on a 
leading mobile analytics company, 90% of the time that we spend on mobile 
devices is spent on mobile apps where statistics show a constant increase in global 
app downloads per year.  For the years 2016-2019 this increase was at the level of 
7%-27% (© Statista 2020). This is encouraging news for app developers. In the 
market of mHealth apps for medical professionals, The research has shown that 
there is still a lot of space for improvement. A range of apps still remain untapped 
relevant to medical professionals that would be of use and could promote their 
medical practice and medicine as a whole. Such future apps may utilize artificial 
intelligence at a greater level. 
But in order to be successful in this space, two things need to happen. First, the 
designers of health apps need to make improvements in the credibility of their 
app’s information and the visibility of this credibility, as well as IT security 
features must increase its ability to create a trustworthy environment for its users. 
Second, the regulators should also take legislative action to enforce minimum rules 
for ensuring the trustworthiness of the mHealth apps’ market. Moreover, our 
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society demands responsible consumers of IT systems. Education should play an 
important role in this area. Towards this direction tools have been created for 
users to assess the credibility of an app, such as the CRAAP Assessment of Health 
Promotion Mobile Applications (Apps) (McNiel and McArthur 2016). 
Finally, governments must consider the large-scale implementation of successful 
and useful mHealth innovations. For example, “Tools for patient management’ 
and “Connection with doctors” are the two types of apps that could have a 
tremendous effect in the healthcare at busy health centers in the first instance and 
of geographically disperse areas in the other. The World Health Organization and 
other stakeholders will need to issue guidance to help prioritize and accelerate 
governmental mHealth adoption (Labrique et al. 2013). 
Therefore, technology firms can become wiser about customer engagement, 
download intention behavior and brand loyalty by performing customer analytics 
with regards to the app capabilities they use (e.g. demographic characteristic of 
health professionals who download apps with specific purpose/capabilities). Based 
on this information they can optimize app content for specific user segments and 
length of description for better navigation, since this feature was also found to be 
important to users. This reveals that increased app downloads depend on the app 
publishers’ behavior since developers can manipulate app features and app 
descriptions. Moreover, a similar approach can be followed with regards to star 
rating and reviews. Since rating and reviews of other users are crucial for app 
downloading, app developers should use customer analytics (e.g. text analytics to 
user reviews) to understand customer expectations, likes and dislikes. Based on 
this information, they can improve app content, features, etc., for offering a more 
appealing app and offer the necessary bug fixes as identified in the user reviews. 
Developers can also increase the number of reviews by responding to each review 
which a thank you note, or an explanation note in case of complaints as the study 
has shown the number of reviews highly related to the number of downloads. 
  
Nonetheless, developers must be cautious with the finding that more capabilities 
(usefulness) lead to more downloads and should find a balance between increased 
capabilities and low complexity, as other research has shown that complex 
functionalities tend to confuse users in decision-making (Alnsour et al. 2016) and 
decrease the engagement of health professionals to the new technology (Venkatesh 
et al. 2002; Zapata et al. 2015; P. Llorens-Vernet, & Miró, J. 2020).  Meaning that 
although the app is downloaded it is used only for a limited time period and then it 
is uninstalled. . 
 




7. Discussion and Conclusions 
 
These days, smartphones are more than accessible and provide unique 
processing powers that allow for complex apps to run, such as those providing health 
services (Balapour et al 2019). Medicine has been profoundly affected by the 
availability of mobile devices (smartphones and tablets) in clinical practice and 
education due to fast access to information and better communication and information 
resources at the point of care. Given the increased adoption of smartphones by 
healthcare professionals (Cleary 2018; Mosa 2012) the second part of the PhD Thesis 
provided  three separated analysis based on a unique  sample of 168 health applications 
addressed to health professionals and students.  
In the first analysis there is a description of the apps of the sample and an 
explanation of their features, especially the ones that can be explicable in terms of 
ethical concerns in privacy, security and reliability. An expanded version of the 
Communication Privacy Management theory has been followed to explain privacy and 
reliability features that developers should incorporate in the apps, so that the boundaries 
(criteria) of data owners (health professionals) to trust an mHealth app are not shaken. 
Moreover, based on the content of each app, there is also a classification of the apps 
into certain categories denoting their usefulness, spotted the apps that included artificial 
intelligence and emphasized their outcomes. Technology studies emphasize the way 
technology acts on the world as well as that its deployment creates socio-ethical 
implications that reshapes professional relationships, creates moral consequences about 
issues such as privacy and trust, reinforces or undercuts ethical principles and enables or 
diminishes stakeholder rights and dignity (Martin et al. 2019).The contextualization of 
technology and the way is used in the health sector reveals that the information systems 
innovators will need to consider the conflicts and challenges it creates (Flick et al. 
2020).Technological innovations in medicine have allowed the use of mobile devices in 
clinical practice and education due to fast access to information and better 
communication at the point of care. Following the Normalization Process Theory (May, 
2013),  the second analysis of  the  study, explained step by step the path to the adoption 
of an innovative health application in an everyday clinical routine measured every stage 
of this path by using relevant scales. Namely, there has been used mHealth apps’ 
categories (education, decision-making, patient management) at the implementation 
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stage, the app features organized in three tiers (security, reliability, usability)for the 
embedding stage, and finally the MARS quality score, stars rating and number of 
downloads as the dimensions of integration of the NPT model. 
Observing the significant associations among the research framework elements, 
it is obvious that the integration dimensions of mHealth app downloads, their star rating 
and their quality score are all highly intercorrelated with each other. Furthermore, from 
the integration dimensions of the mHealth apps, the quality score is correlated to the 
reliability tier of the embedding stage of the conceptual model that incorporate the 
features of credible source and the feedback communication feature that users can 
benefit from while using the app. The social sharing feature is positively associated with 
the existence of the feedback mechanism and ads, as marketeers most probably find this 
a useful tactic to increase ads exposure. Privacy is positively correlated to the in-app 
purchases and ads indicating that developers include a privacy policy statement when 
they try to earn from the release of their app by acknowledging the promotional 
material. There is also evidence that the more features in an app the better its quality 
score, especially when credible source, feedback opportunities and guidance on how to 
use the app are present. Apps belonging to the categories of decision-making for 
prognosis and especially patient management score higher in quality and incorporate 
more features overall compared to the educational category apps. 
Finally, the last part of the second research of the PhD Thesis, attempted to 
understand the relative importance of the determinants of the professionals’ consumer 
preference for the health mobile apps. Based on the literature review, it has been 
developed a research model applying the combination of two theoretical models related 
to the acceptance of innovation, namely the Technology Acceptance Model and the 
Theory of Reasoned Action in order to explain the integration intention of the 
innovation of health apps in clinical routine. This study reviewed a number (n = 168) of 
health apps addressed to professionals available in the Play Store and is the first study to 
have quantitatively modeled the health mobile apps’ use for professionals. The main 
goal was to understand consumer behavior about digital health and to specify the 
variables that attract health stakeholders in downloading related apps.  
There is a wide literature with regards to the adoption of mobile apps in health  
using questionnaires to targeted populations (Jahn et al. 2019; Holdener et al. 2020; 
Byambasuren et al. 2019)or statistical analysis (Krishnan and Selvam 2019) to 
investigate and predict the factors that influence app downloads in the healthcare field. 
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Literature has also investigated the importance of mobile apps in specific clinical 
routines by health professionals (Ventola 2014) or the effectiveness of mobile health 
(mHealth) technologies to train healthcare professionals (O'Donovan et al. 2015) 
conducting systematic reviews (Gagnon et al. 2016) or surveys (Hofer & Haluza, 2019). 
All the above-mentioned literature has indicated the usefulness, usability and trust, 
among others, as the most important moderators affecting users’ intention to download 
and use mobile applications. However, this analysis gathered all possible determinants 
that proved to be influential for app downloading and statistically tested whether these 
are important at a job relevant population such as health professionals using features 
that are distinctive and easily recognizable in the search for a useful app. 
This study has also revealed some interesting results controversial to past 
evidence. For example the statistical analysis of the sample, using the moderators based 
on the TAM model of perceived usefulness, perceived ease of use and trust, has clearly 
indicated that health professionals intend to download apps that fulfil their temporary or 
long term need to complete a work task (usefulness) without taking under consideration 
the ease of use and trust features. Therefore, app features that define the perceived ease 
of use (usability) and perceived trust do not significantly affect the health professionals’ 
decision to download the app.  
However, Gagnon et al (2016) in their systematic review found evidence in ten 
published surveys that ease of use is an important factor of using mobile technology in 
the working environment. Moreover, in Austria,  a survey on 151 doctors recognized 
the usability elements are among the most important features in order to use a new app 
(Hofer & Haluza, 2019). Nonetheless, although health professionals, when participating 
in surveys, state that usability is important, when it comes to download  the app, this 
study has shown, that ease of use is not the factor that will influence their decision. 
Similarly, the same conclusion can be made about trust. Privacy, security and brand 
recognition have been indicated as very important elements of behavior intention to 
engage with mobile technology ( Lee, & Raghu, 2014; Fuller et al. 2017; Goldhahn 
2018), nonetheless, this study has proved that app downloads are not related to trust, 
although a positive relationship would have been expected especially with regards to the 
trust of mHealth app content. 
On the other hand, with regard to the perceived usefulness of TAM ( Davis 
1989) and influence moderators of TRA that determine the subjective norms of an 
individual’s behavior intentions (Moore & Benbasat, 1996),the study has identified that 
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app’s quality, social influence and app’s specific features which promote usefulness 
directly influence consumer behavior. In particular, the research model identified that 
app downloads, which reflects the dimension of consumer preference, are positively 
significant to the app quality, the users’ evaluation and the features that relate to 
increased operational capabilities for medical professionals. Moreover, it indicated that 
downloads are positively related to the number of reviews, the length of the app 
description, the existence of in-app ads and the years since app first release. 
Therefore, based on the results of this study, mHealth apps which receive a 
higher rating from the users, lead to a greater number of downloads. Similarly, the 
quality of apps, which in our case is represented by an evaluation rating scale called 
MARS, is also positively significant to the mHealth apps downloads from professionals 
and therefore the quality of an app could motivate professionals to use it. These findings 
are aligned with the findings of many other relevant studies about health mobile apps 
(Chatterjee et al. 2009; A. Ghose, & Han, 2014;  Pereira-Azevedo et al. 2016; Salazar et 
al. 2018; Krishnan and Selvam 2019). 
The results also indicate that app downloads are positively related to the number 
of reviews from other users, consistent to the results of Kübler et al (2018) and 
Krishnan & Selvam (2019). The time since first app release has also a positive 
significant coefficient indicating that apps with longer presence in the market have more 
downloads, which is generally reasonable. Moreover, the length of the app description 
also has a positive effect which indicates that the more explanatory the description of an 
app in the app store is, the more downloads is expected to have. All the above results 
has also been indicated from previous literature ( Ghose, & Han, 2014).  Obscure is, 
however, the result that in-app ads are related to downloads although one would expect 
that in-app ads would deter the professionals from using these apps, as it has been 
proved in Ghose & Han (2016). However, it is true that professionals would come to 
know about the existence of in-app ads only after they download it, although some app 
descriptions in the Play Store do mention it.  
During the empirical analysis, and from testing the relationship of any two 
conceptual framework variables and app features, a few additional insights have been 
gained. These are mostly related with the following: the existence of the feedback 
feature and the offline use feature increase the perceived quality of the app, and apps of 




Conclusively, the explosion of mHealth and the wide adoption of mobile apps in 
medicine practice and education have created an innovative and vibrant mobile 
ecosystem. As health professionals tend to use mobile devices in their daily clinical 
routine, it becomes important for app developers to understand the factors that influence 
user demand for mobile apps (Ghose, & Han, S. P. 2014). This three stage analysis has 
also attempted to understand how consumers, and more specifically health professionals 
interact during the decision of the adoption of a mobile app for assisting them in 
practicing medicine, giving insights to developers for the success of their brand strategy 
but nonetheless for the launch of useful mHealth apps that can promote healthcare 
 
CHAPTER B. 8 
 
8. Limitations and Future Research 
This research is not without limitations. Due to the fact that a mobile app can be 
regarded as an innovative product recently introduced in the market, it is likely 
that personal innovativeness would influence the intention to adopt a healthcare 
device (Lee & Lee 2018). In the present study there is an examination of the 
concept of the integration of technology innovation in a clinical context and the 
associated dynamics, providing a framework for mapping important elements 
(Murray et al. 2010). However, there is no prediction of the engagement rate of 
health professionals to the use these apps in their everyday routine for a long 
period, meaning that an app can be downloaded, used only for a limited period 
and then been uninstalled, if proved not useful/acceptable. Therefore, future 
research can investigate through a concept centric survey targeted to health 
professionals, with panel data, whether the identified features’ correlations can 
influence the long-term adoption of mHealth apps in clinical diagnosis and 
increase the users’ engagement rate, also taking into consideration behavior 
intention. The findings of this research form the basis for an extended future 
investigation of this hot topic with the use of various methodologies. 
Future research could also investigate through surveys and questionnaires whether 
app features that promote trust are positive related to mHealth app adoption by 
professionals. With the assumption that professional apps will probably require a 
particular trust level for their final adoption, many issues concerning the 
trustworthiness must be resolved before their introduction in the market and 
especially with regards to their credible source which is currently present in less 
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than 40% of the examined mHealth apps. For instance, security, reliability and 
usability issues are raised for automated healthcare consultation (Char et al. 2018) 
offered by differential diagnosis apps. For example, app results may be calculated 
based on biased information or incomplete Electronic Health Records (Zulman et 
al. 2016) because of developer’s ignorance or  profit intention. Such results may 
lead to unintentional prejudice or non-usable apps and future research should 
examine this assumption. Moreover, all mHealth apps IT security measures should 
be enforced to create a reliable environment for treating users’ personal 
information. Important here is the role of the legislation, as well as the education 
of health professionals, for demanding and using only trustworthy mHealth apps. 
Advertisements on the other hand, and their existence while downloading or using 
the mobile is a debated matter because most of the times are offered instead of a 
fee for accessing the app.  Therefore, surprisingly this study, does not indicate 
negative relationship between downloads and ads, probably because health 
professionals understand that this is the developer’s funding source who offers it to 
them for free or they see the ads as a source of information about new products on 
their field or they are not aware of their existence before the  download. A 
suggestion on this subject could be that instead of the business model of free or 
freemium apps with revenue collection from ads and promotional material, which 
is currently present in 40-50% of the examined apps, to promote the engagement 
of national health organizations, associations and academic institutions to finance 
or create the app themselves and its essential updates. Else developers can move to 
a structure which offers a free trial period for the professional to appreciate the 
usefulness and usability of the app and then charge a fee for its further use. This 
model will also prompt app providers to offer more attractive and quality apps, so 
as to engage the health professionals. Following this, the MARS score, which is 
currently below satisfactory level (average score of examined apps at 3.9/5), would 
also increase for all clusters. Future research could focus on these matters to test 
whether they hold true.  
Moreover, integration of mHealth apps into the healthcare system may slowly 
evolve over time. mHealth apps can be prescribed by doctors and recommended by 
hospitals or health websites (Research 2 Guidance  2016).All stakeholders must 
cooperate in finding the right ways to increase mHealth apps trustworthiness and 
quality which will hopefully lead to a greater health professionals’ engagement and 
app popularity for actual use in their everyday medical practice. Future research 
is required to evaluate these assumptions. 
 
CONCLUSIONS OF THE TWO PARTS OF THE Ph.D THESIS 
Summarizing the scope and the findings of the Ph.D Thesis, this research 
consists two parts: the first part, in which there is a systematic review of the literature in 
the field of BDA and the second part where there is an investigation of technology 
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innovation in healthcare concentrating in mobile applications addressed to health 
professionals. For that reason, a sampling literature review in the domain has been 
conducted and 804 papers published for the years 2000-2016 have been identified and 
systematically reviewed using content analysis to provide an in depth description of 
BDA elements in health concerning the innovative decision-support systems in the 
field.  
With reference to the resource-based view theory this Doctoral Thesis has 
focused on how big data resources are utilised to create organizational and social values 
and capabilities, discussing the classification of big data types related to healthcare, the 
associate analysis techniques, the created values for the stakeholders and society, the 
platforms and tools for handling big health data and future aspects in the field. It also 
reveals that one of the main values created is the development of analytical techniques 
which provides personalized health services to users and supports human decision-
making using automated algorithms, challenging the power issues in the doctor-patient 
relationship and creating new working conditions.  A main challenge to data analytics is 
data management and security when processing large volumes of sensitive, personal 
health data. Future research is directed towards the development of systems that will 
standardize and secure the process of extracting private healthcare datasets from 
relevant organizations. The results of the study have been presented under a number of 
pragmatic examples to show how the advances in healthcare were made possible. 
The second Part of the Doctoral Thesis reviewed available mHealth apps 
addressed to medical professionals and students for the diagnosis process and explore 
ethical challenges related to their data governance and reliability. It also investigated the 
specific apps’ market which is addressed to medical professionals and students and 
explained how the specific consumers’ behaviour is affected by certain app 
characteristics and attributes. Content analysis has been conducted to the descriptions, 
functions and user’s reviews for 168 smartphone apps which were classified based on 
their type for diagnosis and features with a special discussion on artificial intelligence 
applications. Moderate levels of trustworthiness and quality are observed for the 
existing mHealth apps revealing margins of potential improvement. Development of 
apps from credible sources can increase their trustworthiness and further technological 
advances embedded in these apps can increase their usefulness in order to improve 
mHealth apps’ quality for the benefit of health professionals in their everyday practice 
as well as for improved provision of healthcare for society. An empirical analysis has 
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also been conducted to test the existing relationships between consumer intention and 
quality evaluation of health mobile applications. Therefore, based on the results of this 
study, mHealth apps which receive a higher rating from the users, higher quality 
evaluation and more reviews than others lead to a greater number of downloads staying 
in the line with the findings of many other relevant studies. The more explanatory the 
description of an app in the app store is, the more downloads are expected to have.  
Finally, the findings of both reviews are stimulating and provide valuable 
information to practitioners, policy makers and researchers while presenting them with 
certain paths for future research and implications. They also prove that Health analytics 
and mHealth provide a unique opportunity for advancing health information research 
and medical decision-making. New tools in problem-solving are offering new avenues 
in prognosis and diagnosis of diseases and can benefit health professionals, managers 
and researchers for the forthcoming years that medicine and humanity are facing new 
challenges that require fast solutions. 
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1 Prognosis : Your Diagnosis 
2 InSimu Patient  
3 Diagnose  
4 VisualDx 
5 Differential Diagnosis 
6 Common Differential Diagnosis 
7 FREE Nursing Care Plans and Diagnosis 
8 Nursing Diagnosis and Care Plans FREE  
9 Clinical Medicine Differential Diagnosis  
10 CURRENT Medical Diagnosis and Treatment 2020 
11 Quick Medical Diagnosis & Treatment  
12 Clinical Cases Diagnosis 
13 Differential Diagnosis Mnemonics  
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14 Eye Diagnosis  
15 Medical Differential Diagnosis  
16 Clinical Sense - Improve Your Clinical Skills 
17 MobileDDx - Pocket Differential Diagnosis Tool 
18 Nursing Diagnosis List  
19 Symptom to Diagnosis An Evidence Based Guide  
20 Nursing Diagnosis 
21 Manual of Nursing Diagnosis  
22 USMLE Step1 & 2 CK Differential Diagnosis 
23 Pediatric Disease and Treatment 
24 Diagnosis of Oral Ulceration 
25 Clinicals – History & Physical  
26 Dermion : Differential diagnosis for dermatologist  
27 ECG Cases 
28 Human Dx  
29 All Respiratory Disease and Treatment  
30 CURRENT Diagnosis & Treatment Psychiatry  
31 Nursing Diagnosis Ref Manual - Sparks and Taylor's  
32 All Blood Disease and Treatment A-Z  
33 ECG 100 Clinical Cases  
34 PID Phenotypical Diagnosis  
35 Diagnosaurus DDx 
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